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1. ABBREVIATIONS 
aa  Amino acid 
ABC  ATP-binding cassette 
AJ  Adherens junctions 
α-SMA  α-smooth muscle actin 
Ang-1/-2  Angiopoietin-1/-2 
ARNT  Aryl-hydrocarbon receptor nuclear translocase 
AQP4  Aquaporin-4 
BBB  Blood-brain barrier 
BED  Biotin ethylendiamin  
bFGF  Basic fibroblast growth factor 
bHLH  Basic helix-loop-helix 
BM  Basement membrane 
BMP  Bone morphogenic protein 
CAM  Cell adhesion molecule 
CM  Conditioned medium 
CNS  Central Nervous System 
COX  Cyclooxygenase 
CVO  Circumventricular organs 
DDC  Dystroglycan dystrophin complex 
ECs  Endothelial cells 
ECF  Extracellular fluid 
ECM  Extracellular matrix 
CLUT-1  Glucose transporter-1 
GDNF  Glia derived neurotrophic factor 
HA  Hyaluronic acid 
HACE  High altitude cerebral edema 
HIF-1  Hypoxia inducible factor-1 
HRP  Horseradish peroxidase 
HRE  Hypoxia responsive element 
iBRB  Internal blood-retinal barrier 
ICAM-1  Intercellular adhesion molecule-1 
IgSF-CAM Immunoglobulin super family cellular adhesion molecule 
JAM  Junctional adhesion molecule 
LIF  Leukemia Inhibitory Factor 
MCAO  Middle cerebral artery occlusion 
MMP  Matrix metalloproteinase 
MRP  Multidrug resistant protein 
NPC  Neuronal precursor cell 
NO  Nitric oxide 
NT  Neural tube 
ODD  Oxygen dependant degradation domain 
PDGF  Platelet-derived growth factor 
PECAM-1 Platelet endothelial cell adhesion molecule-1 (CD31) 
P-gp  P-glycoprotein 
PHD  Prolyl-4-hydroxylase domain 
PNVP  Perineural vascular plexus 
pVHL  Van-Hippel Lindau factor 
SPARC  Secreted protein acidic rich in cysteine  
SLC  Solute carrier 
Shh  Sonic hedgehog 
SSeCKS  Src suppressed C-kinase substrate  
SVZ  Subventricular zone 
TAD  Trasnactivation domain 
TEER  Transendothelial electrical resistance 
TGF-β   Transforming growth factor β 
Tie2  Angiopoietin receptor 
TJ  Tight junction 
VEGF  Vascular endothelial growth factor 
VEGFR-1/2 Vascular endothelial growth factor recptor-1/-2 
VSMC  Vascular smooth muscle cell 
Wnt  Wingless/Int  
ZO-1  Zonula occludens-1 
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2. SUMMARY 
The blood-brain barrier (BBB) is a neurovascular unit formed by specialized brain 
endothelial cells (ECs) surrounded by pericytes and astrocytes end-feet processes. The 
blood-brain barrier plays a crucial role in the maintenance of brain homeostasis by 
avoiding fluctuation of neuron extracellular fluid composition but also penetration of 
any harmful substances that might compromise neuron integrity. Despites breakdown 
of the blood-brain barrier is associated with many neurological diseases, efficient 
therapies to fight such barrier disruption are still missing. In addition, current in vitro 
BBB models still suffer from comparison with in vivo situation and thus allow only a 
poor translation of in vitro results to in vivo situation. Two major issues limit current 
in vitro BBB models: absence of astrocytes and/or pericytes in brain EC cultures and 
limitations in intercellular interactions due to an absence of a 3-dimensional structure. 
The aims of this thesis were to elaborate two innovative in vitro BBB models (a 2-and 
3-dimensional models respectively) that consider the presence of both astrocytes and 
pericytes but also that allows adequate cellular interactions. Using these models we 
addressed the respective roles of astrocytes and pericytes on endothelial barrier 
function during physiological conditions and during hypoxia, an important stress 
factor involved in barrier breakdown. 
Our study performed in the 2-dimensional model showed that brain EC barrier 
function was compromised only after prolonged exposure or during severe O2 
deprivation (near-anoxia) insult. Loss of barrier function was associated with 
increased permeability to water-soluble compounds, cellular junctions disruption and 
increased apoptosis by activation of caspase-dependant pathway. In addition we 
observed that both astrocytes and pericytes induced barrier function during normal 
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conditions and play important roles as modulators of the barrier function during O2 
deprivation stress, promoting both EC barrier function and cell survival. 
In addition we observed that pericytes, but not astrocytes, were able to provide decent 
EC protection during severe insult suggesting that astrocytes and pericytes may have 
distinct response to O2 deprivation stress. We showed that VEGF signaling plays an 
important role in induction of barrier breakdown during hypoxic stress, as subsequent 
inhibition of such signaling resulted in enhancement of the barrier function during 
hypoxic stress. 
The second study focused on the characterization of a 3-dimensional BBB model 
based on collagen matrix to study the influence of a 3-dimensional structure on EC 
morphology and its interactions with astrocytes and/or pericytes. We observed that 
EC were able to form tube-like structures. These tubes showed many similarities with 
in vivo capillaries, especially by presence of a lumen within these structures. In 
addition, we observed that presence of astrocytes and pericytes were able to interact 
directly with these tubes by formation of cellular processes similar to in vivo 
observations. Such interactions resulted in modulation of tube morphology but also in 
induction of a BBB phenotype as observed by localization of tight junction complexes 
and localization of ABC transporters in the lumen of these structures.  
Taken together this work provided design of enhanced in vitro BBB models and 
shows the importance to consider the BBB as a neurovascular unit and the importance 
of cellular interactions as astrocytes and pericytes induce BBB phenotype and 
partially maintain the barrier function during hypoxic stress.  
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3. ZUSAMMENFASSUNG 
Die Blut-Hirn-Schranke ist eine neurovaskuläre Einheit, bestehend aus spezialisierten 
cerebralen Endothelzellen, die von Perizyten und den Endfortsätzen der Astrozyten 
umgeben sind. Die Blut-Hirn-Schranke spielt eine wichtige Rolle bei der 
Aufrechterhaltung der Homeostase des Gehirns und verhindert Fluktuationen in der 
Zusammensetzung der extrazellulären Flüssigkeit, welche die Neuronen umgibt. Im 
Weitern verhindert sie, dass für die Neuronen schädliche Substanzen ins Hirn 
gelangen. Obwohl verschiedenste neurologische Krankheiten mit der 
Beeinträchtigung der Blut-Hirn-Schranke verbunden sind, fehlen bisher effiziente 
Therapien, welche die Schranke schützen oder wiederherstellen könnten.  
Die vorhandenen in vitro Modelle entsprechen nur ansatzweise der in vivo Situation, 
was die Interpretation von in vitro Forschungsergebnisse erschwert. Zwei 
Hauptaspekte schränken die aktuellen Blut-Hirn-Schranken-Modelle ein: fehlende 
Astrozyten und/oder Perizyten in cerebralen Endothelzellkulturen und limitierte 
interzelluläre Interaktionen durch die 2-dimensionale Kultur. 
Das Ziel dieser Arbeit war es, zwei innovative in vitro Blut-Hirn-Schranken-Modelle 
zu schaffen, (ein 2-dimensionales und ein 3-dimensionales), die sowohl Astrozyten 
und Perizyten beinhalten als auch adäquate interzelluläre Interaktionen erlauben. Mit 
Hilfe dieser Modelle erforschten wir den Einfluss von Astrozyten bzw. Perizyten auf 
die endotheliale Schrankenfunktion unter physiologischen Bedingungen und während 
Hypoxie, einem bedeutenden Stressfaktor für die Schrankenfunktion. 
Unsere Resultate aus dem 2-dimensionalen Modell zeigten, dass nur langanhaltender 
oder (nahezu) kompletter Sauerstoffmangel die Schrankenfunktion der Endothelzellen 
beeinträchtigt. Der Verlust der Schranke führte zu einer erhöhten Durchlässigkeit für 
wasserlösliche Stoffe, Öffnung der Zell-Zell-Verbindungen und vermehrte Apoptose 
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durch die Aktivierung von caspase-abhängigen Signalwegen. Im Weiteren 
beobachteten wir, dass sowohl Astrozyten als auch Perizyten die Schrankenfunktion 
unter normalen Bedingungen induzierten. Unter Sauerstoffmangel spielten sie eine 
wichtige Rolle als Modulatoren der Schranke indem sie die Funktion und das 
Überleben der Endothelzellen förderten. Zusätzlich hatten Perizyten eine schützende 
Rolle unter erhöhtem Sauerstoffmangel, was darauf hindeutet, dass Astrozyten und 
Perizyten auf unterschiedliche Sauerstoffkonzentrationene verschieden reagieren. 
Wir zeigten, dass der VEGF Signalweg (mit-)verantwortlich ist für die 
Beeinträchtigung der Schrankenfunktion unter Hypoxie, da die pharmakologische 
Hemmung dieses Signalwegs zur Verbesserung der Schranke führte. 
Die zweite Studie fokussierte auf der Charakterisierung des 3-dimensionalen Blut-
Hirn-Schranken-Modells. Dieses Modell basiert auf einer Kollagenmatrix und erlaubt 
die Erforschung der 3-dimensionalen Interaktionen zwischen Endothelzellen, 
Astrozyten und Perizyten. Die 3-dimensionale Struktur erlaubte es den Endothelzellen 
röhrchen-ähnliche Strukturen zu bilden. Diese Röhrchen sind vergleichbar mit in vivo 
Kapillaren und enthalten ein Lumen. Im Weiteren stellten wir fest, dass Astrozyten 
und Perizyten einen direkten Einfluss auf die Bildung dieser Röhrchen hatte, so wie es 
auch in vivo bei der Bildung von Kapillaren beobachtet wurde. Die Interaktionen 
zwischen den verschiedenen Zelltypen beeinflussten die Morphologie der Röhrchen, 
aber auch die Induktion des Blut-Hirn-Schranken-Phenotyps, das heisst, der 
Lokalisierung von Zell-Zell-Verbindungen (tight junction complexes) und ABC-
Transportern im Lumen dieser Strukturen. 
Zusammenfassend beschreibt diese Arbeit die Erschaffung von innovativen, 
erweiterten in vitro Blut-Hirn-Schranken-Modellen und betont die Wichtigkeit, die 
Blut-Hirn-Schranke als neurovaskuläre Einheit zu betrachten. Die interzellulären 
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Interaktionen zwischen Endothelzellen, Astrozyten und Perizyten sind essenziell um 
die Schrankenfunktion zu errichten und unter hypoxischem Stress aufrechtzuerhalten. 
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4. INTRODUCTION 
 
4.1. The blood-brain barrier  
 
4.1.1. Introduction 
The central nervous system (CNS) is a highly specialized multicellular structure 
responsible of the coordination of both cognitive and non-cognitive processes in 
vertebrates. The brain represents the central organ of the CNS. It represents one of the 
densest organs in vertebrates, both by the number of cells (~100 billions neurons in a 
average human brain) and by the number of cellular interactions (one neuron establish 
up to 104 contacts with other neurons by synaptic connections) and thus we may 
consider it as one of the most important organ in vertebrates.  
It is clearly understandable that such organ has an important dependency towards O2 
and nutrients to ensure its proper function, therefore the presence of an efficient O2 
and nutrient supply is definitively required. Such nutrients need is complied by the 
presence of a rich cerebral vascular density, providing an optimal brain tissue 
perfusion. In addition to their important dependency to O2 and nutrients, neuron 
activity is susceptible to variation in the extracellular fluid (ECF) compartment but 
also to presence of any harmful and lethal agents. Thus, in order to protect neurons 
from such insults, vertebrate cerebral vasculature has developed a barrier phenotype 
that impeach any fluctuation in ECF composition and penetration of any agents that 
might compromise neuron integrity. This physical and chemical barrier, formed by a 
neurovascular unit in which cerebral endothelial cells (ECs) plays a pivotal role is 
classically referred as the “blood-brain barrier” (BBB).  
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4.1.2. Historical aspects of the BBB   
The first description of the BBB dates from the end of the 19th century by Paul 
Ehrlich (1854-1915). Ehrlich, a famous bacteriologist and physiologist, had a certain 
attraction concerning the use of chemical stains for observation of histological and 
cellular preparation. His first observation of the barrier was first described in 1885.  
Intravenous injection of Trypan blue, a water-soluble dye, resulted in the absence of 
staining inside the CNS whereas all other organs were stained. However, Ehrlich 
attributed such remarkable feature to low affinity of the CNS tissue towards the dye 
rather than to presence of a physical barrier. In 1900, Lewandowsky investigated 
potassium ferrocyanide penetration into the brain tissue by intravenous injection. Like 
Ehrlich, Lewandowsky observed absence of staining within the CNS. Unexpectedly, 
Lewandowsky attributed his observations to the presence of a barrier between the 
blood and CNS tissue, denominating such barrier “bluthirnschranke”. Edwin 
Goldmann confirmed the concept in 1909 and 1913, by performing two experiments. 
In the first experiment Goldmann, one of Ehrlich’s students, repeated Ehrlichs 
experiment and also noted the absence of staining in the CNS. In the second 
experiment, Goldmann injected directly the dye into the CSF and observed staining of 
the CNS but an absence of dye in other organs. These experiments showed the 
presence of a barrier between the blood and the CNS compartment, but also an 
absence of barrier between the CNS and the CSF. As no other studies showed any 
membranes that might explain such observations, Goldmann attributed the barrier role 
to the cerebral blood vessels. However, the presence of a BBB was still rejected by a 
certain part of the scientific community until the end of the 1960s. In fact, Goldmann 
and colleagues experiments raised controversies. The main controversy was that CSF 
and plasma compositions differ and thus may induce diffusion artifacts. Therefore 
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injection of dyes into the CSF cannot be compared with dyes injected into the 
bloodstream. Another point of controversy concerned the aniline based dyes. Aniline 
has two electrochemical forms: one neutral basic form and one positively charged 
acidic form. The basic form is able to cross the apparent BBB whereas the acidic form 
cannot. Friedemann reviewed such observations in 1942 (Friedemann, 1942). In this 
review, Friedemann reviewed known permeability of various substances and 
concluded ”the ability of substances to pass the capillaries of the C-N-S is determined 
by their electrochemical properties. The cerebral capillaries are permeable to 
substances carrying a positive or no charge at the pH of blood while they are 
impermeable to those carrying a negative charge…the problem is only part of the 
more general problem of capillary permeability…” 
Although this review pinpointed the problem of electrochemical status of certain 
molecules such hypothesis has been since shown to be not strictly true. Further 
hypothesis described the physicochemical nature of the molecules that can cross the 
BBB include molecular weight, size, affinity and dissociation coefficients, 
lipophilicity and electric charges (Tschirgi, 1962). In addition to the apparent 
chemical selectivity of the BBB, anatomical studies that were performed to explain 
the determination of solute diffusion constituted a supplementary step in the 
controversy. Despites the emergence of electron microscope in 1931 by Ernst Ruska 
and Max Knoll would bring crucial informations about cerebral microvessels 
ultrastructure and thus clarify the controversy, the absence of adequate staining 
techniques did not provide experimental arguments advocating the presence of a 
BBB.   
In 1957, Maynard and colleagues (Maynard et al., 1957) suggested that the BBB was 
only a experimental artifact, justifying their argument by the following citation: “The 
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present authors believe that the ‘blood-brain barrier’ may be mainly an illusion. 
Physiologists have been led to postulate its existence on the assumption that there are 
considerable extracellular tissue spaces. Which would be in equilibrium with blood 
plasma if a barrier did not exist. We see, however, that the basic assumption is 
incorrect and these tissue spaces simply do not exist.” Later on, the authors wrote, 
”When the physiologist quantitatively studies the penetration of ions, organic 
crystalloids, proteins, vital dyes, etc. into nervous tissue, he must actually be studying 
the penetration (or lack of it) into the glial nervous cells… Thus, we believe that the 
physiological data available should be re-interpreted on the assumption that nearly 
all substances are within cytoplasmic compartments. Under these circumstances there 
would be no expectation of a simple correlation with their distribution into the blood 
plasma. The commonly accepted laws of permeability, which apply in the brain 
without important exception and without invoking a specialized barrier.”  
However in 1961 Dobbing counteracted such statement. Relying on the previous 
findings of Hodgkin and others, Dobbing argued that the argumentation provided by 
Maynard were in contradiction with the gradient need of electrolytes to support neural 
function. At the same time, Davson and colleagues (Davson and Spaziani, 1959) 
argumented that the hypothesis evocated by Maynard would apply only if diffusion of 
molecules within the cerebral compartment would remain constantly low, even after 
removal of the brain from the cranium.  
Using different water-soluble compounds such as iodide, p-aminohippurate and 
sucrose, Davson showed that it was not the case. Peripheral injection of these 
compounds showed that their penetration occurred at “barely measurable rates by 
contrast with their penetration into skeletal muscle” as expected. However diffusion 
of these molecules into excised brain tissue was comparable to excised skeletal 
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muscle tissue, indicating that the presence of an extracellular space inside the brain 
tissue, diffusion of water-soluble compounds from the blood to the brain were 
therefore limited by the presence of a barrier between the blood vessel and the brain 
tissue. Hoffman and Olszewski (Hoffman and Olszewski, 1961) supported such 
argumentation by injecting fluorescein inside the vascular bed from the area postrema. 
They showed diffusion of fluorescein into the area, but also in the regions surrounding 
the area postrema, demonstrating the presence of an extracellular space and concluded 
that the barrier function is carried by the brain vasculature rather than an absence of 
extracellular space. 
Another point of discord concerned the anatomical location of the BBB. Scientific 
community was split between scientists believing that the barrier function was carried 
by the capillary endothelium itself, whereas other scientist attributed the barrier 
feature to the astrocytic end-feet processes or to the basal lamina. 
Astrocytic end-feet processes have been described as a continuum with the basal 
lamina and thus overlap most of the capillary surface, several observations agreed 
with the hypothesis that astrocytes per se were responsible of the barrier function 
(Gershenfeld et al., 1961).  However, such hypothesis was eliminated by the study of 
Reese and Karnovsky (Reese and Karnovsky, 1967). In this study, using high-
resolution electron microscopy and HRP staining, they showed that intravenously 
injected HRP activity was restricted to the lumen, whereas no trace of HRP activity 
was detectable in the perivascular space. Furthermore, these authors described 
presence of tight contacts at the interendothelial clefts, showing similarities with 
epithelial “tight” junctions. Thus the authors proposed that the capillary lumen 
presents tight junctions that form a continuous, impermeable membrane and therefore 
constitute the corner stone of the BBB. This statement was later confirmed by 
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injection of HRP into the brain tissue that brought the final proof that endothelial cells 
but not astrocytes end-feet processes, mediate the anatomical barrier function 
(Brightman and Reese, 1969). 
 
4.1.3. Development of the BBB 
Formation of the BBB occurs at late embryonic and early post-natal stages. Thus 
formation of the cerebral vasculature fundamentally follows identical developmental 
pattern as the vasculature of other organs. Chick and mouse embryos provided us with 
crucial information on the different cellular stages occurring during vascular 
development in vertebrates. However, further investigations to understand the nature 
of the different genes involved in vertebrate vascular development are limited in such 
models as they represent an important technical challenge. More recently, the 
scientific community raised its interest on zebrafish model, as it constitute a model of 
choice for genetic studies and therefore provided an important quantum leap in our 
understanding of the nature of the genes involved during development of the 
vasculature. This chapter summarizes the formation of the vasculature in vertebrates 
based on different studies performed in zebrafish (Baldessari and Mione, 2008), chick 
and mouse embryos (Flamme et al., 1997; Kurz, 2000; Kurz et al., 1996; Risau, 1997; 
Risau and Flamme, 1995; Risau and Wolburg, 1990). 
Development of vasculature occurs by two major physiological processes:  
- Vasculogenesis: that consists of the formation of a primitive vascular network from 
non-existing vasculature. 
- Angiogenesis: that extends and develops the vascular tree by relying on the pre-
existing vascular network. 
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Vasculogenesis occurs during gastrulation phase (see Fig.1), when the three germ 
layers are formed. Haemangioblasts constitute the first cells of the endothelium 
differentiation lineage. Haemangioblasts are directly derived from migrating cells of 
ventral mesoderm.  
Differentiation of mesodermic cells into haemangioblasts occurs under influence of 
the notochord and endoderm. The notochord secretes Sonic hedgehog (Shh) (Lawson 
et al., 2002) whereas the endoderm secretes vascular endothelial derived growth 
factor (VEGF) (Gale and Yancopoulos, 1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic view of vasculogenesis in vertebrates  
(From (Risau and Flamme, 1995) 
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A certain population of mesodermic cells, mostly located in the ventral mesoderm, 
express VEGF receptor-2 (VEGFR-2, also known as Flk-1/KDR) (Liao et al., 1997) 
and under the influence of VEGF, these cells initiate a migration from the lateral plate 
mesoderm to the notochord, by sliding over the endoderm (Jin et al., 2005). In 
parallel, these VEGFR-2 positive mesodermic cells intitate their differentiation into 
haemangioblasts, such differentiation already occurs in the lateral plate mesoderm. 
Haemangioblasts constitute the common progenitor of both blood cells (e.g. red blood 
cells, leukocytes, platelets…) and endothelial cells (ECs). 
Haemangioblasts that reach the notochord initiate the formation of spherical structures 
comparable to cysts: the blood islands. Haemangioblasts contained within the blood 
islands initiate their differentiation between endothelial cell lineage (angioblasts) and 
hematopoietic cell lineage. Under the influence of bone-morphogenic protein family 
(BMP) (Gupta et al., 2006) and by Wingless/Int (Wnt) (Lindsley et al., 2006) 
gradients, haemangioblasts initiate their differentiation into angioblasts (Feinberg and 
Noden, 1991; Noden, 1989; Noden, 1990) and hematopoietic cells. The 
haemangioblasts that initiated differentiation into angioblasts express different sets of 
EC-specific genes such as friend leukemia integration (fli1), growth differentiation 
factor 5 (gdf5) and endothelium-specific receptor tyrosine kinase (tie1, tie2). In 
addition, angioblasts initiate the secretion of a fibronectin-rich primitive extracellular 
matrix (ECM) essential for further development of the vasculature (Jin et al., 2005). 
In parallel, formation of interconnections between blood islands allows formation of a 
primitive network, classically referred in the literature as vascular cord or primitive 
plexus. The primitive plexus formed by differentiating angioblasts consists of a 
primitive capillary network formed by filled tubular structures. ECs and pericytes 
originate from the mesoderm EC lumen formation is initiated by the formation and 
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the fusion of pinocytic intracellular vacuoles (Bayless et al., 2000; Davis and 
Camarillo, 1996). Recent studies performed by Koh and colleagues (Koh et al., 
2008a; Koh et al., 2008b) demonstrated in vitro the importance of Cdc42 and Rac1 
(two small GTPases involved in cytoskeleton regulation) during lumen formation in 
EC vessel-like structures. 
Besides lumen formation, the primitive plexus extends the vascular network density 
by angiogenesis. Angiogenesis differs from the vasculogenesis by different aspects: it 
requires the presence of a pre-existing vascular network and involves formation of 
hollow tubular structures. Angiogenesis occurs by two different mechanisms: 
sprouting angiogenesis and non-sprouting angiogenesis (Risau, 1997). Non-sprouting 
angiogenesis is defined by formation of new vessels by a split of pre-existing vessels 
(Patan et al., 1996), whereas sprouting angiogenesis forms new vessels by branching 
processes based on pre-existing vessels. Interestingly, sprouting angiogenesis 
constitutes the main mechanisms by which brain angiogenesis occurs. Brain 
angiogenesis is initiated after embryonic day 9.5 (E9.5) in mice. At this embryonic 
stage, the perineural vascular plexus (PNVP) that surrounds the neural tube (NT, 
Fig.2) constitutes the basement for the formation of cerebral vasculature.  
 
 
 
 
 
 
 
 
 
Figure 2: Structure of the neural tube (Source: http://upload.wikimedia.org/wikipedia/commons/8/89/Gray642.png) 
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Formation of cerebral arteries occurs from the medial portion of the PNVP, whereas 
formation of cerebral veins occurs from the lateral portion of the PNVP (Kurz et al., 
1996). The floor-plate and the ependymal layer mediate primitive cerebral artery 
invasion by secretion of two important angiogenic factors: VEGF (Aitkenhead et al., 
1998; Breier et al., 1992; Plate, 1999; Strong, 1961) and angiopoietin-1 (Ang-1) 
(Koblizek et al., 1998; Suri et al., 1998). Interestingly, the guidance of the newly 
formed vascular structures inside the NT relies on similar cues used by the nervous 
system for axonal guidance such as ephrins/EphB (Kuijper et al., 2007) or 
semaphorin/plexin  (Bussolino et al., 2006) signaling pathways. In addition to cue 
signaling molecules, the ECM plays also an important role in the blood vessel 
guidance. The loose mesenchyme and mitogenic fibronectin ECM found in the PNVP 
(Poelmann et al., 1990) greatly contrast with the densely populated NT, in which 
hyaluronic acid constitutes the main ECM component (Turley et al., 1994). Such 
dramatic changes in the ECM composition results in a decreased EC proliferation rate 
compared to other developing vasculature, despite the persistence of VEGFR-2 
expression in EC and the intense VEGF secretion by the neural tube (Plate, 1999). In 
addition brain EC must face another important challenge, the attachment to the 
ependymal layer. 
Interestingly, the ependymocyte and cerebral EC do not show any common adhesion 
molecules and therefore need to find a method to form cell-cell contacts. A 
mechanism hypothesized by Kurz (Kurz, 2000) may explain how ECs and 
ependymocytes are able to interact without using any adhesion molecules. Kurz 
suggests that ECs migrate between the neuroblasts and the radial glia by formation of 
filipodia (Fig.3), reaching the ependymal neuroblasts and anchors to them by 
formation of TJ strands. Tip cells that successfully anchored the ependymal layer 
 20  
serve as a “pillar” for surrounding EC filipodia and lead to the formation of a vascular 
cord and lumen formation. Once the cerebral vascular tree is formed and stabilized, 
formation of the BBB can occur.  
 
 
 
 
 
 
 
 
 
 
Figure 3: Brain EC migration during cerebral angiogenesis (From Engelhardt, 2003) 
 
However, the question addressing the presence of a BBB or not during embryonic 
stages is still debated. Since Wislocki’s experiments (Wislocki, 1920) performed on 
immature animals, investigations of the presence of a BBB during embryonic 
development continue to rely on extravasation of century-old markers such as Trypan 
Blue, Evans Blue or HRP. In fact, use of such techniques might constitute a major 
stress for fragile immature brain vasculature and therefore might result in the apparent 
leakiness of the vasculature (Saunders et al., 2000).  
More recently, Ek and colleagues (Ek et al., 2006) proposed an alternative technique 
to assess vascular permeability in immature mammals that induce less damage to the 
vascular structures by using biotin ethylendiamin (BED), a small water-soluble 
organic molecule (molecular weight: 286 Da). Ek and colleagues demonstrated that 
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Opossum (Monodelphis domestica) brain vasculature was impermeable to BED, 
suggesting that brain ECs in the forming vasculature already display a vascular 
phenotype. However, such study needs to be carefully extrapolated. In this study, Ek 
and colleagues used Opossum, a marsupial mammal at post-natal day 5 (P5). It is well 
known that rodents show already a mature BBB at P5 (Butt et al., 1990; Senjo et al., 
1986). The question that can be therefore addressed in such a study is how 
comparable is a P5 opossum compared to a P5 rodent? Therefore additional studies 
using the same technique should be conducted on rodent embryos in order to provide 
a clear statement on the presence or not of a BBB in mammals during development. In 
parallel to such studies that are mainly focused on the assessment of barrier function 
during development, other investigators rather focused on expression of tight 
junctions protein, another marker of the BBB phenotype in adults. Virgintino and 
colleagues (Virgintino et al., 2004) investigated occludin and claudin-5 expression 
and localization during human gestation. They described positive staining against 
both occluding and claudin-5 in 12 weeks-old fetal brain microvessels. However, the 
staining for both proteins appeared diffuse within the cytoplasm, suggesting that at 
this gestational time period, brain EC were not able to form a cohesive barrier. 
However, in 14-weeks-old fetuses, occludin and claudin-5 staining shifted from the 
cytoplasm to the cell borders, suggesting that brain ECs started formation of a barrier 
phenotype. 
The debate generated by the question on the presence or not of a BBB during 
development reflects our limitation on the techniques available so far to address such 
questions. In one hand we have in vivo models that might give us useful information 
but limited by usage of century-old permeability assays. In the other hand, we do not 
have yet any suitable in vitro model that reproduce simultaneously brain angiogenesis 
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and cellular interactions as they occurs during development. Therefore usage of other 
animal models or innovative cell culture techniques is definitively required to provide 
a definite answer to such questions. 
 
4.1.4.The blood-brain barrier: a neurovascular unit 
The BBB (Fig. 4) is a neurovascular unit formed by specialized EC delimitating the 
blood compartment from the cerebral tissue. The basement membrane (BM) that lines 
the EC allows induction of cell polarity by formation of luminal and abluminal sides. 
The luminal side (apical side) of the endothelium is directly in contact with the 
circulating blood flow, whereas the abluminal side (basolateral side) directly faces the 
BM. Pericytes constitutes the unique cell type that makes direct contact with EC, 
facing directly the EC and sharing the inner side of the BM. In addition to EC and 
pericytes, the perivascular cells constitute the third cell type located in the inner side 
of the BM. It is located between the pericytes and the inner face of the BM.  
On the outer side of the BM, astrocytes, a cell type that belongs to the glia, indirectly 
interact with EC through formation of astrocytic end-feet processes over the 
vasculature. Neurons constitute the last member of the neurovascular unit. Despites 
the presence of axon terminal branches close to the EC, the possible involvement of 
neurons in the BBB remains debateful. The role of different cell types within the 
neurovascular results in the presence of complex cellular interactions, the feature of 
each cell type and its respective interaction with the EC will be subject to more 
detailled discussion in the following chapters. 
Interestingly, the presence of a BBB does not prevail in all cerebral blood vessels. 
Song and Patscher (Song and Pachter, 2003) observed that the highest expression of 
various BBB markers (i.e. transferrin receptor (TfR), P-glycoprotein (P-gp), glucose 
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transporter-1 (GLUT-1)) occurs in small caliber cerebral blood vessels (<40µm) 
including microvessels, arterioles and venules, suggesting that the BBB phenotype 
may be carried on by brain EC located in microvessels.     
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Schematic representation of the BBB (From (Francis et al., 2003) 
 
4.1.5. The brain EC 
Brain ECs constitute the corner stone of the neurovascular unit, as it is responsible for 
the barrier function. Brain ECs differ from other ECs by the presence of the BBB 
phenotype. The BBB phenotype is based on the presence of different features: 
- Tight junction complexes that allow brain ECs to act as a selective filter against 
diffusion of small water-soluble compounds. 
- Low vesicle-associated transcytosis that considerably limits the exchange between 
the compartment either by pinocytosis or by receptor-mediated transcytosis. 
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- Solute carriers and ABC transporters that provide an important restriction in 
amino acids and glucose diffusion from the blood to the brain tissue, but also limit the 
penetration of lipophilic drugs. 
 
a) EC cell-cell contacts: 
EC cell-cell contacts play an important role for the cohesion of the vascular tissue, but 
also to ensure the barrier function. The contacts are formed by interactions of 
transmembrane proteins through their extracellular domains. These transmembrane 
proteins are anchored to the actin cytoskeleton by presence of cytosolic proteins that 
play the role of coupling between the transmembrane protein and the actin 
cytoskeleton respectively.  
Cell-cell contacts are divided into two major types distinguished by the nature of 
proteins involved, the adherens junction (AJ) and tight junction (TJ) proteins.  
AJ are present in all EC. The primary role of AJ is to maintain cohesion of the 
vasculature during physical stress (i.e. shear stress), but also be physical barrier 
against circulating blood cells and proteins (Brown and Davis, 2002; Corada et al., 
2001; Corada et al., 1999). The second role of the AJ is to regulate EC proliferation 
during vascular growth by inducing contact inhibition. The third role of AJ in EC is to 
initiate cell polarity by the delimitation on a luminal and abluminal domains in the 
plasma membrane. AJ are divided two superfamilies: The cadherin superfamily and 
the immunoglobulin superfamily cellular adhesion molecules (IgSF-CAM). 
 
The cadherin superfamily consists of a variety of transmembrane proteins that 
requires presence of Ca2+ ion to ensure their function. Members of the cadherin 
superfamily include cadherins, protocadherins, desmogleins and desmocollins.  
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Cadherins (Fig.5) contain an extracellular domain containing an extracellular Ca2+ 
binding domain and interact with other cadherins through homophilic interactions. 
Until now, 18 different family members have been described in humans (Hill et al., 
2001). ECs possess a specific cadherin, the vascular endothelial (VE)-cadherin (Breier 
et al., 1996), but express also isoforms found in other tissues, such as epithelial  
(E-cadherin) and neuronal (N-cadherin) cadherin isoforms (Abbruscato and Davis, 
1999; Gerhardt et al., 1999). 
 
 
 
 
 
 
 
 
 
Figure 5: Schematic representation of cadherin structure 
(Source: http://calcium.uhnres.utoronto.ca/cadherin/images/pub_pages/general/regulation.jpg) 
 
In the BBB, VE-cadherin mRNA and protein levels are remarkably low compared to 
other vasculature during embryonic development and it is even further reduced during 
the adulthood (Breier et al., 1996), suggesting that VE-cadherin role in the BBB 
phenotype is minimal. However, a possible compensatory effect between the different 
cadherin isoforms has not been demonstrated yet and still needs to be addressed. 
Recently, Williams and colleagues (Williams et al., 2005) described the expression of 
a novel kind of cadherin in brain microvessels, the cadherin-10. Interestingly, 
cadherin-10 expression was found in “BBB” microvessels, but was absent in the 
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vasculature found around the circum ventricular organs (CVO), a vascular territory 
marked by the absence of barrier phenotype in EC. In this region, ependymal cells, 
the epithelium that delimits the choroid plexus, plays the role of barrier. Interestingly, 
these ependymal cells also expressed cadherin-10 at the cell borders. This study raises 
therefore the possible direct or indirect roles of cadherins in the BBB phenotype. 
The IgSF CAMs constitute the second member of the CAM superfamily. EC express 
three different members of the IgSF CAMs: intercellular CAM-1 (ICAM-1), vascular 
CAM-1 (VCAM-1) and platelet-endothelial CAM-1 (PECAM-1). ICAM-1 and 
VCAM-1 functions are classically associated with EC-leukocyte interactions and 
therefore with neuroinflammation (Greenwood et al., 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Schematic representation of PECAM-1 
 (From (Ilan and Madri, 2003)) 
 
PECAM-1 (Fig.6) expression is widely distributed on ECs but also found in 
leukocytes, including monocytes, granulocytes and lymphocytes population (Albelda 
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et al., 1990; Muller et al., 1989; Ohto et al., 1985; Stockinger et al., 1990). PECAM-1 
may have two major functions: maintenance of EC cell-cell contacts, but also ensures 
EC-leukocyte interactions. Interestingly, PECAM-1 and ICAM-1 levels in brain EC 
are rapidly down-regulated to minimal levels during post-natal stages in developing 
mice (Lossinsky and Wisniewski, 1998; Lossinsky et al., 1997) and therefore suggest 
that these proteins might not play a role in the barrier function at the BBB. However, 
since these molecules are involved in EC-leukocyte interactions, we can speculate that 
down-regulation of these proteins might be tightly involved in the CNS immune 
privilege phenomenon (for review see (Carson et al., 2006)). Subsequent alteration in 
either protein expression levels or activation might suggest their possible implication 
in neuroinflammatory diseases.  
The role of PECAM-1 in the BBB came out from a study performed on PECAM-1 
knock-out (KO) mice subjected to experimental autoimmune encephalomyelitis 
(EAE) (Graesser et al., 2002), a mouse model of multiple sclerosis, a 
neuroinflammatory disease. In this study, Graesser and colleagues observed that 
PECAM-1 KO animals presented an early onset of the clinical symptoms EAE 
compared to wild-type animals, but also presented increased leukocytes infiltration 
and increased paracellular permeability to Evans Blue dye. These results suggest that 
PECAM-1 may acts as an inhibitor of leukocyte infiltration, such inhibition may 
occurs by modulation of ICAM-1 signaling by PECAM-1 (Couty et al., 2007). We 
can therefore imagine that PECAM-1 may have a positive role during 
neuroinflammation. However other investigations rather suggest that PECAM-1 up-
regulation may occurs in neuroinflammatory disease and other neurological diseases 
(Kalinowska and Losy, 2006; Schnell et al., 1999). Apart from the contradictory 
results obtained with PECAM-1 studies, we can speculate that inhibition of IgSF-
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CAMs activity or their signaling at the BBB might constitute a source of investigation 
to counteract neuroinflammatory disorders.  
Cadherins and IgSF-CAMs superfamilies interact with the cytoskeleton by a variety 
of proteins that allows coupling between the CAMs and the actin cytoskeleton. β-
catenin constitutes a common coupling protein for both cadherins and for PECAM-1. 
In addition to its role in the cytoskeleton, β-catenin acts as a signal transducer in the 
Wnt signaling pathway (Kuhl and Wedlich, 1997). Wnt/β-catenin signaling plays an 
important role in vascular development by promoting angiogenesis (Goodwin and 
D'Amore, 2002) and more recently in a study performed by Liebner and colleagues 
(Liebner et al., 2008), in the maturation of the BBB during development by inducing 
expression of claudin-3, a protein involved in TJ complex. This study raises the 
hypothesis of a possible link between and AJ and TJ complexes, and thus an indirect 
contribution of AJ to the BBB phenotype. 
 
On the other side of cell-cell contacts, TJ constitute the most important and thus the 
most studied cell junctions of the BBB as they represent the molecular structure 
responsible for the barrier phenotype in brain EC (Schneeberger and Lynch, 1992; 
Schneeberger and Lynch, 2004). In contrast to AJ, TJ proteins are divided into three 
major families: occludin, claudins and JAMs. TJ proteins show the presence of 
several transmembrane domains (with the exception of junctional adhesion molecules 
(JAMs) that share similarities in their structures with the CAM superfamilies).  
Occludin (Fig.7) constitutes the unique member of the occludin family and the first TJ 
protein discovered in epithelial and endothelial TJ complexes (Furuse et al., 1993). It 
has a molecular weight (MW) of 65 kDa (504 amino acids (aa)) and possesses four 
transmembrane domains with two extracellular loops and two intracellular domains. 
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The N-terminal intracellular domain (149 aa) is associated with the barrier function as 
the truncated form results in loss of TJ complexes (Bamforth et al., 1999). Such 
deleterious effect suggests that N-terminal domain may be involved in the clustering 
of occludin with other TJ proteins to form the TJ complex. 
 
 
 
 
 
 
 
 
Figure 7: Schematic representation of occludin 
 (From Feldman et al., 2005) 
 
The C-terminal intracellular domain (254 aa) is involved in the interaction with the 
actin cytoskeleton, but also in the TJ complex assembly (Chen et al., 1997). 
Interactions between occludin are achieved by homophilic interactions via their 
extracellular domains. Interestingly, Bazzoni and colleagues (Bazzoni et al., 2000) 
demonstrated that occludin and JAMs form clusters in the TJ complex, suggesting 
presence of occludin-JAM oligomeric complex in the TJ strands. Notably occludin 
expression is high in the BBB and very low in non-BBB vasculature (Hirase et al., 
1997). In addition, occludin expression increase during rat brain development. 
Occludin appears to be weakly expressed in P8 rats and constantly increase its 
expression levels during development (Hirase et al., 1997). These studies reflect that 
occludin constitutes an important TJ protein involved in the BBB. Surprisingly, 
generation of occludin KO animals by Saitou and colleagues (Saitou et al., 2000) 
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resulted in the absence of TJ-associated epithelial and endothelial barrier leakage, 
these animals were viable and fertile. It is important to notice that although this study 
did not investigate the barrier function in the BBB, the authors have observed a 
calcification of the brain, with important calcium mineral deposits around the cerebral 
vasculature, suggesting that occludin barrier function may be associated with selective 
ion permeability. This study also shows that occludin is not the sole TJ protein to 
mediate the barrier function and likely other proteins may be involved in the 
formation of the BBB.  
Claudins (Fig.8) constitute the second protein family involved in TJ (Furuse et al., 
1998; Krause et al., 2008). Claudin family comprises 24 different members divided 
into classic and non-classic claudins according to their degree of similarity.  
 
   
 
 
 
 
 
Figure 8: Schematic representation of claudin 
 (From Krause et al., 2008) 
 
Brain EC expresses four different claudins: claudin-1 (Liebner et al., 2000), claudin-3 
(Wolburg et al., 2003), claudin-5 (Morita et al., 1999; Nitta et al., 2003) and claudin-
12 (Nitta et al., 2003).  Remarkably, claudin-5 expression is restricted to brain EC and 
thus constitutes a classical marker of BBB phenotype. Claudins constitute smaller 
molecules than occludin, with an average molecular weight between 20-27 kDa (180-
245 aa), but share the same structures. Claudins form a four-transmembrane protein 
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with 2 extracellular loops and 2 intracellular domains. N-terminal intracellular domain 
constitutes the shortest domain present in mammalian claudins (~7 aa) and no 
function has been associated yet. The C-terminal intracellular domain (25-55 aa) 
constitutes the interaction domain with the actin cytoskeleton through coupling with 
ZO-1. As occludin, claudins interact with the same claudin members by homophilic 
interactions through their extracellular loops (Furuse et al., 1999). The function of 
claudins in the barrier function has been obtained by generating KO animals; claudin-
5 deletion study by Nitta and colleagues (Nitta et al., 2003) raised most curiosity on 
the roles of claudins in the BBB phenotype. Interestingly, KO animals were not 
embryonic lethal and showed normal morphology after birth. However, these animals 
rapidly died few hours after birth. Surprisingly, microscopic analyses of claudin-5 
deficient brain vessels did not show any differences in TJ complexes, but also no 
changes in other claudins such as claudin-12, suggesting that TJ complexes were still 
present. However, permeability assays provided more information and showed clear 
differences between wildtype (wt) and KO mice. Using a perfusion mixture of 
rhodamine-dextran (10 kDa), microperoxidase (1.9 kDa) and Hoechst 33258 (562 
Da), Nitta and colleagues showed that brain frozen-sections obtained in wt animals 
were not stained with any of the markers used. However, claudin-5 KO animals were 
positively stained against the Hoechst staining (562 Da), suggesting that the BBB in 
these animal was compromised compared to the wt, but also that BBB leakiness 
occurs for size-specific molecules. These results suggest that claudin-5 and probably 
other claudins define a size-selectivity of the TJ complexes that form the BBB, but 
also may occur in other barriers. Furthermore it is not a single TJ molecule that 
induces the barrier phenotype, but rather the accumulation of different TJ proteins. 
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JAMs (Fig.9) constitute the third TJ protein involved in the BBB (Orlova and 
Chavakis, 2007; Weber et al., 2007). Interestingly, JAMs do not share the occludin 
and claudin structures, but present a structure comparable to the proteins of the 
immunoglobulin-like superfamily. The JAM family present three different members: 
JAM-A, JAM-B and JAM–C. JAM extracellular portion consists of two Ig-like 
domains, with one transmembrane domain and a small cytoplasmic C-terminus tail 
that allow interactions with the actin cytoskeleton through ZO-1. 
 
 
 
 
 
 
 
Figure 9: Schematic representation of JAM (From (Weber et al., 2007) 
 
Expression of these three different isoforms has been described in EC. Notably JAM-
B was highly expressed in venules. As described for occludin and claudins, JAMs 
interactions occur by homophilic interactions.  Interestingly, down-regulation of 
JAM-A activity by soluble JAM-A (Ostermann et al., 2005) resulted in increased 
permeability. Conversingly, JAM-C inhibition by soluble JAM-C (Orlova et al., 2006) 
resulted in decreased permeability, suggesting that JAM-A and JAM-C play 
antagonistic roles in EC regulation of paracellular permeability. Unlike occludin and 
claudin-5, no exhaustive studies performed on JAM KO animals have been performed 
yet, thus the roles of JAMs in the BBB remain unclear. However, some studies have 
shown that JAM-A down-regulation is associated with BBB breakdown (Yeung et al., 
2008), whereas abnormal increased JAM-A expression has been reported in the 
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cerebral vessels of multiple sclerosis patients (Padden et al., 2007). These studies 
suggest that JAMs may contribute in the BBB phenotype, but also may play important 
roles in neuroinflammatory diseases.  
As observed with β-catenin and the AJ proteins, TJ proteins share the same adapter 
proteins in order to interact with the actin cytoskeleton. ZO-1, an important member 
of the ZO family, seems to allow interactions between occludin, claudins and JAMs 
and actin cytoskeleton. Thus, the strategic position occupied by ZO-1 suggests an 
important role for this protein in terms of regulation of the barrier function.  
For example, it has been shown that ZO-1 phosphorylation impairs barrier function 
and results in increased permeability in various barriers (Howarth et al., 1994; Singer 
et al., 1994; Stevenson et al., 1989) including the BBB (Antonetti et al., 1999; Fischer 
et al., 2002; Wong, 1997). Therefore, ZO-1 plays not only important roles in the 
function of the BBB but also is involved in BBB breakdown. Another remarkable 
feature that ZO-1 shares with β-catenin is nuclear translocation and it may act as a 
transcription factor (Gottardi et al., 1996). Unlike β-catenin in which the signaling 
pathway and target genes have been clearly identified, the possible mechanism and 
genes regulated by ZO-1 remains completely unknown. Therefore the role of ZO-1 
nuclear translocation in the BBB remains largely hypothetical and speculative.    
 
b) Solute carriers and transporters 
As described before, the BBB acts as a formidable barrier against diffusion of water-
soluble compounds from the blood compartment to the cerebral tissue. In addition to 
the physical barrier formed by the TJ complexes, the BBB acts as a metabolic barrier 
towards water- and lipid-soluble molecules. In order to play such a role the BBB has 
developed an array of different features. Firstly, brain ECs display a very low 
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pinocytic activity, resulting in a very low exchange between the plasmatic 
compartment and the ECF, contribute to the maintenance of a constant ECF 
composition. The second feature performed by the BBB is the presence of different 
solute carriers (SLC) that allow the transport of different water-soluble compounds 
necessary for proper neuron activity such as amino acids, glucose or lactate, but also 
the recycling and the purge of the neurotransmitter metabolites, contributes therefore 
to the CNS homeostasis. The third major feature allows the BBB to act as a barrier to 
lipophilic molecules, by expression of an array of ATP-binding cassettes (ABC) 
efflux transporters both at the luminal and abluminal sides (Soontornmalai et al., 
2006). These transporters ensure an important limitation of lipid-soluble toxins 
diffusion from the blood to the brain compartment, thus protecting the neurons from 
any harmful substances. However, an important number of drugs including 
neuroprotective drugs are substrates for different ABC transporters. Therefore their 
penetration inside the CNS is largely compromised, resulting in a penetration of only 
a fraction of the plasmatic dose. Thus drug delivery to the CNS tissue constitutes an 
important challenge in elaboration of novel therapies targeting the CNS (Neuwelt et 
al., 2008) and requires us a better understanding of the BBB transporters physiology 
in order to optimize their delivery in the brain. 
 
4.1.6. Astrocytes and the BBB: roles of the glio-vascular interactions 
Glial cells constitute the second important cell type present in animal nervous system 
after neurons. Interestingly, glial cells and neurons share the same common 
neuroepithelial progenitor cells, although respective morphology and function of these 
two cell types differ during development. Glial cells are classically divided into two 
major families: macroglia and microglia. Astrocytes constitute a major member of the 
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macroglia family. For decades astrocytes were simply considered as “brain glue” 
cells, their roles in the CNS were thought to be strictly limited to the maintenance of 
the cerebral cytoarchitecture and neuron microenvironment. In addition, as astrocytes 
are unable to produce action potential and thus are not considered as excitable cells, 
they were thought not to be able to convey any signals inside the brain. It is only 
recently that our vision of astrocytes changed. Recent studies mostly performed by 
Volterra and colleagues (Bezzi et al., 2001; Bezzi and Volterra, 2001; Volterra and 
Meldolesi, 2005) revealed presence of glutamate receptors but also presence of 
secretion machinery in the astrocytes, showing presence of vesicles comparable to the 
ones found in neurons. These studies suggest that astrocytes may respond to synaptic 
activity, act as signal transducer and release glial transmitters or “gliotransmitters” 
towards neurons and other glial cells and ultimately regulate activity of both. 
However, such hypothesis remains mostly speculation and therefore more 
investigation need to be performed to understand the relevance of gliotransmitters in 
astrocyte-neuron interactions. 
Interactions between astrocytes and ECs constitute the most studied cellular 
interactions of the neurovascular unit. The different microscopical studies performed 
by Brightman and Reese (Brightman and Reese, 1969) and Kacem and colleagues 
(Kacem et al., 1998) provided us important information concerning these important 
interactions. Certain astrocyte populations, classically referred in the literature as the 
perivascular astrocytes, invest the cerebral microvasculature by establishment of 
astrocytic “end feet processes” (Fig.10). The onset of astrocyte-endothelial 
interactions during development differs between human and rodents. Whereas 
astrocyte-endothelial interactions already occur in human brain vasculature during the 
12th-18th gestation week (Bertossi et al., 1999; Virgintino et al., 1998), they appear in 
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brain rodents during post-natal stages as suggested by Zerlin and Goodmann (Zerlin 
and Goldman, 1997), when gliogenesis occurs. 
 
 
  
 
 
 
 
 
Figure 10: Schematic representation of astrocytic end-feet process 
 (From (Kacem et al., 1998)) 
 
 
The authors described that astrocyte-endothelial interactions were initiated between 
blood vessels and immature progenitor cells originated from the sub-ventricular zone 
(SVZ) during the first post-natal day. Under the influence of the microenvironment 
nearby the blood vessels, but also by the influence of paracrine factors secreted by 
ECs, the migrating SVZ progenitors cells that contacted the blood vessels begin their 
differentiation into perivascular astrocytes. In parallel, these differentiating astrocytes 
increase their interactions with the blood vessels, by increasing the number of end-
feet processes formed but also by increasing the average end-feet surface overlap over 
the vasculature. 
Astrocytic end-feet processes invest the vascular structure by direct apposition on the 
BM, forming a dense and complex rosette-like structure (Fig.10) according to the 
description performed by Kacem and colleagues (Kacem et al., 1998). One end-feet 
process may contact different EC locally by the rosette-like structure but also contacts 
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distal ECs by formation of different end-feet processes. On the other hand, different 
end-feet processes can contact a single EC. Notably, it is important to remember that 
astrocytes end-feet do not directly anchor to ECs, the BM that delimit the vasculature 
impeaching direct physical interactions, suggesting that endothelial-astrocyte cross-
talk occurs mostly by secretion of paracrine factors. Astrocyte end-feet interactions 
with the BM form a highly organized structure (Amiry-Moghaddam and Ottersen, 
2003; Wolburg et al., 2008), sharing many morphological similarities with the 
neuromuscular junction (Fig 11).  
As the neuromuscular junction, astrocyte end-feet process interacts with the basal 
lamina by formation of a dystrophin/dystroglycan complex (DDC) that allows direct 
interactions between the astrocyte end-feet process with laminin and agrin included 
within the BM. Formation of such astrocyte junctions with the basal membrane 
reflects that astrocyte end-feet processes may form stable static structures over the 
vasculature and the maintenance of such structures might play important roles in 
astrocytes differentiation but also for the maturation and the maintenance of the BBB. 
In addition, these end-feet processes lead to formation of specialized micro domains 
on the astrocytes cell surface, restricting the localization of certain proteins at the end-
feet processes. Aquaporin-4 (AQP4) constitutes one of these proteins restricted to the 
end-feet processes (Badaut et al., 2007). AQP4 is a water channel protein formed by 
six transmembrane domains with N- and C-terminal intracellular domains. 
Interestingly, AQP4 expression in astrocytes is restricted in the astrocytic synaptic 
and astrocytic end-feet processes (Badaut et al., 2000a; Badaut et al., 2000b; Nielsen 
et al., 1997). Like other AQPs, AQP4 is involved in regulation of water movements 
between the intracellular and extracellular compartments and therefore plays a crucial 
role in the maintenance of the brain tissue osmotic pressure. In addition to regulation 
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of the osmotic pressure in the extracellular compartment, AQP4 plays a role in cell 
adhesion between astrocytes and the other cell types of the neurovascular unit 
(Guadagno and Moukhles, 2004; Warth et al., 2004), however the role of AQP4 as a 
cell adhesion molecule on the endothelial barrier function remains unclear and 
requires further investigations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Schematic representation of the dystrophin/dystroglycan complex located in astrocyte end-feet process 
(From(Amiry-Moghaddam and Ottersen, 2003) 
 
Interestingly, increased AQP4 expression levels occur in different neurological 
pathologies involving cerebral edema formation such as brain trauma (Sun et al., 
2003a) or cerebral ischemia (Kaur et al., 2006; Ribeiro Mde et al., 2006). In addition, 
brain edema volume was lower in AQP4 KO-mice compared to wild type after an 
ischemic insult (Manley et al., 2000), suggesting that AQP4 induction during 
pathological state may overload water transport across the BBB, resulting in cerebral 
edema formation. However a study performed by Papadopoulos and colleagues 
(Papadopoulos et al., 2004) suggests that AQP4 rather has a protective role during 
cerebral edema by clearing water from the brain the blood compartment. Therefore 
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the contribution of AQP4 during edema formation remains debateful and requires 
further investigations.    
Apart from the physical closeness between astrocyte end-feet process and the ECs, 
secretion and release of factors by both cells constitute the second remarkable feature 
of such interface. The existence of soluble factors released by astrocytes towards ECs 
in order to induce BBB phenotype has not been extensively studied yet. Most of the 
studies have been performed in vitro using astrocyte-EC co-cultures. However, the 
first study that demonstrate the induction of BBB phenotype by astrocytes was 
performed in vivo by Senjo and colleagues (Senjo et al., 1986). In this study, a 
correlation between the increase of glutathione-S-transferase activity, an astrocyte 
specific marker, and decreased permeability in rat embryos during embryonic and 
post-natal development was demonstrated. This study suggested that maturation of the 
barrier phenotype in the BBB was correlated with astrocyte differentiation. Later on, 
Janzer and Raff (Janzer and Raff, 1987) described a similar phenomenon using chick 
embryos. In this study, Janzer and Raff implanted rat primary astrocytes cultures over 
the allantoidal vasculature of chick embryos. They showed that presence of astrocytes 
significantly decreased allantoidal vascular permeability compared to the control 
group. Again, this study suggested that astrocytes might be necessary to induce barrier 
phenotype in EC. However, these in vivo studies were performed in immature 
organisms and therefore the induction of barrier function might be due to other 
differentiating cells. Therefore in vivo models based on differentiating embryos might 
not constitute adequate models to address the specific roles of astrocytes in barrier 
phenotype induction.     
Generally, in vitro models constitute the major model of choice for deciphering the 
roles of astrocytes in the induction of barrier function. Arthur and colleagues 
 40  
performed the first in vitro study (Arthur et al., 1987) based on astrocyte-endothelial 
co-cultures. In this study, the investigators showed that astrocyte-conditioned medium 
(CM) was able to restore ZO-1 localization in prolonged primary brain EC cultures 
that had lost adequate ZO-1 localization, suggesting that astrocytes constitutively 
release a soluble factor that induces barrier properties in brain EC. Further in vitro 
experiments performed by Tao-Cheng and colleagues (Tao-Cheng et al., 1987) 
showed that astrocytes-EC mixed co-cultures or astrocytes CM induced TJ complexes 
in vitro, showing a significant increase in the TJ length and width but also a decrease 
in gap junctions. Later on, Rauh and colleagues (Rauh et al., 1992) showed similar 
effects of direct astrocyte co-cultures on the restoration of BBB phenotype in primary 
brain EC. However, these studies need to be criticized as they established their 
statement on changes in structures but did not provide any evidence of changes in the 
barrier function. Therefore, the study performed by Dehouck and colleagues 
(Dehouck et al., 1990) constitutes the seminal work that defined actual in vitro BBB 
models. More details about such in vitro models will be discussed in a later section 
(see section 4.2.2.) 
Different molecules have shown to up-regulate barrier function in brain EC. Growths 
factors such as basic fibroblast growth factor (bFGF/FGF-2) (el Hafny et al., 1996) or 
glial cell-derived neurotrophic factor (GDNF) (Igarashi et al., 1999) have been shown 
to induce barrier function in brain ECs. Garcia and colleagues (Garcia et al., 2004) 
recently showed that astrocyte contacts were necessary to significantly increase TEER 
in co-cultures and such contacts were required to induce transforming growth factor-β 
(TGF-β) production, providing direct evidence of an inducible factor released by 
astrocytes towards ECs. Another important factor that has been associated with 
increased barrier function is Ang-1. Ang-1 release in astrocytes is under control of 
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src-suppressed C-kinase substrate (SSeCKS), a protein kinase C substrate (Lee et al., 
2003). Although the description of a signaling cascade that activates SSeCKS and 
ultimately results in release of Ang-1 is still missing, recent evidence of Ang-1 up-
regulation at mRNA and protein levels by dexamethasone has been described in 
astrocytes (Kim et al., 2008), suggesting that glucocorticoids activate a signaling 
pathway resulting in astrocytes Ang-1 secretion. 
This section provided a detailed description of very limited astrocyte-derived secreted 
factors and should not exclude the probability that a number of other factors involved 
in barrier induction may be involved. Although the identification of such factors is 
constantly requested by the scientific community (Haseloff et al., 2005), it appears 
clearly that current in vitro models cannot answer such request yet. Therefore the 
design of more sophisticated in vitro co-culture models is definitively required in 
order to achieve an identification of these unknown astrocyte-derived factors. 
 
4.1.7. Pericyte-EC interactions in the BBB 
Pericytes constitute the third type of cell involved in the BBB. They were firstly 
discovered by Rouget in 1873 (Rouget, 1873), followed by a detailed description by 
Zimmermann (Zimmermann, 1923) and attributed the name of “pericytes”. From the 
different cell types constituting the BBB, pericytes represent the most mysterious and 
therefore the most fascinating one. Pericytes share many similarities with vascular 
smooth muscle cells (VSMC) and thus they are classically assumed to share similar 
embryonic cell lineage. Pericytes are present in all capillaries, including fenestrated 
and non-fenestrated ones. Like the other cell types that form the neurovascular unit, 
pericytes share the same BM than brain ECs. However the BM layer between ECs 
and pericytes is fenestrated, allowing ECs to invest pericytes with invagination 
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processes usually referred in the literature as “peg-socket interactions” (Rucker et al., 
2000). These interactions are constituted by AJ, TJ and gap junction complexes 
(Cuevas et al., 1984; Gerhardt and Betsholtz, 2003; Gerhardt et al., 1999). Such 
closeness between pericytes and EC may underlie an important cross talk between the 
two cell types. Pericytes are found around arterioles, venules and in capillaries, with 
an endothelial-pericyte ratio varying considerably between vascular beds. Pericytes 
originate from the mesoderm (Hungerford and Little, 1999), however CNS pericytes 
derive from the neurectoderm (Etchevers et al., 2002) and suggests that CNS pericytes 
may have additional functions than other pericytes. Interestingly, CNS vasculature 
displayed the highest pericyte-EC ratio, showing values of 1:1-1:3 and 1:1-1:5 in the 
retina and the brain respectively, whereas their presence is limited to a ratio of 1:100 
in skeletal muscle (Frank et al., 1987; Shepro and Morel, 1993). Such variation in 
pericytes numbers would suggest their presence is elevated in barrier vasculature and 
thus suggests that pericytes may modulate EC barrier properties. Like astrocytes, 
pericytes were considered for decades just as “mural cells” and thus playing a static 
role, but recent studies have highlighted the role of pericytes in physiological (e.g. 
vascular development) and pathophysiological (i.e. tumor-associated angiogenesis, 
diabetic retinopathy) situations (Hammes et al., 2004; Hellstrom et al., 2001; Lindahl 
et al., 1997; Sundberg et al., 2002). The contribution of CNS pericytes during 
pathological states is becoming more and more accepted, especially for pericytes of 
the inner blood-retinal barrier (iBRB) during diabetic retinopathy in which a massive 
loss of pericytes is classically described during the onset of the disease (Gerhardt and 
Betsholtz, 2003; Hammes et al., 2004). 
This section highlights the phenotype diversity within pericytes and how such 
heterogeneity constitutes an important challenge for endothelial-pericyte interaction 
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studies. Firstly, pericytes display a heterogeneous cellular morphology according to 
the culturing conditions (Balabanov et al., 1996; D'Amore, 1990). For instance, on 
uncoated dishes, pericytes appear as large cells with a stellar shape whereas they 
adopt a round morphology on collagen-coated dishes. Secondly, pericytes originate 
from different vascular beds and display important differences in cell proliferation. 
Wong and colleagues (Wong et al., 1992) have observed that brain pericyte growth 
was significantly higher than retinal pericytes in medium with normal or high glucose 
levels. It is therefore important to establish standardized protocols in order to allow 
direct comparison between the different studies involving pericytes cultures. 
Unlike the other cells of the BBB, characterization of pericytes by immunological 
markers constitutes an important challenge and still remains debated, as no specific 
marker has been described so far. Balabanov and Dore-Duffy (Balabanov and Dore-
Duffy, 1998) investigated expression of different markers in brain pericytes compared 
to the other cell types present in the BBB (Table 1). It is interesting to note that 
pericytes positively stained against an array of different markers, thus overlapping 
with other cell types such as perivascular, microglial or smooth muscle cells (SMC). 
In addition to such diverse expression of immunological markers, expression of these 
markers varies between pericytes of different vascular beds, but also within the same 
vasculature. (Armulik et al., 2005). Thus the definition of a pericyte-specific marker is 
still unclear and molecular markers such as α-smooth muscle actin (α-SMA) or 
heparan-sulfate proteoglycan (NG2) constitute until now the conventional markers for 
pericytes identification.  
Cerebral pericyte-endothelial interactions take place already between the 17th and 22nd 
gestation week in humans (Braun et al., 2007; Virgintino et al., 2007). However such 
interactions may already occur earlier during development but the absence of 
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Marker/cell α-SMA NG2 Desmin Vimentin VIII GSA CD11b ED-2 CD45 MHC Class II GFAP
PC + + - + - - + +/- - - -
SMC + - + - - - - - - - -
EC - - - + + + - - - - -
PvM - - - + - + + + + + -
AC - - - - - - - - - - +
a-SMA = a-smooth muscle actin; GSA = Griffonia Simplicifolia Agglutinin; GFAP = Glial Fibrillary Acidic Protein; PC = Pericytes,
SMC = Smooth Muscle Cell; EC = Endothelial Cell, PvM = Perivascular Macrophage; AC = Astrocytes.
homogenous markers constitutes a limitation for the determination of interactions 
during earlier stages. It is interesting to note that pericyte coverage in the brain 
vasculature is unequal, according to Braun and colleagues (Braun et al., 2007). 
 
 
Table 1: CNS pericytes markers (Adapted from (Balabanov and Dore-Duffy, 1998) 
 
Pericyte coverage of the germinal matrix vasculature appeared significantly lower 
than the cortical and the white matter vessels, persisting even after the 25th gestation 
week, Presence of greater vascular density in the germinal matrix than the cortex or 
the white matter suggests that pericyte-endothelial interactions may be important for 
regulation of cerebral vascular density (Ballabh et al., 2004). In addition, pericyte-
endothelial interactions are crucial for the stabilization of the cerebral vascular 
network (Abramsson et al., 2007; Armulik et al., 2005; Gerhardt and Betsholtz, 2003). 
It has been demonstrated that impairment of pericytes recruitment in the cerebral 
vasculature resulted in formation of rupturing microaneurysms (Lindahl et al., 1997). 
In addition to a role purely “vascular”, different studies (Dohgu et al., 2005; Hayashi 
et al., 2004; Nakagawa et al., 2007) highlighted the roles of pericytes as possible 
inducer of barrier function in brain EC. However, as described in the astrocyte 
section, the nature of the different factors involved remains largely unclear. 
Notably, pericyte-endothelial interactions rely on multifaceted communications, 
involving gap junctions, cell adhesion and secretion of soluble factors. Two secreted 
factors shown to induce barrier phenotype in brain EC. Interestingly these factors are 
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also found in astrocyte-endothelial interactions: Ang-1 and TGF-β. Ang-1 constitutes 
the first factor shown to induce barrier properties (Thurston et al., 1999), both in the 
iBRB (Park et al., 2003b) and the BBB (Hori et al., 2004). The signaling pathways 
that modulate Ang-1 expression in pericytes are not yet fully known. However, Kim 
and colleagues reported that dexamethasone up-regulated Ang-1 in dose-dependant 
manner in brain pericytes (Kim et al., 2008) whereas Park and colleagues described 
hypoxia and VEGF as inducer of Ang-1 secretion in retinal pericytes (Park et al., 
2003b). Presence of angiopoietin receptor Tie2 on both EC and pericytes may suggest 
that Ang-1 acts both as a paracrine and autocrine factor. However, the possible 
regulation of Ang-1 expression by such autocrine loop remains obscure. 
TGF-β constitutes a second important factor involved in barrier induction. Dohgu and 
colleagues (Dohgu et al., 2005) observed that close contacts between pericytes and 
brain ECs were necessary to provide maximal induction of the barrier function, 
suggesting that physical contacts are crucial for pericytes to induce their effects. 
Inhibition of TGF-β signaling by blockade of TGF-β receptor binding or receptor 
activity resulted in significantly increased permeability and decreased P-gp activity, 
demonstrating that TGF-β/TGF-β receptor signaling pathway is essential for pericyte-
induced BBB phenotype in ECs. Presence of both Ang-1 and TGF-β signaling in 
astrocytes and pericytes suggests that these two cells might use similar mechanisms to 
induce barrier phenotype, but also raises the question of possible additional factors 
specific to each cell type and may participate in a possible cumulative effect when 
both astrocytes and pericytes are present. 
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4.1.8.Neurons and their possible contribution to the BBB 
The BBB plays a crucial role to neurons by providing them with efficient O2 and 
nutrient perfusion but also by isolating them from any fluctuation occurring outside 
the brain. However, we can question whether neurons themselves can modulate O2 
and nutrient supply as well as the BBB phenotype. The ability of neurons to regulate 
local blood flow to ensure optimal O2 and nutrient supply is documented, either for 
the retinal (Pournaras et al., 2008) or the cerebral vasculature (Filosa and Blanco, 
2007; Filosa et al., 2004; Filosa et al., 2006; Iadecola and Nedergaard, 2007). 
Regulation of cerebral and retinal local blood flow occurs through neurovascular 
coupling (Fig.13). Neurovascular coupling can be effected directly or indirectly. In 
the direct neurovascular coupling, neurons directly modulate local blood flow by 
modulating the vascular tone through the release of nitric oxide (NO) and 
prostaglandins (PGs). In the indirect neurovascular coupling, release of both NO and 
PGs are performed by astrocytes. The release of these vasoactive factors is directly 
modulated by the local neuronal activity. Glutamate, an important neurotransmitter, 
and other signaling molecules (i.e. ATP, PGs) released in the synaptic cleft by active 
neurons can initiate astrocyte phospholipase C/inositol-3-phosphate (PLC/IP3) 
signaling pathway. IP3 induces intracellular Ca2+ increase resulting in synthesis of 
epoxyeicosatrienoic acid, NO and PGs by cytochrome P450, NO synthase and 
cyclooxygenase respectively by activation of the phospholipase A2 pathway. Release 
of these compounds by astrocytes induces vasodilation by pericytes/VSMC relaxation 
(Filosa and Blanco, 2007; Filosa et al., 2004; Filosa et al., 2006). With such 
mechanisms, neurons can very efficiently adapt local blood flow according to their 
needs. The question of possible neuronal modulation of the BBB phenotype is more 
disputable. Stewart and Wiley (Stewart and Wiley, 1981) performed the first in vivo 
 47  
experiment that raised the possible role of neurons in induction of BBB phenotype in 
EC. In this study, they used quail and chick embryos to prove the ability of neural 
tissue to induce a barrier phenotype. They grafted quail neural tissue into the chick 
coelomic cavity and allowed vascularization of the graft by the chick blood vessels to 
occur. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Cellular and molecular basis of the neurovascular coupling in the CNS vasculature  
(from Iadecola and Nedergaard, 2007)  
 
They observed that blood vessels that invested the graft developed TJ complexes, 
suggesting that neural tissue induced BBB properties in the invading EC. However, 
this study was performed on a developing brain with immature neurons and glial cells 
and thus does not prove that neurons alone were responsible since the induction might 
be due to astrocyte presence.    
In order to verify that neuron-derived factors induce barrier phenotype in EC, it is 
important to use a simplified model that allows us to test such hypothesis. Schiera and 
colleagues (Schiera et al., 2003; Schiera et al., 2005) have extensively addressed such 
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questions by using a three-cell in vitro BBB model, based on the in vitro BBB model 
developed by Dehouck and colleagues (Dehouck et al., 1990). It is important to note 
that these experiments were performed on non-contacting primary neurons cultures. 
However the results obtained with such models are debateful and rather suggest that 
neurons may only have a modest contribution to barrier induction in EC. For instance, 
the authors showed an increased occludin localization in EC-neuron co-cultures, 
whereas no change in occludin was observed at protein levels. In addition, 
permeability to sucrose decreased modestly compared to EC monocultures with no 
cumulative effects when cells were co-cultured with astrocytes. Weidenfeller and 
colleagues (Weidenfeller et al., 2007) took a different approach to answer this 
question and hypothesized that only immature neurons may induce BBB phenotype. 
In their study, they used an in vitro BBB model consisting of neural progenitor cells 
(NPCs) co-cultured with EC in a non-contact model. The authors showed that NPCs 
were able to induce BBB phenotype in EC, as shown by increased TEER, decreased 
permeability to water-soluble tracers and by increased formation of TJ complexes. 
However, a further analysis of NPC cell population obtained after 24h of co-cultures 
with EC revealed that NPC population initiate a mixed population of neurons and 
astrocytes. Again, we cannot ascribe to neurons the possible effects on the BBB 
phenotype. So, should we consider that neurons have only limited effect on the EC 
biology? 
The answer is certainly negative. Neurons plays important roles in other functions 
associated to EC. Indeed, neurons and EC share the same signaling pathways for both 
vessel and axon guidance. Furthermore, although neurons and EC have completely 
different embryonic origins, they share much anatomical similarities. For instance, the 
tip cell (the EC present in front of forming vessel) acts very similar to axon growth 
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cones. Like axon growth cones, the tip cell filipodia probe the extracellular 
environment and dynamically respond to positive and negative cues resulting in 
proper orientation inside the tissue. 
EC and neurons share four major guidance signaling pathways: Ephrins/Eph 
(Helbling et al., 2000), semaphorins/plexins (Torres-Vazquez et al., 2004), 
Netrin/Unc5b (Park et al., 2004) and Slit/Robo (Park et al., 2003a) signaling 
pathways. Neurons can guide tip cells and established vasculature can guide migrating 
axons to reach the target tissue (Autiero et al., 2005) showing that both systems are 
interconnected and require the help of the other to achieve guidance to the target 
tissue. In conclusion, neurons might not play an important role in BBB compared to 
astrocytes and pericytes but definitively play crucial roles in vascular patterning and 
vessel guidance.   
 
4.1.9. The basement membrane: the matrix reloaded 
The BM does not simply constitute a scaffold structure, but definitively represents the 
foundation of the whole neurovascular unit. Four different molecules (Tilling et al., 
2002; Tilling et al., 1998) compose it: collagen IV, laminin, fibronectin and a secreted 
protein acidic rich in cystein (SPARC). Tilling and colleagues (Tilling et al., 2002; 
Tilling et al., 1998) performed a series of studies to determine which BM components 
play roles in the barrier function. In the first study they compared the possible TEER 
increase when EC were grown on collagen IV-, laminin-, fibronectin- or SPARC-
coated inserts. The authors observed that from the four components tested, laminin 
showed the highest increase in TEER either alone or in combination with fibronectin, 
suggesting that laminin may constitute an important component of the BM for 
induction of barrier phenotype. As astrocytes and pericytes have direct contacts with 
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the BM, their capacity to induce BBB phenotype might involve ECM secretion and 
thus provide modification of EC BM composition.  In a second study, Tilling and 
colleagues demonstrated that astrocytes and pericytes secrete some ECM and both 
secreted matrices were able to increase TEER in brain ECs. However this study did 
not provide any information on the composition of such matrices. Thus the nature of 
the ECM secreted by astrocytes and pericytes is still not defined, composition of such 
matrices will definitively help us to understand more the inductive effects carried on 
by astrocytes and pericytes. 
In addition to the ability to induce barrier properties in brain EC, the BM may also act 
as a barrier under certain circumstances. Willis and colleagues have observed (Willis 
et al., 2004) that loss of astrocyte contacts induced disruption of the BBB towards 
small molecules (500Da), but it remained impermeable to mid-size molecules 
(10kDa) suggesting the presence of another barrier, that gives a higher size-selectivity 
than brain EC. In order to test whether the barrier was the BM, Willis and colleagues 
(Willis et al., 2007) investigated the barrier properties of the BM located in the area 
postrema, a region of the brain belonging to the circumventricular organs (CVO), a 
brain area that physiologically show an absence of barrier phenotype in EC. This 
region of the brain is unique as EC that form the vasculature show a total absence of 
BBB phenotype, but also an absence of astrocyte end-feet processes.  Ependymal cells 
that line the cerebral ventricles play the role of barrier in this region. Willis and 
colleagues showed that the BM can acts as a size-selective filter in cerebral vascular 
regions in absence of the BBB and suggest that such filter may constitutes an 
additional line of defense in cerebral vasculature displaying a BBB phenotype.  
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4.1.10. The perivascular cells and the microglia: the immune cells of the BBB 
Perivascular cells and microglia constitute the two last cell types present in the BBB 
(Guillemin and Brew, 2004). Perivascular cells are present in the perivascular space 
located between pericytes and the BM, whereas microglia share same location with 
astrocytes or neurons (see Fig.4). Perivascular cells may derive from both monocytes 
and pericytes (Balabanov et al., 1996; Thomas, 1999) whereas microglial cells are 
derived mostly from migrated monocytes. Unlike astrocytes and pericytes, 
perivascular and microglial cells appear not to have a role on EC barrier phenotype 
during physiological condition. However, these two cells may play crucial roles 
during pathological states. Activation of perivascular and microglial cells induces 
release of important pro-inflammatory cytokines, including interleukin-1β (Stoll, 
2002), monocytes chemoattractant protein-1 (Guillemin et al., 2003) or tumor-
necrosis factor-α (Poritz et al., 2004), responsible for the BBB breakdown during 
neuroinflammatory diseases as well as other neurological diseases. Both activated 
cells facilitate leukocyte migration through the BBB by TJ breakdown and EC 
activation. Therefore we need to have a better understanding of the cellular cross talk 
between these two cells and ECs to develop new anti-inflammatory drugs that 
specifically inhibit activation of these cells.  
 
4.2. Models of the blood-brain barrier 
 
4.2.1. In vivo models 
 
In vivo models of the BBB constitute the model of choice in order to understand 
human BBB physiology and pathophysiology. Until now, most of the models are 
based on mammalian systems that allow a direct comparison with humans. Mouse, rat 
and in lesser extent cat and dog constitute the most common species used as in vivo 
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models to reproduce human neurological diseases involving barrier breakdown such 
as cerebral ischemia (mouse middle cerebral artery occlusion model) or multiple 
sclerosis (mouse EAE model) (Webb and Muir, 2000),. In addition to usage of these 
models for studying BBB alteration during adulthood, it is important to note the usage 
of mouse, dog, marsupial or sheep models in the literature constitute as in vivo the 
BBB study models during development (Ek et al., 2006; Ment et al., 1992; Ment et 
al., 1986a; Ment et al., 1986b; Saunders et al., 2000; Stonestreet et al., 1996; 
Stonestreet et al., 2006). However, usage of mammalian models as in vivo models of 
the BBB constitute an important technical approach as it allows only to observe 
macroscopic changes of the barrier function but also need to face ethical constrains, 
thus limit the usage of these models routinely. Recently, non-mammalian BBB in vivo 
models, based on zebrafish and drosophila, have been suggested as an alternative to 
mammalian models (Daneman and Barres, 2005; Jeong et al., 2008). Apart that such 
animals constitute excellent genetic models to discover the nature of the genes 
underlying the barrier function in brain endothelium, it is important to note that such 
models still lack a complete characterization of the BBB and requires further 
investigations to assess the relevance of such non-mammalian models. 
 
4.2.2. In vitro models 
In vitro models constitute, by their accessibility and reproducibility, useful alternative 
to in vivo models for the study of cellular and molecular mechanisms at the BBB.  
Most of in vitro models rely on usage of mammalian brain ECs isolated from either 
primary cultures or immortalized brain EC lines (Deli et al., 2005; Roux and Couraud, 
2005). Primary cultures are classically isolated from bovine, porcine or murine brain 
microvessels. Despites brain EC isolation techniques are standardized and highly 
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reproducible, the yield and cell contamination (e.g. pericytes) constitute major issues 
for broaden usage of primary cultures routinely. 
For this purpose many different groups established immortalized brain EC lines. 
Among the different cell lines established, it is important to mention that only a 
fraction of such cell lines are extensively used in the literature. The cell lines 
classically used in the literature are the mouse (b.End3, b.End5), rat (RBE4, GPNT) 
and human (ECV304, HBMEC) brain EC lines (Al Ahmad et al., 2009; Brown and 
Davis, 2005; Neuhaus et al., 2008; Rist et al., 1997; Roux and Couraud, 2005; Roux 
et al., 1994; Weksler et al., 2005).  
Most in vitro BBB models rely on the usage of a 2-dimensional cell culture model 
similar to the model initially described (Dehouck et al., 1990; Rubin et al., 1991). It 
consists on the usage of a modified Boyden chamber (Fig.13) that separates two 
compartments by a presence of a semi-porous membrane. Such membrane allows 
solute diffusion between the two compartments. ECs are seeded on the top of the 
membrane, thus allows the formation of a monolayer and the induction of cell 
polarity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Schematic representation of in vitro BBB contact (left) and non-contact (right) co-culture models  
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Formation of a barrier phenotype can be easily quantified by determining the 
transendothelial electrical resistance (TEER) across the monolayer but also by 
measuring the diffusion of water-soluble labeled compounds (e.g. sucrose, inulin, 
dextran) across the monolayer. However, these models based on EC monocultures 
rapidly demonstrated its limitation due to an important discrepancy between TEER 
values obtained in vitro (10-100 Ω.cm2) compared to in vivo (1000 Ω.cm2) situation  
due to a rapid loss of barrier phenotype in cultured brain ECs (Butt et al., 1990; Rubin 
et al., 1991). Dehouck and colleagues (Dehouck et al., 1990) proposed an enhanced 
model by developing a co-culture model by addition of astrocytes of the opposite face 
of the membrane and thus recreate the astrocyte-endothelial interactions as they 
naturally occur in vivo. In most studies found in the literature, addition of astrocytes 
were able to significantly induce higher TEER values than EC monocultures (Deli et 
al., 2005), however the degree of induction remains significantly lower than in vivo 
situation. Treatment of the cultures by different drugs such as cyclic adenosine 
monophosphate (Rist et al., 1997), dexamethasone (Kim et al., 2008) or 
hydrocortisone (Hoheisel et al., 1998) have shown to artificially elevate TEER in 
mono- and co-cultures, however such empirical methods may alter EC response to 
various stimuli. More recently addition of pericytes showed the ability to increase of 
the barrier function (Hayashi et al., 2004; Lai and Kuo, 2005), presence of both 
astrocytes and pericytes appear to be necessary to obtain optimal induction of barrier 
phenotype in brain ECs (Al Ahmad et al., 2009; Nakagawa et al., 2007). In addition to 
the presence of the different cell types, some authors suggest that enhancement of 
current in vitro models require the addition of a flow-induced shear stress over the EC 
monolayer (Cucullo et al., 2008; Cucullo et al., 2002). In conclusion, it appears 
clearly that an oversimplification of the BBB in vitro cannot reproduce efficiently in 
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vivo phenomenon and demonstrates that the different components found in the 
neurovascular unit (e.g. astrocytes, pericytes, basement membrane, flow) are indeed 
necessary in order to obtain satisfactory in vitro BBB models. 
 
4.2.3. Designing BBB models: an important challenge  
The BBB constitutes probably one of the most difficult vascular bed to model, as it 
forms a cellular and molecular complex involving different cell types. In addition, the 
BBB distribution within the cerebral vasculature is heterogeneous but also difficult to 
access physically as it requires invasive techniques. On the other hand, current in vitro 
models importantly reduced the in vivo situation by omitting many parameters 
including the presence of both astrocytes and pericytes or appropriate cellular 
interactions between ECs and the other cells of the neurovascular unit. Such extreme 
simplification constitutes an important pitfall, as obtained in vitro results are poorly 
transferable to in vivo situation. Therefore it is important to design elaborated in vitro 
models to allow a better reproduction of in vivo situation.  
In conclusion, design of in vitro models that allow both the ease of actual in vitro 
models and the complexity of in vivo situation are urgently required to provide a 
significant quantum leap within the field.   
4.3. Hypoxia 
4.3.1. Hypoxia inducible factor-1: an overview 
Hypoxia is defined as a deficit of O2 availability for a tissue compared to O2 need. 
Hypoxia occurs in many physiological states such as embryonic development or high-
altitude exposure but also during pathological conditions such as ischemia or cancer. 
Physiological adaptation to hypoxia involves different steps in order to increase O2 
availability towards the hypoxic tissue. At the cellular level, adaptation to hypoxia 
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involves hypoxia inducible factor (HIF) (Hopfl et al., 2003; Hopfl et al., 2004; Wang 
et al., 1995). HIF-1 transcription factor constitutes the best known transcription factor 
described in the mammalian response to hypoxia and therefore this chapter will limit 
the discussion to the HIF-1 pathway. HIF-1 is a heterodimer formed by HIF-1α/HIF-
1β subunits. Whereas HIF-1α protein degradation rapidly occurs under normal O2 
concentration (normoxia), HIF-1β protein levels remain constant. HIF-1α and HIF-1β 
(Fig.14) N-terminal domains present a basic helix-loop-helix (bHLH) sequence 
involved in DNA binding activity of the heterodimer complex and a Per-Arnt-Sim 
(PAS) domain responsible for the interactions between the α and β subunits. On the 
C-terminus, HIF-1α presents additional domains absent in HIF-1β. HIF-1α presents 
an O2-dependant degradation domain (ODD), responsible for its degradation under 
normoxic conditions. HIF-1α also has a N-terminal and C-terminal transactivation 
domains (N-TAD and C-TAD respectively) involved in the recruitment and 
interactions with co-activators necessary for the transcriptional activity of the HIF-1 
complex. 
HIF-1α degradation and hypoxic stabilization mechanisms may represent one of the 
most interesting molecular mechanisms involved in transcription factor regulation. As 
we mentioned previously, HIF-1α is constantly produced and degraded under 
normoxia. HIF-1α degradation occurs by different molecular steps (Fig.15). The first 
step is the prolyl-hydroxylation step (Ivan et al., 2001; Jaakkola et al., 2001). Prolyl-
hydroxylation involves modification of two proline residues (Pro402 and Pro564) 
present in the HIF-1α ODD domain. Such biochemical step is processed by three 
different prolyl-4-hydroxylase (PHD) isoforms known as PHD1, PHD2 and PHD3 
respectively (Bruick and McKnight, 2001; Huang et al., 2002). Whereas PHD1 
expression appears to be hypoxia independent, PHD2 and PHD3 are upregulated by 
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hypoxia, both at the mRNA and protein levels, suggesting that these two PHDs are 
involved in a negative feedback loop for regulating HIF-1α protein level even during 
hypoxia (Metzen et al., 2003; Stiehl et al., 2006). 
 
Figure 14:  HIF-1α, -2α , -3α and HIF-1β structures 
  (From (Hopfl et al., 2004)) 
 
Proline hydroxylation by the three different PHD isoforms requires presence of O2 but 
also presence of co-substrates such as 2-oxoglutarate, ascorbate and Fe2+. The Von 
Hippel-Lindau protein (pVHL)-E3 ubiquitin ligase complex recognizes 
prolylhydroxylated HIF-1α and induces ubiquitinylation of HIF-1α at different sites 
(Ivan et al., 2001; Jaakkola et al., 2001). Finally, the proteasome degrades the 
polyubiquitinylated HIF-1α (Krek, 2000) resulting in its complete inactivation. 
Presence of O2 in the environment is crucial for PHDs activity; therefore the absence 
or reduction of O2 environment results in a substantial decrease in their enzymatic 
activity (Stiehl et al., 2006). When O2 concentration decreases in the environment, 
PHD activity is drastically reduced, resulting in HIF-1α stabilization. Once stabilized, 
HIF-1α can translocate to the nucleus and associate with HIF-1β, forming the HIF-1 
heterodimer complex. The HIF-1 heterodimer complex recognizes a specific 
consensus sequence formed by six base pairs classically referred to “hypoxia 
responsive elements” (HRE) located in promoter or enhancer regions of HIF target 
genes. Interactions between HIF-1 and HREs allow recruitment of transcription 
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machinery and initiation of transcription of a number of important HIF target genes. 
HIF-1α stabilization/degradation cycle constitutes a remarkable mechanism for O2 
sensing. It allows a very rapid response to hypoxia resulting in a very fast nuclear 
translocation (<2 min), whereas reoxygenation very rapidly causes HIF-1α 
degradation (~5min) (Jewell et al., 2001). In addition to such transient switch in 
feedback loops, HIF-1α levels vary exponentially according to O2 levels. Whereas 
HIF-1α protein level is undetectable under normoxic condition, stabilization and 
therefore its detection increase exponentially as O2 levels decrease (Jiang et al., 1996). 
In conclusion, HIF-1 pathway constitutes an efficient O2 sensing system in the 
mammalian organisms to allow a rapid adaptation to environmental changes in O2 
concentration.  
  
4.3.2. HIF target genes and their role in EC response to hypoxia 
As described in the previous chapter, the HIF-1 heterodimer acts a transcription factor 
and activates transcription of many hypoxia-regulated genes. More than 100 genes 
have been described as hypoxic-responsive (Semenza, 2002), the number of genes 
described as hypoxia-inducible genes is in constant increase. The gene products play 
different roles in the organisms by acting on glucose metabolism, O2 transport and 
delivery or cell survival/cell death. This chapter will primarily discuss on hypoxia-
induced genes in EC during hypoxic conditions and the next chapter will focus on the 
BBB response to hypoxic stress. 
A variety of different genes are up regulated in EC to allow cellular adaption to 
hypoxia but the most striking and visible EC response is certainly the initiation of 
angiogenesis in hypoxic tissue, in order to re-establish appropriate O2 levels to the 
tissue. Tumor growth and its subsequent neo-vascularization by newly formed blood 
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vessels constitute the study model of choice to understand the hypoxia-induced 
angiogenesis. 
 
 
Figure 15:  HIF-1α degradation and stabilization during normoxic and hypoxic conditions  (From (Hopfl et al., 2004)) 
 
Tumor angiogenesis occurs by different steps (Fig.16): Hypoxic tumor cells secrete 
angiogenic factors reaching neighboring capillaries (i), initiating EC activation. 
Activated EC (aEC) induce expression of secreted and membrane-bound matrix-
metalloproteinases (MMPs) that allow degradation of the basement membrane and the 
surrounding ECM (ii). EC present at the degradation site sprouts and migrates (iii) 
following the gradient formed by the angiogenic factor released by the tumor cells. 
Neighboring EC show an intense mitogenic activity to allow extension of the 
vasculature. In parallel newly formed vessels synthesize a newly formed basement 
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membrane (iv) that allows recruitment of mural cells and induce stabilization of the 
newly formed blood vessels (v).  
Among the different genes induced by HIF-1α stabilization, an important amount of 
gene products are involved in angiogenesis including the following ones: 
angiopoietin-2 (Ang-2) (Pichiule et al., 2004), angiopoietin-receptor 2 (Tie2) (Willam 
et al., 2000), bFGF (Phillips et al., 1995), endostatin (Wu et al., 2001), platelet-
derived growth factor-B (PDGF-B) (Yoshida et al., 2006), TGF-β (Sakuda et al., 
1992), VEGF and VEGF receptor-1 (VEGFR-1/Flt-1) (Gerber et al., 1997; Iyer et al., 
1998). 
The case of Ang-2 is very interesting. Ang-2 is directly secreted by EC under hypoxia 
(Pichiule et al., 2004). In addition, Ang-2 signaling occurs by interactions with Tie-2 
receptor and therefore shares the same receptor as Ang-1, another  important factor 
involved in vessel stabilization. Whereas Ang-1/Tie-2 interactions result in Tie2 
autophosphorylation, Ang-2 acts as a negative factor, inhibiting Tie-2 
autophosphorylation and subsequent activation of the signaling cascade (Maisonpierre 
et al., 1997). Inhibition of Tie2 signaling cascade results in detachment of 
pericytes/VSMC and vasculature destabilization. Ang-2 plays an important role in 
tumor angiogenesis as it involved in the disruption of endothelial-matrix (Lauren et 
al., 1998). 
As other fragments found in the BM such as endorepellin (Bix et al., 2006; Bix et al., 
2004; Bix and Iozzo, 2005) or collagen IV fragments (Marneros and Olsen, 2001), 
endostatin plays an important role as anti-angiogenic factor and therefore its down-
regulation by HIF-1 allows EC activation and angiogenesis. Endostatin constitutes 
one of the vasoactive molecules down-regulated by HIF-1 (Wu et al., 2001). 
Endostatin is a 20-kDa C-terminal proteolytic fragment obtained from the collagen 
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XVIII, a matrix component secreted by EC and pericytes and is present in almost all 
EC BM (Marneros and Olsen, 2005; Wu et al., 2001). 
 
  
 
 
 
 
 
Figure 16:  Hypoxia-induced angiogenesis in tumor 
(From Yue et al., 2007) 
 
 
PDGF-B belongs to the PDGF family (Fredriksson et al., 2004). The active form of 
PDGF-B consists of homodimer (PDGF-BB) or heterodimer (PDGF-AB) formation. 
PDGF-A and -B bind to PDGF (PDGFR)-α (PDGF-AB) or PDGF-β (PDGF-BB) 
dimerized receptor. Secretion of PDGF-BB by the tip cell allows pericytes 
recruitment to the developing vasculature. Such recruitment occurs by activation of 
PDGFR-β in migrating pericytes (Armulik et al., 2005).  PDGF-BB/PDGFR-β is 
important for the stabilization of newly formed blood vessels during angiogenesis 
(Abramsson et al., 2007). Induction of PDGF-B expression by HIF-1 (Yoshida et al., 
2006) during hypoxic exposure might therefore constitute an adaptation mechanism to 
induce stabilization during hypoxic-driven angiogenesis. 
VEGF constitutes probably the best-described hypoxia-driven angiogenic factor. 
VEGF (VEGF-A) belongs to the VEGF family formed by six members: VEGF-A, 
VEGF-B, VEGF-C, VEGF-D, VEGF-E and placental growth factor (PlGF) (Ferrara, 
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2004). Whereas VEGF-C and –D play important roles in lymphangiogenesis, VEGF-
A plays crucial roles in vasculogenesis and angiogenesis. VEGF-A gene product can 
be spliced into four major splice variants that differs by the number of aa present in 
the sequence: VEGF121, VEGF165, VEGF189 and VEGF206 (Rini and Small, 2005).  
Despite these splice variants displayed different heparin and ECM binding affinity, 
they showed similar biological effects (Rini and Small, 2005), Among all these 
splicing isoforms, VEGF165 constitutes the most prominent splice variant by its 
bioavailability and potency (Rini and Small, 2005). Initially described as a tumor-
secreted vascular permeable factor (Rosenthal et al., 1990; Shing et al., 1985), the 
demonstration of its induction by hypoxia through HIF-1 by Shima and colleagues 
(Shima et al., 1995) revealed that VEGF expression occurs in a numerous number of 
cells including astrocytes (Chow et al., 2001; Hossain et al., 2000; Salhia et al., 2000), 
CNS endothelium (Fischer et al., 1999; Josko et al., 2001; Nag et al., 2002; Rajah and 
Grammas, 2002), neurons (Famiglietti et al., 2003; Ment et al., 1997; Ogunshola et 
al., 2002; Ogunshola et al., 2000), retinal pigmented epithelium (Adamis et al., 1993) 
and CNS pericytes (Kim et al., 2008; Park et al., 2003b). It appears indeed that VEGF 
constitutes an important housekeeping gene, as one VEGF allele deletion is 
embryonic lethal showing abnormal vasculature development (Carmeliet et al., 1996; 
Ferrara et al., 1996). Indeed, VEGF plays a crucial role in vascular development 
inducing vasculogenesis and angiogenesis. In addition to its important on the blood 
vessels, VEGF plays important roles as a neuroprotective factor in many neurological 
diseases (Ogunshola et al., 2002; Plaschke et al., 2008; Sun et al., 2003b; Wang et al., 
2007; Wang et al., 2005; Yasuhara et al., 2005), but also contributes to endothelial 
and astrocytes survival during hypoxic/ischemic stress (Chow et al., 2001; Schmid-
Brunclik et al., 2008). However VEGF also acts as a hyperpermeable factor resulting 
 63  
in barrier disruption in the CNS, the effect of VEGF on the BBB will be addressed in 
detail in the next chapter. In conclusion, HIF-1 pathway induces important number of 
genes responsible for cellular adaptation to hypoxic stress (metabolism, cell survival) 
but is also remarkably visible in the endothelium by increasing vascular density in 
hypoxic tissue thus restoring optimal O2 delivery. However, this increased vascular 
density may not be only beneficial but may cause detrimental effects in EC functions. 
 
 4.3.3. The BBB and the hypoxic stress: the road to barrier disruption 
The brain is an important blood flow and glucose consumer, with an average of 13% 
and 20% respectively under resting condition (Vander et al., 1995), showing its 
important dependency of an adequate O2 and nutrient supply. According to Sick and 
colleagues (Sick et al., 1982), rat brain show a heterogeneous O2 partial pressure (PO2) 
inside the brain area, showing values ranging from 1-2 mmHg to 50 mmHg and more, 
with an average around 10 mmHg. It shows that the brain constitutes one of the 
organs in mammals with the lowest physiological pO2 levels compared to other 
tissues and suggests that the brain tissue is highly susceptible to any decrease in O2 
supply level, in particularly during hypoxic stress. 
Adaptation of the CNS to hypoxia is therefore crucial to maintain the organism 
integrity. Such adaptation occurs with slight differences whether the CNS faces an 
acute or a chronic mild hypoxia. In the rat brain, different mechanisms provide 
adaptation to hypoxia (LaManna et al., 2004).  During acute hypoxia, an increase in 
both cerebral blood volume and flow is observed, accompanied by an increase in 
glucose metabolic rate. Prolonged mild hypoxia involves increase in glycolysis and 
glucose transport by up-regulation of GLUT-1 expression at the BBB but also 
important structural changes in the cerebral vasculature including vascular remodeling 
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that allow restoration of the normal tissue oxygenation profile at long-term. Hypoxic 
stress occurs in the BBB during two major situations: when changes in O2 
concentration occur in the environment (Hackett and Roach, 2004) or during an 
ischemic situation when O2 and glucose supply are both impaired (del Zoppo, 2006; 
del Zoppo and Mabuchi, 2003; Zlokovic, 2008), most of the time such stress result in 
BBB breakdown. 
In vivo studies indicate us that hypoxia-driven BBB disruption occurs in rats exposed 
for 1-24 hours at 6-12% O2 (Kaur et al., 2006; Schoch et al., 2002; Witt et al., 2003; 
Witt et al., 2008) or after 90-mins in the middle cerebral artery occlusion (MCAO) 
models (Kilic et al., 2006; Kumai et al., 2007; Yang et al., 2007b), whereas in vitro 
models showed barrier breakdown occurring between 2-48h at 0-3% O2 levels 
(Abbruscato and Davis, 1999; Al Ahmad et al., 2009; Brown and Davis, 2005; 
Fischer et al., 2004; Fischer et al., 2000; Fischer et al., 2002; Hayashi et al., 2004; 
Kuhlmann et al., 2007; Schroeter et al., 1999; Yang et al., 2007a). Regarding such 
variations between the different experimental paradigms observed in the literature, it 
is obvious that direct comparison between the different studies cannot be totally 
performed and provide us with fragmented information on the onset of the barrier 
breakdown. However these studies have provided us with important information 
concerning different mechanisms occurring in the BBB during such insult that may 
lead to barrier disruption.  
Barrier disruption involves dramatic changes at different levels: cytoskeleton, cell-cell 
and cell-matrix interactions but also cell-cell communications. At the cytoskeleton 
level, hypoxia induces F-actin stress fiber formation (Brown and Davis, 2005) and 
myosin light chain kinase activation (Kuhlmann et al., 2007), and results in formation 
of actin/myosin contractile machinery. EC contraction during injury may therefore 
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contribute to barrier breakdown. In addition to changes in cytoskeleton disruption of 
both AJ and TJ occur during hypoxic stress, mostly characterized by decrease in E-
cadherin (Abbruscato and Davis, 1999), claudin-3 (Witt et al., 2003), occludin 
(Brown and Davis, 2005; Fischer et al., 2004; Witt et al., 2003), and ZO (Fischer et 
al., 2004; Fischer et al., 2002) protein expression levels, delocalization of proteins 
from the membrane to the cytoplasm and increased phosphorylated state (Fischer et 
al., 2002). Thus BBB disruption involves multi-modal alterations of the cell junctions 
that ultimately result in compromised barrier function.    
Hypoxia also induces dramatic changes in the ECM by up-regulating MMP-2, MMP-
3 and MMP-9 (Cunningham et al., 2005; Fukuda et al., 2004; Yang et al., 2007b) 
resulting in both TJ complexes and BM degradation. A fragilized and partially 
degraded BM will compromise BBB recovery during reoxygenation. Autocrine and 
paracrine release of various cytokines constitutes an important aspect of the cellular 
communication during hypoxic stress and different factors have been involved in 
BBB breakdown following hypoxic/ischemic insult. For instance, VEGF constitutes 
one of the most important secreted factors that induces BBB breakdown (Fischer et 
al., 2002; Schoch et al., 2002). Hypoxic-driven VEGF secretion is up regulated during 
hypoxia in ECs (Argaw et al., 2006; Fischer et al., 1999; Fischer et al., 2002; Josko et 
al., 2001), but also by astrocytes (Chow et al., 2001; Schmid-Brunclik et al., 2008) 
and pericytes (Park et al., 2003b), suggesting that such transient VEGF 
overexpression by all the members of the neurovascular unit might induce barrier 
breakdown. Inhibition of VEGF/VEGFR signaling might therefore contribute to 
protect the BBB opening during hypoxic insult (Vogel et al., 2007). In addition of 
VEGF signaling, down-regulation of Tie2 signaling by Ang-2 during ischemic insult 
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(Beck et al., 2000) suggest that both VEGF and Ang-2 might contribute to the barrier 
breakdown during hypoxia/ischemia situation. 
A question that needs to be addressed concerns the role of astrocytes and pericytes 
during hypoxic stress. Surprisingly, although their role in induction in the barrier 
function during physiological conditions is relatively well described, their importance 
during hypoxic situation remains more obscure.   
Astrocytes appear to have beneficial roles towards EC during hypoxia by partially 
maintaining high TEER values (Kondo et al., 1996), low paracellular permeability 
(Fischer et al., 2000), low oxidative stress (Schroeter et al., 1999) and maintenance of 
AJ expression at the protein level (Abbruscato and Davis, 1999). On the other hand, 
pericytes have shown similar behavior as astrocytes, by moderating decrease in TEER 
(Hayashi et al., 2004) and by secretion of Ang-1 and PGs (Dore-Duffy et al., 2005; 
Park et al., 2003b). However, these experiments were addressed at defined hypoxic 
timepoints and do not allow to appreciate how such protection is maintained over time 
and at different O2 concentrations, or how astrocytes and pericytes co-operate to 
provide optimal barrier protection during hypoxic insult. Importantly this thesis will 
address a number of these important yet unanswered questions. 
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5. OBJECTIVES 
Alteration of the BBB constitutes a hallmark of many neurological diseases including 
stroke, neurodegenerative diseases and neuroinflammation. Notably, hypoxia also 
constitutes an important stimulus in induction of the BBB breakdown. Therefore, it is 
important to understand by which mechanisms hypoxia induces BBB breakdown and 
how the different component of the neurovascular unit may modulate the response of 
the BBB during insult. 
Despite usage of in vivo models constitutes a necessary step to understand the effect 
of hypoxia on the BBB, such studies remain technically difficult for the elucidation of 
the cellular and the molecular mechanisms underlying the hypoxic response of the 
neurovascular unit.  However current in vitro models are also limited. These models, 
based on 2-dimensional approach, do not allow formation of 3-dimensional structures 
and cellular interactions as they normally occur in vivo. Furthermore, many 
researchers have neglected the presence of both astrocytes and pericytes in EC 
cultures. Thus these models cannot directly address the roles of astrocytes and 
pericytes in the modulation of the barrier function during physiological and 
pathological states. The aim of this thesis is to understand the roles of astrocytes and 
pericytes as modulators of the BBB phenotype by using two innovative in vitro BBB 
models. 
In the first part of the thesis, the role of astrocytes and pericytes as modulators on the 
barrier function in brain EC during normal and hypoxic states was investigated. In 
order to perform such investigation, brain EC cultured alone or in co-cultures with 
astrocytes and/or pericytes using the classical in vitro model developed by Dehouck 
(Dehouck et al., 1990) and described in the previous chapters (see Chapter 4.1.6) was 
employed. We firstly observed EC response to hypoxia stress by investigating 
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alterations in barrier function by TEER measurements and barrier permeability to 
different water-soluble compounds. In addition we investigated alterations in EC cell 
integrity by investigating AJ and TJ protein localization, cell viability and caspase-
dependant cell death activation during hypoxic stress. Notably we investigated the 
possible roles of astrocytes and pericytes as modulators of EC response to hypoxic 
stress. We particularly focused on their modulation of EC barrier function and cell 
viability during hypoxic insult. 
In the second part of the thesis, we designed an innovative in vitro BBB model that 
reproduced the 3-dimensional structure of the BBB as observed in vivo. This model 
was also used to investigate the roles of astrocytes and pericytes during BBB 
maturation. The model is based on a 3-dimensional EC culture based on collagen 
matrix, a classical in vitro model used in the literature that allows EC to form tube-
like structures comparable to in vivo capillaries (Bayless et al., 2000; Davis and 
Camarillo, 1996; Koh et al., 2008a; Koh et al., 2008b; Madri and Pratt, 1986). We 
firstly investigated the effect of astrocytes and pericytes on EC the tube-like structure 
morphogenesis. In addition, the ability of astrocytes and pericytes to induce BBB 
phenotype on these tubes was observed. We also investigated cell junction (AJ & TJ) 
formation and localization of ABC transporters in the luminal side by 
immunocytochemistry. This model showed that new in vitro systems might provide 
valuable information on the BBB induction and disruption. 
The design of such innovative in vitro models will provide an enhancement of current 
in vitro models and raise the importance to recreate the BBB environment as it is 
described in vivo and boost the usage of these models to find novel therapeutic target 
to fight neurological diseases and ultimately help patients to fight against such 
diseases. 
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6. OWN RESEARCH 
The following sections summarize the published or submitted data as shown in the 
manuscripts enclosed with this work. 
 
6.1. 2-dimensional study (manuscript 1): Pericytes perform better than 
astrocytes in maintaining barrier function during prolonged oxygen deprivation 
The aim of this study was to understand the roles played by astrocytes and pericytes 
on the barrier function during hypoxic insult. 
 
6.1.1. Prolonged hypoxic or near-anoxic exposure induces barrier breakdown and 
cell death in RBE4 cells 
Hypoxic exposure of endothelial monolayers results in alterations of cell junction 
proteins and loss of barrier function. Severity and duration of O2 deprivation stress 
might constitute important parameters that need to be considered during BBB 
breakdown. In our study we demonstrate that RBE4 cells, a rat brain endothelial cell 
line, were able to efficiently maintain barrier function during 24h of hypoxic exposure 
(1% O2), followed by dramatic opening after 48h. Notably, reoxygenation allowed 
barrier function recovery. However exposure of RBE4 cells to near-anoxia (0.1% O2) 
dramatically accelerated barrier breakdown and reoxygenation allowed only a slight 
recovery of barrier function in RBE4 cells. In addition, we have demonstrated that 
such discrepancy in barrier function was accompanied by major disruption in cell 
morphology as well AJ (PECAM-1, β-catenin) and TJ (Claudin-5, ZO-1) proteins that 
demonstrates that prolonged O2 deprivation severely disrupts cell-cell contacts. In 
parallel to such dramatic morphological changes hypoxia, and even more near-anoxia, 
resulted in decreased cell survival through activation of caspase-dependant pro-
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apoptotic pathways. In conclusion, O2 deprivation impairs both barrier and cellular 
integrity in RBE4 cells. 
 
6.1.2. Pericytes provide better barrier protection than astrocytes during severe O2 
deprivation stress 
 Astrocytes and more recently pericytes have been shown to induce barrier properties 
in endothelial cells. Therefore, we firstly assessed the ability of astrocytes and 
pericytes to induce barrier function in RBE4 cells, in a contact co-culture model. Our 
study demonstrated that astrocytes and pericytes induced barrier phenotype in 
endothelial cells against molecules of different size (i.e. sucrose and 40-kDa dextran). 
Such induction requires presence of these specific cells since substitution with another 
cell type (i.e. HeLa cells) did not enhance barrier properties in RBE4 cells. 
Additionally, we challenged the different co-cultures to hypoxic stress in order to 
demonstrate a positive advantage of astrocyte and pericyte co-cultures over RBE4 
monocultures. We observed that astrocyte and pericyte co-cultures partially 
maintained barrier function during prolonged hypoxia. Moreover, presence of both 
astrocytes and pericytes resulted in the highest capacity in the maintenance of the 
barrier function, suggesting a synergistic effect between astrocytes and pericytes. 
Surprisingly, under more severe O2 deprivation stress (near-anoxia) astrocyte co-
cultures failed to avoid TJ breakdown in RBE4 monolayers whereas pericytes 
strongly maintained barrier integrity even after prolonged near-anoxic exposure. 
Presence of both cells did not show any synergistic effect compared to pericytes co-
cultures, suggesting that such protection was mediated by pericytes only. Thus 
pericytes perform better than astrocytes during near-anoxia.  
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6.1.3. Maintenance of the barrier function during O2 deprivation involves caspase 
and VEGF signaling pathways  
As evocated before, hypoxia-induced barrier breakdown involves alteration of both 
cell junctions and also activation of cell death mechanisms in endothelial cells.  
We demonstrated that astrocytes and pericytes were able to partially inhibit caspase-3 
activity in RBE4 cells during hypoxic stress. Again, presence of the three cells further 
inhibited caspase-3 activity. However, during prolonged near-anoxia, pericytes only 
were able to attenuate caspase activation. Treatment of RBE4 monolayers with 
ZVAD-fmk provided an advantage only during prolonged O2 deprivation stress and 
during reoxygenation phase, suggesting that additional factors are involved in barrier 
breakdown during acute stress.  
VEGF, one of many hypoxia-induced growth factor, has been demonstrated to 
strongly increase vascular permeability in vitro and in vivo (Fischer et al., 1999; 
Minchenko et al., 1994; Schoch et al., 2002). Using SU1498, a VEGF receptor-2 
inhibitor, we showed that barrier breakdown initiated by O2 deprivation was reversed 
in treated RBE4 cells monolayers. In addition, inhibition of VEGF signaling in 
astrocytes co-cultures resulted in enhancement of the barrier function during hypoxia 
and near-anoxia, suggesting that VEGF/VEGF receptor-2 signaling plays an 
important role in astrocytic response to O2 deprivation and ultimately to their capacity 
to maintain barrier function. Pericyte co-cultures showed improvement only under 
hypoxia, whereas no further enhancement was observed in near-anoxia. Notably, 
three-cell co-cultures did not show any further increase in barrier function in presence 
of SU1498, neither in hypoxia nor near-anoxia, suggesting a possible endogenous 
inhibition of VEGF/VEGF receptor-2 signaling axis. 
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6.2. 3-dimensional study (Manuscript 2): building up an innovative BBB model 
on a dish. Design and characterization. 
The aim of this second study was to provide an innovative 3-dimensional in vitro 
BBB model that allows proper interactions between the different cell types. 
 
6.2.1. RBE4 cells reproduce in vivo vasculogenesis-angiogenesis 
The capacity of endothelial cells to form a vascular network from non-existing 
structures constitutes the most important criteria in 3-dimensional endothelial cell 
culture. Therefore, we firstly assessed the ability of RBE4 cells to reproduce in vivo 
vasculogenesis-angiogenesis.  
Within the matrix, RBE4 cells reproduced a phenotype similar to in vivo situation by 
formation of cysts from which emanated sprouting processes. These sprouting 
processes were able to interact with other sprout, to fuse and to form intercystal 
connections that allow formation connection formation between cysts. Interestingly, 
intercystal connections changed morphology over time, mainly by showing increased 
length and diameter, but also by appearance of tube-like structures. These tube-like 
structures, displaying similar morphology to in vivo capillaries, differ from intercystal 
connections by absence of cysts at their terminus and by formation of collateral 
branches. In conclusion, our model allows RBE4 cells to reproduce cellular events 
that naturally occur during in vivo vasculogenesis and angiogenesis. 
 
6.2.2. BBB maturation and induction involves astrocytes and pericytes  
Formation of BBB in vivo involves maturation of the cerebral vasculature followed by 
induction of BBB phenotype in brain endothelial cells. Thus the second important 
criteria that need to be assessed in our 3-dimensional model is the ability of astrocytes 
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and pericytes to induce a maturation and induction processes in RBE4 tube-like 
structures.  
We firstly assessed the ability of astrocytes and pericytes to modulate RBE4 cell 
angiogenesis. Remarkably, presence of astrocytes and pericytes decreased cell 
density, cysts and intercystal connections numbers. Interestingly, both astrocytes and 
pericytes did not influence intercystal connection length and diameter suggesting that 
vasculogenesis might not be directly regulated by astrocytes and pericytes. However, 
we observed that astrocytes and pericytes were able to modulate formation of tube-
like structures. Astrocytes did not significantly reduced tube-like structures numbers 
and increased tube length and diameter. At the opposite, pericytes strongly up-
regulated formation of tube-like structures but also resulted in decreased diameter. 
The presence of both astrocytes and pericytes significantly reduced tube-like 
structures number compared to other groups but significantly increased their length 
suggesting that astrocytes inhibit pericyte induction. Indeed astrocyte inhibition was 
even potentiated by presence of pericytes. However, tube-like structure diameters 
were significantly different from either astrocytes and pericytes groups thus 
suggesting under such conditions pericytes plays an important role in the regulation of 
tube-like structure diameter. In conclusion, our model shows that astrocytes and 
pericytes constitute important modulators of RBE4 cells angiogenesis underlying their 
importance during brain vasculature development. 
Using immunocytochemistry techniques, we demonstrated that tube-like structures 
formed in RBE4 monocultures displayed an immature phenotype, showing an 
inability to localize AJ proteins (β-catenin, PECAM-1) at the cellular borders, 
suggesting an immature and instable vasculature. In addition, we observed similar 
impairment in protein localization for different BBB phenotype markers such as TJ 
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proteins (ZO-1, claudin-5) proteins at cellular borders, but also localization of some 
ABC transporters at the luminal face (P-gp and MRP2). Notably, both astrocytes and 
pericytes were able to induce BBB phenotype by inducing localization of TJ proteins 
and ABC transporters at the cell borders and in the luminal face respectively. 
In conclusion, we have demonstrated that presence of astrocytes and pericytes were 
necessary to induce maturation of RBE4 cells vasculature, but also to induce BBB 
phenotype. These results shows a nice correlation with in vivo studies concerning 
BBB formation and maturation during development and clearly demonstrates the 
ability of our model to reproduce many in vivo features, demonstrating that our model 
constitute a unique and innovative model compared to actual in vitro models and thus 
we currently validating this model to prove its suitability as a tool to study changes in 
the BBB during pathological states. 
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7. DISCUSSION 
This thesis focused on the development of innovative BBB models based on 2-
dimensional and 3-dimensional cell culture. Our models considered the presence of 
EC, astrocytes and pericytes, but also the reproduction of 3-dimensional structure and 
cellular interactions as they occur naturally in the BBB in vivo. These two criteria are 
considered to be essential to understand the BBB physiology and pathophysiology. 
The work contained in this thesis was performed using RBE4 cell, an immortalized rat 
brain EC. In the 3-dimensional model, RBE4 cells were able to form tube-like 
structures presenting an internal lumen and thus were comparable to in vivo 
capillaries. These tubes showed positive expression of claudin-5 and ZO-1 (two TJ 
markers) but also expression of P-gp and MRP-2 (two ABC transporters) suggesting 
that the tubes displayed important BBB phenotype. In the 2-dimensional model, 
RBE4 cells developed high TEER values, low permeability to water-soluble 
compounds and localization of claudin-5 and ZO-1, showing presence of a BBB 
phenotype in RBE4 monolayers. Our results correlated with values classically 
described in the literature and therefore validate the usage of RBE4 cells as a brain 
EC (Roux and Couraud, 2005). 
It is assumed that that brain vasculature is leaky during development and investiture 
of the immature vessels by astrocytes end-feet processes results in induction of barrier 
phenotype in EC. However, recent studies suggest that developing immature cerebral 
vasculature already expresses TJ proteins (Ballabh et al., 2005) and presents a barrier 
function against small water-soluble compounds (Ek et al., 2006). Thus presence of a 
certain barrier phenotype in the developing brain and re-evaluation of the concept of 
“leaky barrier” may need to be reconsidered. On the other hand, we observed that in 
our 3-dimensional model, RBE4 cells were not able to induce proper localization of 
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TJ proteins at the cellular borders and ABC transporters in the luminal compartment. 
This observation would suggests therefore that brain EC in vivo cannot perform a full 
development of a BBB phenotype on their own and therefore may need interactions 
with the surrounding cells and ECM. This fact has been largely studied in the 
literature showing that brain EC-ECM interactions are crucial for EC maturation (del 
Zoppo and Milner, 2006; Del Zoppo et al., 2006), whereas EC-astrocytes (Abbott, 
2002) and EC-pericytes (Balabanov and Dore-Duffy, 1998; Hellstrom et al., 2001) 
interactions are important role for the stabilization and the induction of the BBB.  
The roles of pericytes during BBB development are relatively unclear although some 
studies showed that pericytes coverage of developing cerebral vasculature were 
associated with vascular stability (Braun et al., 2007). We showed that pericytes play 
important roles in our 3-dimensional cell cultures, by increasing angiogenic processes 
in RBE4 cells, down-regulating RBE4 cell proliferation and by increasing the tube-
like structures density compared to RBE4 cells monocultures and astrocytes co-
cultures. This observation correlates with other studies performed both in vitro (Liu et 
al., 2008; Saunders et al., 2006) and in vivo (Virgintino et al., 2007) showing the 
importance of pericytes as angiogenesis promoters. An additional important feature 
observed was the induction of BBB phenotype by pericytes both in our 2-dimensional 
or 3-dimensional models. Our 3-dimensional pericyte co-culture model was able to 
reproduce behavior observed in vivo and thus shows that our 3-dimensional in vitro 
may be used for studying BBB formation during development.  
Our results showed significant up-regulation of barrier function in RBE4 cells in the 
2-dimensional model and thus correlates with other studies (Dohgu et al., 2005; 
Hayashi et al., 2004; Nakagawa et al., 2007), but also to induce proper localization of 
both TJ and ABC proteins at the cell borders and in the lumen respectively in our 3-
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dimensional model. This induction of proper localization would therefore suggest that 
pericytes might contribute to induce BBB phenotype in EC even before establishment 
of astrocyte contacts. Therefore this induction would explain the presence of an early 
BBB phenotype during development supporting our hypothesis and as suggested by 
others (Ballabh et al., 2005; Virgintino et al., 2008; Virgintino et al., 2004). However, 
further investigations are necessary and an establishment of micro-perfusion 
techniques to perfuse our tube-like structures would directly allow us to assess if 
pericytes induction of proper protein localization correlates with decreased 
permeability to water-soluble compounds. 
Astrocytes are classically described to induce BBB phenotype in brain EC both in 
vitro (Arthur et al., 1987; Dehouck et al., 1990; Rauh et al., 1992) and in vivo (Butt et 
al., 1990). Our two different in vitro models show that astrocyte co-cultures were able 
to up-regulate barrier phenotype in RBE4 and thus make our finding consistent with 
the literature. In our 2-dimensional model, astrocytes were able to induce significant 
increase in TEER but also decrease paracellular permeability to water-soluble 
compounds. As observed with 3-dimensional pericyte co-cultures, astrocytes co-
cultures were able to induce appropriate TJ and ABC proteins localization in RBE4 
tube-like structures and therefore suggest that astrocytes may induce BBB phenotype. 
Unlike pericytes, astrocytes did not influenced angiogenesis but played important 
roles in tube-like structure stabilization and maturation as we observed a decrease in 
RBE4 cell proliferation and increased tube length and caliber suggesting that 
astrocytes may play also in important in the maturation process that follow the onset 
of cerebral vasculature. 
The presence of both astrocytes and pericytes do to not occur simultaneously during 
development, as pericyte-endothelial interactions precede astrocyte-endothelial ones. 
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Therefore astrocytes and pericytes should coordinate to induce maturation processes 
that ultimately lead to mature BBB phenotype. In our 2-dimensional study presence of 
both astrocytes and pericytes resulted in a maximal barrier phenotype induction and 
therefore the study of Nakagawa and colleagues (Nakagawa et al., 2007) agrees with 
ours as we both conclude that astrocytes and pericytes have a synergistic effect in 
induction of barrier phenotype. Previously described in the thesis (see chapters 4.1.6 
and 4.1.7) is that astrocytes and pericytes secrete Ang-1 and TGF-β which would 
explain why we did not obtain only a partial cumulative effect. On the other hand, 
astrocytes and pericytes may release specific factors that might activate distinct 
signaling pathways resulting in the partial cumulative effect observed in our 2-
dimensional study. However the nature of such factors is still unclear and needs 
further investigation.  
In addition to the synergistic effect demonstrated in the 2-dimensional study, using 
our 3-dimensional model we saw that both astrocytes and pericytes presence caused a 
significant decrease in numbers of tube-like structures, as well as a significant 
increase in average tube length compared to astrocyte and pericyte co-cultures. These 
results suggest that pericytes might potentiate astrocyte effect instead of inhibiting it. 
This would further suggest that a cellular cross talk occurs between astrocytes and 
pericytes that result in such potentiation. 
It is interesting to note that the BM delimitating the neurovascular unit physically 
separates astrocytes and pericytes from each other, therefore direct physical contact 
between astrocytes and pericytes, but also between EC and astrocytes, appears 
unlikely. Therefore astrocyte-endothelial interactions may involve secretion of soluble 
factors, but also a modification of the BM composition may result in induction of 
BBB phenotype as suggested by different studies made on 2-dimensional in vitro 
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models (Tilling et al., 2002; Tilling et al., 1998). Our two models allowed close 
contacts between astrocytes and EC, with investiture of RBE4 tube-like structures by 
astrocytic end-feet processes in our 3-dimensional model. Therefore we can speculate 
that induction of barrier phenotype in RBE4 tube-like structures might be due to ECM 
secretion by surrounding end-feet processes in addition to release of soluble factors. 
Using our 3-dimensional in vitro model, we will in future address the possible 
presence of ECM secretion between EC and astrocytic end-feet process and hopefully 
determine the nature of these potential secreted matrix proteins. 
Pericytes share the same BM as EC and also directly interact with EC by gap 
junctions, suggesting an additional communication mode between pericytes and EC, 
besides the release of factors or matrix proteins. Our 3-dimensional model allowed 
direct interactions between tube-like structures and pericytes and therefore we can 
speculate that gap junctions may occur between these two cell types.  
In our 2-dimensional study, RBE4 cells monolayers maintained an efficient barrier 
function during acute hypoxic (1% O2) or near anoxic (0.1% O2) exposure. However 
barrier disruption occurred significantly after prolonged exposure with both loss of 
barrier function and TJ complexes at the cell borders. Our data are in agreement with 
the literature as we also observed an increase in paracellular permeability (Plateel et 
al., 1995) and loss in ZO-1 localization (Fischer et al., 2002) and therefore validate 
the usage of our model to study the effect of astrocytes and pericytes co-cultures. 
However we showed that drastic alterations in barrier function occurred only after 
prolonged hypoxic stress, whereas previous studies mostly focused on short-term O2 
deprivation. In addition we demonstrated that disruption of the barrier function in 
RBE4 monolayers was reversible only during mild hypoxic insult, reoxygenation did 
not allow recovery after prolonged near-anoxia. Thus our study emphasized that 
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duration and intensity of the hypoxic insult dictates not only the onset of the barrier 
breakdown, but also the ability of the BBB to recover adequate barrier function after 
insult.  
HIF-1α stabilization may influence directly or indirectly EC response to hypoxia and 
therefore raise the role of HIF-1 on the barrier function. Although we did not directly 
investigate changes in HIF-1α levels during hypoxic stress, we did investigate the role 
of VEGF signaling, a HIF-1 target gene, in our 2-dimensional cultures. As we have 
previously discussed (see chapters 4.2.2 & 4.2.3), VEGF constitutes one of the most 
important HIF-1 target genes. In addition to its important roles pro-angiogenic role, 
VEGF is known as a factor that induces brain vascular leakage (Fischer et al., 1999; 
Fischer et al., 2004; Issbrucker et al., 2003; Schoch et al., 2002). Therefore VEGF 
signaling may play an important role in the onset of the BBB disruption during 
hypoxia. We observed that VEGF signaling inhibition by blocking VEGFR-2 
activation resulted in restoration of the barrier function in RBE4 cell monolayers both 
in prolonged hypoxia and near-anoxia, correlating with previous studies that showed 
inhibition of VEGF signaling restored ZO-1 protein localization (Fischer et al., 2004; 
Fischer et al., 2002) and decreased brain vascular permeability (Kilic et al., 2006; 
Kumai et al., 2007; Schoch et al., 2002). Therefore we can consider that presence of a 
VEGF autocrine loop occurs in RBE4 monolayers, leading to pathway signaling 
activation and ultimately barrier breakdown. Thus excessive VEGF production by 
prolonged HIF-1α stabilization can cause barrier breakdown. 
Astrocyte co-cultures provided partial protection of the barrier function, as we 
observed better TEER and permeability values compared to RBE4 monocultures 
during both hypoxia and near-anoxia and agrees with a few studies that have been 
performed on hypoxic co-cultures (Fischer et al., 2000; Kondo et al., 1996). However 
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we observed that astrocytes beneficial effect during hypoxia were significantly 
reduced in near-anoxic co-cultures, such effects were unlikely due to decrease in 
astrocytes cell survival, as no changes in astrocytes cell survival rate occurred. 
Therefore the effect might be carried by a hypoxic-inducible factor that elicit barrier 
breakdown such as VEGF. Our group recently demonstrated that astrocyte VEGF 
secretion was significantly up-regulated by O2 and glucose deprivation. Notably, 
increase in VEGF secretion was proportional to the severity insult, as near-anoxic 
astrocytes showed a significant increase in VEGF secretion compared to hypoxic 
astrocytes (Schmid-Brunclik et al., 2008). Therefore, we may consider that the 
discrepancy in astrocytes protection observed in near-anoxia might be due to 
exacerbated VEGF secretion levels. Using VEGFR-2 inhibitor we observed that the 
barrier function was enhanced only in long-term hypoxic and short-term near-anoxic 
co-cultures suggesting that a gradual increase in VEGF secretion in astrocytes is 
elicited by decrease in O2 levels and VEGFR-2 playing again a central role in 
induction of barrier breakdown in our model. It is interesting to note that both RBE4 
and astrocytes showed VEGFR-2 expression, astrocytes VEGFR-2 playing an 
important role as inducer of astrocytes proliferation (Schmid-Brunclik et al., 2008). 
However the role of VEGFR-2 signaling in astrocyte VEGF secretion has not been 
addressed yet, thus further studies would provide useful information concerning a 
possible negative feedback loop.  
Pericytes co-cultures displayed particular response to O2 deprivation stress as they 
rapidly lost the ability to maintain appropriate barrier function during acute hypoxic 
stress and showed protective effects only during long-term hypoxia or during near-
anoxia. Our data would agree with a study performed by Hayashi and colleagues 
(Hayashi et al., 2004), however this study provided only fragmented information on 
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pericyte co-culture response to hypoxia. We observed that VEGF blockade had an 
effect in pericyte co-cultures only during hypoxia with no additional increase in 
barrier function was observed in near-anoxic samples, suggesting that VEGF 
signaling might be endogenously inhibited. 
Different studies have described that VEGF acts as a negative signal for pericyte 
recruitment as subsequent VEGFR-2 inhibition allowed proper vascular coverage by 
pericytes (Greenberg et al., 2008). Our study therefore corroborates that 
VEGF/VEGFR-2 signaling may impair pericyte function and their protective effects 
towards EC. Nomura and colleagues described that VEGFR-2 was not expressed in 
pericytes during hypoxia (Nomura et al., 1995). Thus the enhancement of the barrier 
function observed in presence of VEGFR-2 inhibitor would suggest that activation 
VEGF/VEGFR-2 autocrine loop in EC during hypoxia might result in release of 
negative factors compromising protective effects carried on by pericytes. Although 
we do not know the nature of such negative secreted factors, Ang-2 as a hypoxic-
inducible factor secreted by EC might constitute one of these negative factors as Ang-
2 results in important impairment in the vasculature and loss of pericyte-induced 
barrier function in the retina (Feng et al., 2008; Hammes et al., 2004; Maisonpierre et 
al., 1997; Pichiule et al., 2004). 
Our 2-dimensional study showed that presence of both astrocytes and pericytes were 
necessary to obtain maximal induction of barrier function in RBE4 cells in normoxia. 
Presence of both astrocytes and pericytes was also necessary to maintain appropriate 
barrier function during hypoxia showing significant higher values versus two-cell co-
cultures. This result again underlines the synergistic effect afforded by presence of 
both astrocytes and pericytes in the maintenance of the BBB during hypoxic injury. 
However the synergistic effect was attenuated during near-anoxia despite the 
 83  
maintenance of the barrier function remaining significantly higher compared to 
astrocyte co-cultures. Indeed, we observed no significant difference compared to 
pericyte co-cultures suggesting that pericytes might constitute the cell type that 
maintains the barrier function in the three-cell co-cultures. Discrepancy of the 
astrocyte effect might be due to elevated VEGF secretion during near-anoxia. 
However, we did not observe further improvement of the barrier function in presence 
of VEGFR-2 inhibitor either in hypoxia or near-anoxia, suggesting that endogenous 
VEGF signaling inhibition occurs during O2 deprivation stress, such inhibition likely 
involves a cross-talk between astrocytes and pericytes. However additional studies 
needs to be performed to understand how these two cell type coordinate their 
responses during hypoxia leading to the synergistic effect observed on the barrier 
function.  
Notably although astrocytes and pericytes show relative opposite behavior in regards 
of endothelial barrier function during O2 deprivation stress, our current understanding 
of pericytes response to O2 deprivation remains still unclear. Therefore further 
investigation on the pericyte response to hypoxia, focusing on HIF-1α mediated 
response to hypoxia in pericytes might help to clarify the situation. 
In this chapter we mostly discussed of VEGF as a negative factor, inducing BBB 
breakdown. However it is important to mention that VEGF has non-vascular effects 
and plays important roles as cell survival factor for EC and other cells during hypoxic 
stress (Chow et al., 2001; Plaschke et al., 2008; Scheid et al., 2000; Wang et al., 2007; 
Wang et al., 2005). We have demonstrated that prolonged or severe hypoxic stress 
induces caspase-3 activation and apoptosis in RBE4 cells; astrocytes and pericytes 
were able to partially inhibit apoptosis by inhibiting caspase-3 activation. However, 
other studies have specifically shown that alteration of VEGF signaling occurs in 
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many neurological diseases (Kilic et al., 2006; Kumai et al., 2007; Sun et al., 2003b; 
Villar-Cheda et al., 2008; Wang et al., 2007; Yasuhara et al., 2004; Yasuhara et al., 
2005) highlighting the importance of VEGF as an important neuroprotective factor. 
Inhibition of VEGF-mediated barrier breakdown and the maintenance of its 
neuroprotective role would probably rehabilitate VEGF as a neuroprotective agent 
(Plaschke et al., 2008; Vogel et al., 2007; Wang et al., 2007; Wang et al., 2005). 
The roles of astrocytes and pericytes in the maintenance of the barrier function during 
hypoxia were investigated extensively using a 2-dimensional model. However, as we 
have discussed in the beginning of the chapter, this model do not allow optimal 
physical cellular interactions as they naturally occur in vivo. We hypothesized that 
such contacts between the different components of the BBB might play important 
roles during cerebral injury. 
Data obtained with our 3-dimensional model showed that prolonged hypoxia induced 
alterations in astrocyte-endothelial interactions. We firstly observed that astrocyte 
end-feet morphology was altered by prolonged hypoxia, resulting in irregular 
distribution of the end-feet over the tube and process retraction. This was 
accompanied by notable changes in tube diameter, suggesting that alteration in 
astrocyte-endothelial interactions could directly modulate endothelial morphology. 
Such alterations were more visible in near-anoxic astrocyte co-cultures, showing 
significant end-feet processes retraction, disruption of the tube-like structure 
morphology and complete loss of the vascular structure. These results correlate nicely 
with the data obtained from our 2-dimensional study and therefore may suggest that 
astrocytes contacts through end-feet processes do indeed play important roles in the 
maintenance of the barrier function during hypoxic stress. Willis and colleagues 
(Willis et al., 2004) have suggested the importance of astrocyte-endothelial 
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interactions for the induction of the BBB, although the experimental approach used in 
this study remains disputable. In this in vivo study, they observed that loss of 
astrocytes was accompanied by loss of barrier phenotype in the adjacent vasculature 
and restoration of astrocyte-endothelial interactions was accompanied by restoration 
of a BBB phenotype in EC. 
Although we have not performed yet any study of alterations in endothelial-pericytes 
interactions in our cultures, recent studies performed by Duz and colleagues (Duz et 
al., 2007; Gonul et al., 2002) showed that pericytes migration occurs during early 
onset of cerebral injury, resulting in decreased pericyte coverage of the injured 
vasculature. Such decrease in pericyte coverage might be associated with 
destabilization of the blood vessel and subsequent formation of leaky vessels.  We are 
currently investigating the importance of such pericyte movement and migration on 
barrier integrity using our 3-dimensional model. 
In summary this thesis provides a new dynamism within the field by the design of 
these two innovative in vitro models that emphasize the importance of astrocytes and 
pericytes presence on one hand and the reconstitution of the 3-dimensional cellular 
interactions as in vivo situation on the other. Furthermore these models are easily 
customizable, allowing addition or removal of different cell types to dissect signaling 
pathways underlying different cellular interactions, opening these models to a 
multitude of in vitro studies investigating the BBB under physiological or 
pathological situations. The enthusiasm reflected by the scientific community towards 
our models and especially to our 3-dimensional model further suggests that there is a 
need for such new innovations that will be adopted by others. We expect that these 
models will be frequently used in the near future encouraging the consideration of 
other integrative approaches during development of in vitro models in general. 
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Despite the fact that our models still remain a simplification of in vivo situation, they 
reach an integrative dimension superior to current in vitro models. The two models 
are not just a simple overlap, but indeed are complimentary as they allow 
investigation of different features of BBB interactions. We are convinced that these 
models have a definite place in the field and will contribute to enhance our 
understanding of the BBB during physiological and pathological situation. Our 
models, and in particular the 3-dimensional model, define a new step in achievement 
of the design of integrative in vitro models and bring powerful tools to the research 
field for better understanding of the BBB as a neurovascular unit. 
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Maintaining Blood–Brain Barrier
Integrity: Pericytes Perform
Better Than Astrocytes During
Prolonged Oxygen Deprivation
A. AL AHMAD, M. GASSMANN, AND O.O. OGUNSHOLA*
Institute of Veterinary Physiology and Zurich Centre for Integrative Human Physiology (ZIHP), University of Zu¨rich,
Zurich, Switzerland
The blood–brain barrier (BBB), consisting of specialized endothelial cells surrounded by astrocytes and pericytes, plays a crucial role in
brain homeostasis. Many cerebrovascular diseases are associated with BBB breakdown and oxygen (O2) deprivation constitutes a critical
factor that onsets its disruption. We investigated the impact of astrocytes and pericytes on brain endothelial cell permeability and survival
during different degrees of O2 deprivation. Prolonged exposure to 1% O2 caused barrier breakdown and exposure to 0.1% O2
dramatically accelerated disruption and induced cell death, mediated at least in part via caspase-3 activation. Reoxygenation allowed only
cells exposed to 1% O2 to re-establish barrier function. Notably co-culture with astrocytes and pericytes substantially enhanced barrier
function under normoxic conditions, and produced differential responses during O2 deprivation. At 1% O2 astrocytes partially maintained
barrier integrity whereas pericytes accelerated its disruption in the short-term, having positive effects only after prolonged exposure.
Unexpectedly, at 0.1% O2 pericytes were more effective than astrocytes in preserving barrier function although the protection afforded by
both cells involved inhibition of caspase-3 pathways. Furthermore, cell-specific regulation of auto- and paracrine VEGF signaling pathways
were also in part responsible for the differential modulation of barrier function. Our data suggests that cellular cross-talk within the
neurovascular unit is crucial for preservation of barrier integrity and that pericytes, not astrocytes, play a significant role during severe and
prolonged O2 deprivation.
J. Cell. Physiol. 218: 612–622, 2009.  2008 Wiley-Liss, Inc.
Cerebrovascular diseases constitute the second cause of death
worldwide (Lopez et al., 2006) and are defined by an
impairment of proper nutrient and O2 delivery to the cerebral
tissue. Hypoxia constitutes one of the critical factors involved in
these diseases inducing blood–brain barrier (BBB) breakdown
that leads to brain swelling and edema formation in vivo (Ballabh
et al., 2004). In vitro studies have demonstrated that hypoxia
induces dramatic alterations in the endothelial actin
cytoskeleton and tight junction protein localization (Mark and
Davis, 2002; Brown and Davis, 2005). Furthermore, in vivo
models showed that rodent brain vascular leakage takes place 1
and 24 h after exposure to 6% (Witt et al., 2003) and 8% (Schoch
et al., 2002) O2 concentrations, respectively. These differences
suggest that injury time and severity might constitute critical
factors to be considered for both rate of breakdown as well as
the ability to recover after injury.
The BBB is a neurovascular unit formed by endothelial cells,
pericytes, and perivascular astrocytes (Pardridge, 1998). It plays
a crucial role in the maintenance of the central nervous system
homeostasis by limiting diffusion of soluble compounds from
the blood to the brain parenchyma. Astrocytes induce barrier
phenotype in brain endothelial cells (that form the blood
vessels) through development of end-feet processes and
release of soluble factors (Arthur et al., 1987; Rist et al., 1997).
In contrast to the wealth of knowledge on astrocyte function,
the contribution of pericytes to BBB phenotype remains more
obscure. However in vitro (Hayashi et al., 2004; Hori et al.,
2004) and in vivo (Hellstrom et al., 2001) studies published
recently indicate that pericytes also contribute to barrier
function. Furthermore other studies have demonstrated an
impairment of astrocyte and pericyte functions in neurological
diseases such as Alzheimer’s disease (Iadecola, 2004), multiple
sclerosis (Argaw et al., 2006) and diabetic retinopathy (Joussen
et al., 2003). Clearly O2 deprivation stress is an important factor
linked to induction of vascular leakage and direct effects of
hypoxia on the response of astrocytes or pericytes must have
significant consequences on BBB function.
Most in vitro studies performed on brain endothelial cells
exposed to O2 deprivation omit the presence of astrocytes and/
or pericytes constituting an important limitation of their
findings. This study investigates the effects of different O2
concentrations on endothelial cell barrier function and the
putative impact of astrocytes and pericytes on barrier
maintenance using transendothelial electrical resistance (TEER)
and permeability measurements. We demonstrate that
monolayer integrity and cell viability depend on the severity
of O2 deprivation. Moreover astrocytes and pericytes display
differential effects during O2 deprivation, with pericytes
performing better than astrocytes during extreme O2
deprivation.
Additional Supporting Information may be found in the online
version of this article.
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Materials and Methods
Cell culture
Rat brain endothelial cell line (RBE4) was used for experiments
(Roux et al., 1994). Primary rat astrocytes were isolated from
neonatal pups as described previously (Chow et al., 2001) and
cultured in 10% FBS and 50 mg/ml gentamycin sulfate. Primary rat
brain pericytes were isolated from male adult rat brains following
an established protocol (Dore-Duffy, 2003). Briefly, cerebral
microvessels were isolated from brains, digested with
collagenase/dispase for 2 h at 378C and plated on uncoated dishes.
Freshly isolated pericytes were cultured in DMEM supplemented
with 20% FBS, 50 mg/ml gentamycin sulfate and 2.5 mg/ml
amphotericin B until near confluency. Subsequent passages were
maintained in astrocyte medium. Pericyte cultures were >95%
pure as estimated from strong positive a-smooth muscle actin
(a-SMA) staining and negative GFAP expression (Supplementary
Fig. 1). HeLa cells were cultured in DMEM supplemented with
10% FBS, 100 U/ml streptomycin, 100 mg/ml penicillin,
1% non-essential amino-acids and 1% sodium pyruvate. Rat-tail
collagen was isolated using a previously described method (Roll
et al., 1980).
O2 deprivation-reoxygenation experiments
Experiments were performed in a purpose-built hypoxic glove-box
chamber (InVivO2 400, Ruskinn Technologies, Pencoed, UK)
maintained at 378C with 5% CO2. Cells were exposed to either 1%
(hypoxia) or 0.1% (near-anoxia) O2 for different durations. Using
this instrument O2 concentration is constantly monitored
internally by an O2 sensor and automatically adjusted.
Reoxygenation was performed at 21% O2 for 24 h. Cells were
cultured in RBE4 medium during monoculture experiments, or in
astrocyte medium during co-culture experiments.
Transendothelial electrical resistance
Transendothelial electrical resistance (TEER) measurements were
performed on TranswellsTM (Corning, Schiphol, The Netherlands)
coated with rat-tail collagen. These inserts allow proper cellular
polarization with formation of an apical (upper compartment) and
basolateral face (lower compartment) mimicking luminal and
abluminal faces (Fig. 3A). RBE4 cells were seeded on the upper side
of the insert at a density of 0.5 106 cells/insert. TEER was
measured using an EVOM chopstick (World Precision Instruments,
Sarasota, FL). All resistance measurements were compared to
collagen-coated blank filters. Prior to O2 deprivation, monolayers
were cultivated for 8 days (Roux et al., 1994).
In co-culture experiments, RBE4 cells were seeded on the upper
side of the filter whereas astrocytes, pericytes or HeLa cells were
seeded on the lower side of the filter (Fig. 3A). Each cell type was
seeded at a density of 0.5 106 cells/insert. Co-cultures were
maintained in astrocyte medium for 8 days prior to the start of
experiment. TEER measurements during O2 deprivation were
performed in the hypoxic glove-box chamber without
reoxygenation.
Permeability assays
Permeability assays were performed on Transwells. Fresh medium
containing radiolabelled sucrose (14C-sucrose, 1 mCi/ml,
Amersham Biosciences, Otelfingen, Switzerland) or 40 kDa
fluorescein isothiocyanate conjugated-dextran (1 mg/ml,
Sigma–Aldrich, Buchs, Switzerland) was added to the upper
compartment. At 0, 15, 30, 45, and 60 min aliquots were taken from
the bottom compartment. Sample radioactivity was determined
using a liquid scintillation b-counter (Tricarb 1600TR, Canberra
Packard, Schwadorf, Austria) whereas fluorescence was
determined with a fluorescence plate reader (FLx800, Biotek
Instruments, Winooski, VT). A clearance slope was established
from the measurements obtained at the different timepoints and
used to calculate permeability coefficient values (Pe) (Rist et al.,
1997).
Cell density and viability
Assays were performed on confluent cells grown on 24-well plates.
An aliquot of cells were mixed with an equal volume of 0.4% trypan
blue solution (Sigma–Aldrich) and cell counting was performed
with a glass hematocytometer (Neubauer, Brand, Wertheim,
Germany).
Caspase-3 activity assay
Caspase-3 activity assays were performed using a colorimetric
activity assay (R&D Systems, Minneapolis, MN). In brief, cells were
washed with ice-cold PBS, harvested into lysis buffer and the
supernatant assayed for caspase-3 activity. Equal protein amounts
were incubated in presence of DEVD peptide conjugated with
p-nitroaniline (DEVD-pNA). Cleavage of DEVD-pNA was
quantified spectrophotometrically at 405 nm (Multiskan RC,
Thermo Labsystems, Zu¨rich, Switzerland). Caspase-3 enzymatic
activity in the cell lysate was proportional to optical density. Optical
densities were normalized to normoxic values and expressed as
fold-change.
Pharmacological inhibition experiments
Caspase inhibition experiments were performed on RBE4
monolayers exposed to RBE4 culture medium supplemented with
100 mM ZVAD-fmk (R&D Systems) or containing 1% DMSO only,
prior to hypoxic and near-anoxic incubation.
VEGF signaling inhibition experiments were performed on
mono- and co-cultures in medium supplemented with 10 mM
SU1498 (Calbiochem, VWR, Dietikon, Switzerland) or containing
0.1% DMSO only, prior to hypoxic and near-anoxic incubation.
Microscopy and immunocytochemistry
Bright-field pictures of confluent RBE4 monolayers were taken
using an inverted phase contrast microscope (Axiovert 40 CFL,
Zeiss, Feldbach, Switzerland) and CCD digital camera (Cybershot
DSC-S85, Sony Corporation, Tokyo, Japan). Micrograph
pictures of fluorescence immunocytochemistry for CD31 (mouse,
1:100, Chemicon, Millipore, Zug, Switzerland), b-catenin
(mouse, 1:100, BD Biosciences, Allschwil, Switzerland), claudin-5
(rabbit, 1:100, Invitrogen, Basel, Switzerland) and ZO-1 (rabbit,
1:100, Invitrogen) were taken using an inverted fluorescence
microscope (Axiovert 200M, Zeiss) coupled to an 8-bit CCD
camera (Axiocam HR, Zeiss).
Statistical analysis
All results are expressed as mean SD from three or more
independent experiments. Statistical significance was assessed by
one-way ANOVA for comparison of different timepoints within a
group, two-way ANOVA for comparison between different
groups. A P-value below 0.05 was considered significant.
Results
Barrier function during normoxia
TEER of normoxic RBE4 monolayers was measured using a
modified Boyden chamber. Under normoxic conditions a
gradual increase in resistance with a peak of 201.13 8.11
V cm2 at day 6 was observed. A period of 8 days was necessary
to obtain constant TEER values. Accordingly, all subsequent O2
experiments were performed after 8 days.
Prolonged O2 deprivation disrupts RBE4 monolayers
RBE4 monolayers were exposed to either 1% (hypoxia) or 0.1%
(near-anoxia) O2 concentration for up to 48 h. Acute hypoxic
exposure (Fig. 1A) caused an initial decrease of resistance that
remained constant till 8 h. Monolayers exposed to near-anoxia
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exhibited an accentuated and sustained decrease in electrical
resistance down to 75.85 4.83 V cm2 at 4 h but surprisingly
TEER again stayed constant thereafter.
Extended O2 deprivation completely disrupted barrier
function in both hypoxia and near-anoxia (Fig. 1A). Resistance
of hypoxic monolayers decreased from 118.79 9.51 to
101.86 6.50 V cm2 at 24 and by 48 h the TEER was just
2.81 1.96V cm2 indicating complete loss of integrity. Despite
this, reoxygenation stimulated resistance recovery indicating a
reduction of permeability. Under near-anoxic conditions
monolayers showed a more pronounced decrease compared
to the hypoxic group with a very significant drop to
54.01 14.31 V cm2 after 24 h. Similar to the hypoxic group
48 h exposure caused complete loss of resistance but
reoxygenation did not support a dramatic improvement in
resistance levels, with TEER values (23.43 4.61 V cm2)
remaining significantly lower than the hypoxic-reoxygenated
group. Notably no significant decrease was observed under
normoxic condition during these timepoints (data not shown),
showing that loss of barrier function is only due to O2
deprivation. Thus the degree of O2 deprivation significantly
influences the recovery of barrier properties as well as the rate
of barrier breakdown during prolonged hypoxia.
O2 deprivation alters RBE4 morphology and
delocalizes cell junction proteins
Under normoxic conditions RBE4 cells exhibit classical
cobblestone morphology (Fig. 1B, first panel) with marked light
refraction around the cell borders indicating close and intimate
contacts. Hypoxic conditions (1% O2) changed the light
refraction over time and induced cell swelling (Fig. 1B, upper
panels). After 24 h approximately 90% of the cells maintained
close contacts but by 48 h a clear decrease was observed.
Subsequent reoxygenation allowed intimate contacts to be
reformed correlating well with previous TEER measurements.
Near-anoxia (Fig. 1B, lower panels) caused loss of
approximately 50% of intimate contacts already at 24 h. At 48 h
Fig. 1. O2 deprivation impairs RBE4 barrier function by disruption of cell morphology and cell junctions. RBE4 monolayers were incubated at
either 1% or 0.1% O2 concentrations and TEER was measured for 48 h and reoxygenation was performed for 24 h (A). During short-term
experiments hypoxia (circles) did not significantly affect TEER. Long-term hypoxia resulted in complete loss of resistance that was reinstated
during reoxygenation. Long-term near-anoxic exposure caused a faster decrease in TEER and significantly worse recovery during reoxygenation.
(MP < 0.05; MMP < 0.01 comparison vs. 0 h timepoint, #P < 0.05; ##P < 0.01 comparison between hypoxic and near-anoxic groups, n U 8 per group).
Bright-field microscopy revealed altered RBE4 cell morphology during O2 deprivation (B). Fluorescence micrographs of CD31 (C),b-catenin (D),
claudin-5 (E) and ZO-1 staining (F) show protein delocalization (arrows) during hypoxia and more rapid alterations in near-anoxia.
Reoxygenation supported re-localization of junctional proteins only under hypoxic conditions. Scale bar U 25mm.
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appearance of large gaps was clearly visible and this remained
even after reoxygenation.
Notably, immunocytochemistry against CD31 (Fig. 1C),
b-catenin (Fig. 1D), claudin-5 (Fig. 1E), or ZO-1 (Fig. 1F) also
displayed significant alterations. Under normoxic condition,
continuous positive staining of all proteins was observed at cell
borders. Hypoxic exposure (Fig. 1C–F, upper panels) resulted
in irregular, discontinuous distribution at 24 h that ultimately
led to loss of staining at some borders at 48 h (arrows).
Remarkably, reoxygenation supported re-localization of these
proteins (arrows), again suggesting an improved barrier
function. During near-anoxia, a drastic and rapid disruption of
cell junction proteins occurred with many regions exhibiting
complete loss of staining (Fig. 1C–F, lower panels arrows) that
only partially recovered during reoxygenation. Thus severe O2
deprivation irreversibly disrupts cellular morphology and cell
junction protein localization.
Cell death of RBE4 cells correlates with severity
of O2 deprivation
We monitored the effect of O2 deprivation on cell density and
survival (Fig. 2A,B respectively). Cell density during normoxic
experiments remained stable. Hypoxia significantly decreased
cell density from 100 6.02% at 0 h to 57.72 17.75% at 48 h
then remained constant during reoxygenation (61.64 8.9%).
Near-anoxia induced an early decrease in cell density to
79.75 14.47% at 24 h reaching a minimal value of
67.79 22.41% at 48 h. As in hypoxia reoxygenation did not
enhance cell density.
Cell survival was monitored by trypan blue exclusion assay
(Fig. 2B). Normoxic cell numbers remained constant while
hypoxia decreased cell survival by approximately 30% at 48 h.
Reoxygenation attenuated this decrease. Interestingly,
near-anoxia accentuated the decrease compared to hypoxic
and normoxic groups, showing a value of only 42.03 16.95%
at 48 h. Reoxygenation again arrested cell death.
O2 deprivation-induced cell death involves
caspase-3 activation
We measured activation of caspase-3-dependent pathways
during O2 deprivation-induced cell death (Fig. 2C). In hypoxic
monolayers activity increased 2 fold (2.18 0.42) at 24 h
compared to normoxic conditions and maximal induction
occurred at 48 h (3.11 0.48 fold increase) followed by a
decrease during reoxygenation to values similar to control
levels. Near-anoxic conditions induced an activity peak of
approximately threefold (3.30 0.64) at 24 and 48 h suggesting
more rapid induction of cell death during near-anoxia. Caspase-
3 levels could not be determined in near-anoxic reoxygenated
samples due to extremely low concentrations of protein
reflecting the severity of the insult. Thus O2 deprivation
activates caspase-3 dependant pathways in endothelial cells in
proportion to insult severity.
Astrocytes and pericytes survive extreme
O2 deprivation
Since astrocytes and pericytes do not grow well in RBE4
medium, we investigated whether astrocyte medium culturing
conditions affected RBE4 cell viability (supplementary Fig. 2).
Astrocyte medium did not alter survival of RBE4 cells during
normoxic, hypoxic or near-anoxic conditions (supplementary
Fig. 2A) compared to standard RBE4 medium. O2 deprivation
did not affect astrocyte or pericyte survival (supplementary
Fig. 2B and C) even after severe stress conditions (48 h at
0.1% O2). Thus astrocytes and pericytes can survive
extreme O2 deprivation well.
Pericytes and astrocytes augment barrier function
during normoxia
Barrier function was measured in RBE4 cells co-cultured in
direct contact with astrocytes and/or pericytes as illustrated in
Fig. 2. O2 deprivation decreased RBE4 cell density and cell viability.
Cell density was determined using trypan blue exclusion assay (A).
Density of confluent RBE4 monolayers decreased faster in cells
exposed to near-anoxia (black bars) than hypoxia (grey bars) and
normoxia (open bars). Cell viability was significantly reduced during
prolonged O2 deprivation (B). Caspase-3 activity was up-regulated in
RBE4 monolayers during prolonged hypoxia and further induced by
near-anoxia (C). (MP < 0.05, MMP < 0.01 compared to the 0 h timepoint;
#P < 0.05, ##P < 0.01 comparison between hypoxic and near-anoxic
groups, n U 8 per group).
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Figure 3A. After 2 days of co-culture with astrocytes (Fig. 3B)
RBE4 TEER increased approximately 50% compared to RBE4
cells alone. Interestingly, co-cultures of RBE4 with pericytes, as
well as three-cell co-cultures, only increased TEER
measurements by 20% at this time. Subsequently, both
astrocytes and pericytes induced the level of resistance by 40%
compared to RBE4 monolayers alone. However three-cell
co-culture presented the highest TEER of 282.81 45.12
V cm2 indicating that astrocytes and pericytes enhance
normoxic barrier function and together have synergistic effects.
Specificity of astrocyte and pericyte effects was demonstrated
by co-culturing with HeLa cells (Fig. 3B). As expected no
resistance change was observed confirming that cell-specific
interactions and/or release of factors are required to induce
endothelial barrier function.
Additionally we performed permeability experiments with
radiolabelled sucrose (Fig. 3C) and with FITC-conjugated
40 kDa dextran (Fig. 3D). Monolayers cultured alone always
presented highest permeability values. Co-culture with
astrocytes, pericytes or both together significantly decreased
endothelial monolayer. Notably, higher permeability values
were obtained using sucrose due to its small size (360 Da
compared to the 40 kDa dextran).
Presence of both astrocytes and pericytes is required to
maintain barrier function during prolonged hypoxia
Little is known about the ability of astrocytes and pericytes to
maintain endothelial barrier properties during hypoxic stress.
We monitored time-dependent TEER changes in RBE4 cells
co-cultured with astrocytes and/or pericytes during O2
deprivation. Short-term hypoxia (Fig. 4A) initially significantly
decreased the resistance values of all groups. Co-culture of
RBE4 with astrocytes or both astrocytes and pericytes
improved TEER values compared to RBE4 cells alone.
Unexpectedly, pericyte co-culture exacerbated barrier
disruption causing a dramatic decrease (60%) in resistance
within 6 h. Long-term hypoxia also increased permeability of
RBE4 monolayers but again co-culture with other vascular-
related cells improved barrier function (Fig. 4A). In presence of
astrocytes TEER was increased by almost twofold over RBE4
cells alone for up to 48 h and reoxygenation allowed further
recovery of electrical resistance. Surprisingly, despite their
negative impact in the short-term, pericytes significantly
enhanced barrier function to levels comparable with astrocytes
during long-term experiments. Notably, presence of all three-
cell types was necessary to maintain barrier function at 24 and
48 h wherein TEER values were similar to those at starting
timepoints indicating a synergistic effect. As previously shown
HeLa did not affect electrical resistance. To confirm the positive
role of astrocytes and pericytes in the maintenance of barrier
function during O2 deprivation, we measured alterations in
sucrose and dextran permeability (Fig. 4B,C, respectively).
RBE4 cell monocultures rapidly increased their permeability to
sucrose at 24 h (4.22 0.95 103 cm/min) reaching a fivefold
increase by 48 h, with a value of 10.60 1.28 103 cm/min.
Notably, presence of astrocytes or pericytes allowed partial
maintenance of the barrier function even after 48 h (Fig. 4B).
Presence of three cells provided an additional advantage with
the lowest increase at 48 h (2.81 0.81 103 cm/min).
Permeability to dextran remained low throughout the
Fig. 3. Astrocytes and pericytes induce barrier properties in RBE4 monolayers. Diagrammatic representation of TEER procedure with RBE4
cells on the topside of the Transwell insert and astrocytes and/or pericytes or HeLa cells on the bottom (A). Astrocytes (AC, solid triangles) and
pericytes (PC, open triangles), but not HeLa cells (circles), induce higher TEER values in RBE4 cells compared to monolayers alone (squares; B).
NotethatTEERincreasesovertime.(MP < 0.05;MMP < 0.01incomparisonbetweenmonoculturesandco-culture.##P < 0.01forthree-cellsco-culture
vs. two-cells co-cultures, n U 8 per group). Sucrose (C) and dextran (D) permeability assays performed on 8 days cultures demonstrate that both
astrocytes and pericytes reduce permeability (Pe) values in RBE4 monolayers. (MMP < 0.01 in comparison between monocultures and co-cultures,
n U 8).
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experiment, suggesting that hypoxia alone is not sufficient to
alter RBE4 permeability to large molecules (Fig. 4C). In
conclusion, during chronic hypoxia both astrocytes and
pericytes partially maintain barrier function of RBE4 cells,
however presence of both cell types confers an additional
advantage against hypoxia-induced barrier breakdown.
Pericytes not astrocytes maintain barrier function
during near-anoxia
The discrepancy between astrocytes and pericytes in
maintaining barrier function was clearly illustrated by severe
(0.1%) O2 deprivation (Fig. 4D). In the short-term RBE4
Fig. 4. Astrocytes and pericytes partially maintain barrier function in RBE4 monolayers during O2 deprivation. (A) Short-term hypoxia
significantly decreased TEER in all groups. In particular the pericyte group (RBE4 & PC, green triangles) responded negatively to hypoxia with low
TEER values compared to monolayers alone (red squares). Maintenance of barrier function during prolonged hypoxia was partially supported by
both astrocyte (RBE4 & AC, blue triangles) and pericyte groups (green triangles) but still remained significantly lower than the initial timepoint.
Presenceofall three-cellsmaintainedbarrier functionthroughouttheexperiment.Astrocytesandpericytesbothsignificantlyreducedthesucrose
permeability increase in RBE4 alone during hypoxia (B), whereas no significant alterations in dextran permeability after hypoxia were observed in
any culture group (C). Short-term near-anoxia (D) significantly decreased resistance of RBE4, AC and HeLa groups but not PC and 3 cells groups.
Astrocytes were least efficient in maintaining barrier function whereas pericytes performed significantly better. Pericytes and three-cell
co-cultures, but not astrocytes, were able to maintain significant lower permeability to sucrose during near-anoxic stress (E). Near-anoxia
significantly increased permeability in RBE4 cells but this was attenuated by co-culture with astrocytes and pericytes. Notably at each time point
astrocytes performed less well than other co-culture groups (F) (MP < 0.05, MMP < 0.01 in comparison with the initial timepoint; ##P < 0.01 in
comparison between co-cultures and monocultures; n U 5-8 for each timepoint).
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monolayer TEER was reduced by O2 deprivation but
co-culturing with astrocytes was again advantageous, despite
resistance decreasing significantly from 250.44 65.99 to
150.11 73.85 V cm2 at 6 h. Pericyte co-cultures did not
prevent a decrease in resistance at 6 h but recovered by 8 h,
providing slightly better TEER values over astrocytes. The
three-cell group also effectively maintained resistance
throughout the experiment similar to results with pericytes.
During prolonged near-anoxia unexpected responses were
observed (Fig. 4D). Astrocyte co-culture permeability
increased after 48 h (65.32 35.89V cm2), although resistance
values remained higher than controls. Surprisingly, pericyte
co-cultures maintained significantly better TEER values
compared to astrocytes both at 24 (252.34 40.72V cm2) and
48 h (232.47 41.52 V cm2) representing a fourfold
improvement over controls at all timepoints. The three-cell
co-culture displayed intermediate resistance values (between
astrocytes and pericytes) with a slight decrease at 24 h
(207.67 39.16 V cm2) followed by a more accentuated
reduction at 48 h (157.45 58.12 V cm2). Additional
experiments performed with sucrose (Fig. 4E) showed that
RBE4 monolayers exhibited increased permeability to sucrose
at 24 and 48 h (6.57 2.03 and 9.32 2.97, respectively).
Notably astrocytes did not show any differences compared to
RBE4 monocultures, suggesting they do not improve
maintenance of the barrier function. Although pericytes
co-cultures also showed increased permeability at 24 and 48 h
(5.11 0.33 and 5.86 0.50, respectively), the values were
significantly lower than monolayers alone or cultured with
astrocytes confirming that pericytes and not astrocytes
maintain barrier function during prolonged near-anoxia. Similar
results were observed with dextran (Fig. 4F). Thus, under
severe prolonged O2 deprivation, astrocytes are less effective
than pericytes at preserving barrier function.
Astrocytes and pericytes promote RBE4 cell survival
during O2 deprivation by caspase-3 inhibition
Since activation of caspase-3 correlated with induced cell death
in RBE4 during O2 deprivation, we investigated the possible
modulation of capsase-3 activity in endothelial monolayers by
astrocytes and pericytes. Notably, hypoxia-mediated activation
of caspase-3 in RBE4 cells was abrogated by co-culture with
astrocytes after 24 h (Fig. 5A). However when co-cultured with
Fig. 5. Caspase-3 inhibition by co-cultures or by pharmacological agent allows better barrier maintenance and recovery during prolonged O2
deprivation stress. Culture of RBE4 cells with astrocytes and pericytes reduced caspase-3 activation under hypoxia (A). Astrocytes performed
better than pericytes at 24 h whereas both cells significantly prevented activation after 48 h. All cells reduced caspase activity after 24 h at 0.1% O2.
Pericytes but not astrocytes maintained low caspase-3 activity during prolonged (48 h) severe oxygen deprivation (B). In RBE4 monocultures
caspase inhibition by ZVAD-fmk significantly improved barrier function during prolonged hypoxic stress (C) and during prolonged near-anoxia
(D). (MP < 0.05; MMP < 0.01 vs. control; ##P < 0.01 vs. vehicle; n U 4).
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pericytes, RBE4 caspase-3 activity levels remained unchanged at
24 h indicating that pericytes unlike astrocytes do not attenuate
early caspase-3 activation (Fig. 5A). Subsequently activation
increased in both groups by 48 h but notably remained
significantly below that of control cells. The three-cell group,
like pericytes, initially displayed higher activity at 24 h
(1.91 0.96) but in contrast to other groups completely
attenuated activation at 48 h (Fig. 5A).
Similar to hypoxic results, astrocyte co-culture completely
prevented caspase-3 activation in near-anoxic endothelial
monolayers for up to 24 h (Fig. 5B). However this anti-apoptotic
effect was completely lost after 48 h when activity significantly
increased (3.24 0.38) compared to even RBE4 alone
(2.62 0.04). In contrast, pericyte co-culture attenuated
caspase-3 activity in RBE4 cells at both 24 (1.21 0.18) and 48 h
(0.76 0.06) again suggesting that pericytes, but not astrocytes,
play an important role in endothelial cell survival during
prolonged severe O2 deprivation. Endothelial cells co-cultured
with both astrocytes and pericytes showed an increase at 24 h
(1.94 0.56) followed by a decrease to basal levels at 48 h
(Fig. 5B). To confirm the importance of caspase-3 inhibition on
the maintenance of barrier function in RBE4 cells, we exposed
monolayers to O2 deprivation in presence of ZVAD-fmk, a pan
caspase inhibitor (Fig. 5C,D). Treatment with the caspase
inhibitor did not induce any significant change in TEER
compared to vehicle-only treated monolayers during
short-term hypoxia (up to 24 h, Fig. 5C). However, after
prolonged hypoxic exposure inhibitor treated monolayers
maintained better resistance values than vehicle and
non-treated samples (76.19 21.07 V cm2 and
16.07 18.25 V cm2, respectively at 48 h). Notably,
reoxygenation reinstated the barrier function in all cases
(Fig. 5C).
Presence of the inhibitor provided an advantage only during
prolonged near-anoxia (Fig. 5D) by maintaining significantly
higher electrical resistance at 48 h timepoint (3.34 7.48
V cm2 in non-treated vs. 46.89 7.85 V cm2 in treated cells).
Importantly, this effect was still evident in the reoxygenation
phase with treated-samples recovering more than 70%. Thus
inhibition of caspase-dependent pathways provides beneficial
during prolonged O2 deprivation as well as during
reoxygenation phase.
Inhibition of VEGF signaling prevents hypoxia-driven
increased permeability
Vascular endothelial growth factor (VEGF) constitutes one of
the most potent soluble factors described to be induced by O2
deprivation and to induce hyperpermeability in endothelial
cells. To appreciate the importance of paracrine VEGF signaling
as an effector of hypoxia-induced barrier breakdown, we
treated RBE4 mono- and co-cultures with 10 mM SU1498, a
selective VEGF receptor-2 (VEGFR-2) inhibitor and measured
changes in TEER (Fig. 6). In RBE4 cell monocultures exposed to
hypoxia in presence of inhibitor (Fig. 6A), we observed a
significant increase of electrical resistance after 6 h that was
maintained throughout hypoxic exposure and the
reoxygenation phase. Remarkably, VEGF inhibition during
near-anoxia also improved barrier function compared to
control and vehicle groups (Fig. 6B). Treatment of astrocyte
co-cultures with SU1498 also induced better maintenance of
the barrier function after 24 h of hypoxia (Fig. 6C). Again, such
positive effects were evident during near-anoxia (Fig. 6D),
suggesting an important role of VEGF paracrine signaling
between astrocytes and RBE4 cells during hypoxia and
near-anoxia. Treatment of pericyte co-cultures with SU1498
also abrogated the breakdown observed during short- and
long-term hypoxia (Fig. 6E). Remarkably the inhibitor did not
provide any notable difference in pericyte co-cultures during
near-anoxia (Fig. 6F), suggesting that inhibition of VEGF/
VEGFR-2 signaling might occur endogenously. Interestingly, in
the three-cell co-cultures inhibitor treatment had no effect on
the barrier function of any of the groups either during hypoxia
or during near-anoxia (Fig. 6G,H), pointing to a possible
abrogation of VEGF/VEGFR-2 signaling in presence of all three
cell types.
Discussion
O2 deprivation constitutes a critical factor that compromises
the integrity of cerebral tissue and is implicated in many
cerebrovascular diseases. Remarkably cellular responses that
trigger BBB breakdown are only poorly understood. This study
directly compares the effects of astrocytes and pericytes on
BBB integrity during both mild and severe O2 deprivation. The
investigation of different O2 levels is very relevant when
considering exposure to physiologically occurring hypoxia (as in
high altitude exposure) or severe prolonged insult as arises
during stroke or other disease states. In particular, this work
underscores an important role for pericytes and advocates that
astrocytes may not always protect the BBB.
Although endothelial cells maintained barrier integrity during
acute severe O2 deprivation, prolonged O2 withdrawal
severely impaired barrier function in a time-dependent manner.
Our data agrees with studies showing that hypoxia decreases
ZO-1 levels and increases phosphorylation and protein
redistribution (Fischer et al., 2002) as well as other junctional-
associated proteins such as occludin (Park et al., 1999), cadherin
(Krizbai et al., 2005), and claudin-5 (Koto et al., 2007) in various
microvascular cells. Similar to work in human cerebral
microvascular endothelial cells (Lee and Lo, 2003) we observed
that hypoxia-induced cell death was mediated at least partially
through caspase-3 activation. Moreover, preservation of
barrier function in RBE4 cells during long-term O2 deprivation
stress by inhibition of caspase-dependent pathways points to
direct involvement of cell death mechanisms in barrier
breakdown. In contrast to others however, reoxygenation for
24 h led to complete abrogation of caspase-3 activation rather
than further induction (Lee and Lo, 2003)—a difference
probably due to variation in experimental set-up and degree
of O2 deprivation. Nevertheless this data together with other
reports (Chow et al., 2001) underlines the importance of
caspase signaling pathways in endothelial cell survival. Thus
severity of O2 deprivation determines not only the rate of loss
of barrier function but also reversibility of disruption and thus
cerebral tissue recovery, likely involving cytoskeletal changes
and deregulation in the balance between cell survival and death.
Both astrocytes (Isobe et al., 1996; Garcia et al., 2004;
Haseloff et al., 2005) and pericytes (Balabanov and Dore-Duffy,
1998; Lindahl, 2007) have been implicated in the maintenance
and stabilization of the BBB. Like astrocytes, pericytes also
secrete factors that upregulate expression of tight junction
proteins in vitro (Hayashi et al., 2004; Hori et al., 2004) and in
vivo (Hellstrom et al., 2001) and their absence leads to
increased brain vascular leakage and edema (Hellstrom et al.,
2001). Our data now suggests pericytes are probably as
important as astrocytes in BBB maintenance during
physiological conditions. This study advocates that O2
deprivation profoundly and differentially affects BBB cells.
Particularly during acute hypoxic exposure, in contrast to
astrocytes, pericytes surprisingly exacerbated barrier
disruption. Nevertheless in the long-term pericytes performed
as well as astrocytes. In contrast to our findings, Hayashi et al.
2004 described pericyte protective effects after 6 h of hypoxia
in endothelial/pericytes co-cultures. However their cell
isolation methods and experimental paradigm differs
significantly from ours. Notably, an O2-free anaerobic jar was
used to obtain hypoxic conditions. Although the O2 tension
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Fig. 6. Inhibition of VEGF signaling improves barrier function during O2 deprivation. Incubation of RBE4 monolayers with SU1498, a VEGFR-2
inhibitor improved barrier function during hypoxic (A) and near-anoxic stress (B). Interestingly astrocytes (AC) co-cultures showed enhanced
TEER values in presence of inhibitor during hypoxia (C) and this beneficial effect was even accentuated during near-anoxia (D). Inhibition of
VEGFR-2 improved pericytes (PC) response compared to non-treated groups at almost all timepoints during hypoxia (E). Surprisingly, presence
of SU1498 did not provide additional advantage during near-anoxia (F). Presence of inhibitor in the three-cells co-culture did not provide further
improvement either during hypoxic (G) or near-anoxic (H) stress, suggesting endogenous inhibition of VEGF/VEGFR-2 paracrine signaling
pathway. (MP < 0.05; MMP < 0.01 for significant differences vs. control, #P < 0.05, ##P < 0.01 between vehicle and SU1498 groups; n U 3).
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measured was approximately 1% after 6 h, such instruments do
not allow proper control of O2 tension over time per se. In our
model, O2 levels were continuously monitored and maintained
constant with all measurements performed within the chamber
without reoxygenation. Furthermore Hayashi et al. did not
obtain significant resistance values for the endothelial culture
alone or compare effects of other cells on monolayer
permeability during shorter or longer exposure timepoints.
Thus, a direct comparison of our results with this study is not
possible.
We demonstrate that during long-term hypoxia the
presence of both cell types has a synergistic effect that enables
re-establishment of barrier function, emphasizing the
importance of investigations such as this in addition to single or
two cell model. This point is further underscored by effective
attenuation of hypoxia-induced caspase-3 activity in endothelial
monolayers co-cultured with both cell types to different
degrees, inferring the involvement of release of pro-survival
factors by both astrocytes and pericytes. The mechanism by
which astrocytes and pericytes block activation of caspase-3
and prolong endothelial cell survival remains unclear but may
occur through inhibition of p38 signaling preventing caspase
activation (Lee and Lo, 2003; Eguchi et al., 2007). Whether
co-culture with astrocytes and/or pericytes alters p38 or other
signaling pathways, is now under investigation.
Surprisingly, pericytes out-performed astrocytes during
severe O2 deprivation and the three-cell culture did not confer
any additional advantage indicating that only pericytes maintain
barrier function at this time. Furthermore, the observation that
astrocytes cause substantial barrier disruption during
extreme O2 deprivation is also intriguing. As neither astrocytes
nor pericytes showed decreased cell survival during
extreme O2 deprivation the discrepancy observed with
astrocytes seems attributable to differences in released factors.
Astrocytes and pericytes secrete many common factors but
VEGF is of particular interest. VEGF is hypoxia-inducible and
due to its potent permeability inducing characteristics is
frequently associated with BBB disruption in vitro (Kaur et al.,
2006; Yeh et al., 2007) and in vivo (Schoch et al., 2002). On the
other hand, VEGF is also a survival factor for endothelial cells
and is constantly secreted by astrocytes under normal
conditions (Ogunshola et al., 2000; Schoch et al., 2002). Since
hypoxia-induced VEGF secretion by astrocytes promoted
survival of RBE4 cells (Chow et al., 2001), it follows that
astrocyte VEGF may also support barrier function by increasing
endothelial cell survival. We have shown that VEGF secretion
by astrocytes is potentiated by the severity of O2 deprivation
(Schmid-Brunclik et al., 2008). Thus excessive VEGF production
and secretion by astrocytes during prolonged near-anoxia may
result in high local concentrations that significantly disrupt
endothelial cell barrier function. This notion is supported by
our findings that VEGFR-2 inhibition reverses barrier
breakdown in endothelial cells. Although direct comparison
of VEGF expression by astrocytes and pericytes during O2
deprivation has not been performed so far, it is interesting
to note that Nomura and colleagues (Nomura et al. 1995)
reported reduced VEGF expression by pericytes. This could
contribute to the inability of pericytes to protect against
caspase-3 induction and increased permeability during early
hypoxic exposure due to reduced levels of protective VEGF.
During chronic insult however lower VEGF concentrations
may be advantageous and cytoprotective. Indeed, co-culture
with pericytes alone was effective during severe O2 deprivation.
VEGF/VEGFR-2 signaling by astrocytes and pericytes plays an
important role in hypoxia-driven BBB breakdown. Receptor
inhibition promoted recovery of barrier function in RBE4
monolayers either during hypoxia or near-anoxia, likely by
inhibition of VEGF autocrine loop. In astrocyte co-cultures
inhibition of VEGFR-2 signaling supported the notion that
elevated VEGF levels constitute a negative factor for the barrier
function during O2 deprivation stress. Surprisingly, pericytes
co-culture had differential responses to SU1498 treatment
during hypoxia and near-anoxia. Although the nature of VEGF
signaling between endothelial cells and pericytes remains
unclear, it was shown that pericytes express VEGFR-1 only
whereas endothelial cells express both VEGFR-1 and VEGFR-2
(Nomura et al., 1995). Thus, the positive effect of VEGFR-2
inhibition observed during hypoxia likely targets the endothelial
cell and raises the hypothesis that O2 deprivation-induced
endothelial VEGF signaling results in secretion of negative
factors towards pericytes. Such a candidate might be
angiopoietin-2 that, like VEGF, is hypoxically up-regulated in
endothelial cells (Pichiule et al., 2004) and astrocytes (Beck
et al., 2000) and can induce pericyte loss and vessel
destabilization (Hammes et al., 2004). Notably, no
enhancement of TEER values in our three-cell co-cultures
under any condition suggests that cell-specific synergy
during O2 deprivation prevents VEGFR-2 activity and
contributes to improved barrier integrity.
Another important factor secreted by pericytes that reduces
permeability and has been demonstrated to be important in
blood retinal barrier (Wang et al., 2007) and BBB (Hori et al.,
2004) stabilization is angiopoietin-1. Indeed many growth
factors secreted by both astrocytes and pericytes are also likely
to modulate permeability of the BBB although current evidence
is very limited. Reports of secretion of TGF-b (Garcia et al.,
2004; Dohgu et al., 2005), erythropoietin (Chavez et al., 2006;
Chi et al., 2008), glial derived neurotrophic factor and
neurotrophin (Lin et al., 2006) by astrocytes and/or pericytes
during cerebral hypoxia/ischemia reveals the diversity of
hypoxically regulated factors that might promote barrier
maintenance and cell survival in endothelial cells.
Surprisingly, presence of DMSO also modulated TEER values
in endothelial cells and astrocyte co-cultures but not in pericyte
and three-cell co-cultures. DMSO is a non-specific free radical
scavenger and a positive effect of DMSO treatment during
reperfusion injury in cerebral ischemia by partially decreasing
lesion size and by partial inhibition of matrix metalloproteinase-
2 (MMP-2) and MMP-9 activities was demonstrated (Nagel
et al., 2007). Indeed, ROS production might constitute an
additional factor that elicits barrier breakdown in endothelial
cells during O2 deprivation, raising questions concerning
possible differences between astrocyte and pericyte ROS
production or antioxidant roles during such conditions.
Nevertheless, our observations clearly demonstrate that
unique responses of astrocytes and pericytes to O2 deprivation
have major consequences for vascular regulation and cell
survival. These observations are of vital importance considering
various conditions and disease states that lead to systemic and/
or local hypoxia in brain regions and other vascular beds. Indeed
modulation of barrier function under physiological and
pathological conditions constitutes a complex mechanism
involving important molecular and cellular interactions
between the vascular endothelium and surrounding cells.
Notably, pericytes seem to have an essential role in maintaining
BBB integrity particularly during severe O2 deprivation. To be
able to identify suitable molecular and cellular therapeutic
targets to combat BBB disruption, future investigations must
focus not only on understanding how the individual
components of the neurovascular compartment function, but
also as a unit in its entirety.
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ABSTRACT 
Formation of the vascular tree constitutes a crucial event in vertebrate development. 
The cerebral vasculature differs from other vascular beds by the presence of the 
blood-brain barrier (BBB). The BBB, consisting of specialized endothelial cells 
surrounded by astrocytes and pericytes, plays a crucial role in cerebral homeostasis. 
Despites BBB breakdown is associated with many neurological diseases, the 
availability of an accurate in vitro BBB model that mimic in vivo situation do not yet 
exist. In this study, we attempted the design of an innovative 3-dimensional in vitro 
BBB model and performed its characterization. In our model, brain endothelial cells 
were able to form tube-like structures by vasculogenesis and angiogenesis. 
Remarkably, astrocytes and pericytes were able to provide cellular interactions with 
such tube-like structures similar to in vivo situation. Such interactions correlated with 
the ability of astrocytes and pericytes to modulate angiogenesis and tube-like structure 
morphology. In addition, presence of astrocytes and/or pericytes was necessary to 
induce appropriate TJ complexes formation and lumen polarization. 
In conclusion, we designed and characterized an innovative 3-dimensional model that 
allows reproduction of many features described in vivo, but also proper interactions 
between the different cells of the neurovascular unit. Such model will hopefully 
become an useful tool to foster our understanding of the BBB as a neurovascular unit 
during physiological and pathological situations. 
 
 
 
 
 
INTRODUCTION 
The blood-brain barrier (BBB) is a neurovascular unit formed by specialized 
endothelial cells (ECs), pericytes and perivascular astrocytes 4,5. ECs present at the 
BBB display a barrier phenotype characterized by presence of tight junctions (TJ) 
between endothelial junctions 6 thus limiting diffusion of water-soluble compounds 
from the blood to the cerebral tissue. In addition, such barrier acts as a selective filter 
towards lipophilic molecules by expression of ATP-binding cassette transporters in 
their luminal and abluminal side 7. Astrocytes and more recently pericytes have been 
shown to induce barrier phenotype in brain ECs using both in vitro 8,9 and in vivo 10-12 
models. Despites the induction of barrier phenotype involves secretion of soluble 
factors by astrocytes and pericytes the nature of most of these factors remains 
unknown. In addition, different studies highlighted the importance of contacts 
between the different cell types in order to obtain optimal induction; in vitro models 
of the BBB (relying on the usage of semi-porous membranes) dramatically restrict 
appropriate cellular interactions between the different cells of the neurovascular unit 
and thus require the usage of innovative cell culturing conditions. 
The aim of this study was to design an innovative in vitro model of the BBB based on 
collagen, a scaffold matrix widely used to study vasculogenesis and angiogenesis in 
vitro 18-20.  This study provides an exhaustive characterization of our newly developed 
innovative in vitro BBB model. Our model was developed using the RBE4 cell line, a 
brain rat brain EC line that maintains a certain barrier phenotype, coupled with 
primary rat brain astrocytes and pericytes. Our 3-dimensional cell culture system 
remarkably allowed brain ECs to form a tube-like structure network sharing many 
similarities with in vivo capillary structures as observed by the presence of a 3-
dimensional network and the presence of a lumen within the tubes. In addition, co-
cultures of these tubes with astrocytes resulted in formation of astrocytic end-feet 
processes overlapping RBE4 tube-like structures. In the other hand, pericytes directly 
overlapped tubes with their cellular bodies.  
 
RESULTS 
Collagen matrix initiates vasculogenesis in RBE4 cells 
We primarily focused on the ability of a 3-dimensional collagen matrix to induce tube 
formation in RBE4 cells (Fig.1b) cultured alone. Remarkably, RBE4 cells were able 
to form cyst structures. These cysts were clearly visible after 1 day of culture, 
singularly contrasting from single cell suspension observed during the first hour of 
culture (Fig.1a). A staining of such structure by fluorescence-based 
immunocytochemistry (Fig.1b, lower panel) revealed that indeed cyst formation 
appeared as a multicellular complex formed by ZO-1 positive cells. Cysts evolved 
over time, as observed by formation of sporuting processes after 2 days and clearly 
visible for up to 4 days. These sprouting processes by which originated the intercystal 
connection (Fig.1b, upper panel) appeared to form a primary endothelial network. PI 
staining (Fig.1b, lower panel) suggests that such intercystal connection may be made 
from single ECs. Interestingly, further cultivation of RBE4 monocultures allowed 
evolution of these intercystal connections to a more elaborated structure, a “tube-like” 
structure that distinguished from intercystal connections by the absence of cysts in 
both extremities but also by the presence of swollen areas within these tubes (see 
arrow). The immunocytochemistry demonstrated that these tube-like structures were 
indeed multinucleated and therefore suggest that such tube may be a multicellular 
complex. It is interesting to note that such structures were clearly absent from 
astrocytes and pericytes monocultures (Supplemental fig.1) demonstrating not only 
the purity of our primary cell cultures but also that the unique phenotype observed 
with ECs may represent the hallmark of vasculogenesis and angiogenesis processes. 
 
The collagen matrix allows BBB cells to form a 3-dimensional cellular network 
Although most of the cellular structures observed in the matrix were exclusively 
visible in RBE4 monocultures, we observed that astrocytes and pericytes were able to 
organize a cellular network between 4 and 6 days of cultures (Supplementary fig.1). 
Therefore we investigated if the different cell types of the BBB were able to form a 
three-dimensional network. In order to clearly observe such cellular network we 
stained each cell types with specific markers (α-SMA, GFAP and PECAM-1 for 
pericytes, astrocytes and RBE4 cells respectively) and subsequently performed a z-
stack image reconstruction (Fig.1c-e). RBE4 cells 3-dimensional network (Fig.1c) 
distinguished from the other monocultures by the presence of reminiscent cysts. It 
also shows that RBE4 cells monocultures appear as a heterogeneous network as we 
can observe cysts (white arrow), intercystal connections (white dot) and tube-like 
structures (white lozenge). In contrast, both astrocytes (Fig.1d) and pericytes (Fig.1e) 
monocultures appeared more homogenous as observed as a 3-dimensional branched 
cellular network. Again, these results highlight the singularity observed with RBE4 
cells monocultures and therefore we will focus mostly on variations of RBE4 cell 
morphogenesis during co-culturing conditions in our further experiments.  
 
RBE4 tube-like structures form a lumen 
In order to assess the similarity between the tube-like structures observed and in vivo 
capillaries, we investigated RBE4 tube-like structures by electron microscopy (Fig.1f 
& 1g). Tube-like structures clearly distinguish from collagen fibers of the 
extracellular matrix (ecm) by its rectilinear shape and by its average size, but also 
presence of endothelial cell organelles (Fig.1f). In some sections that medially cut 
these tube-like structures, we can clearly observe presence of a hollow structure that 
appears as a lumen (lum) delimited by two endothelial cell layers (endo) that clearly 
makes the separation with the extracellular matrix (ecm). It is also interesting to note 
the presence of a nucleus (nuc) facing the lumen, suggesting that these tube-like 
structures share many similarities with in vivo capillaries including the presence of a 
lumen. 
 
 
Collagen down-regulated increase in astrocyte and pericyte cell densities 
We firstly quantified cell density in our different cultures (Fig.2a) to understand if the 
formation of a 3-dimensional network by each cell types was associated with an 
increased cell population. Interestingly, RBE4 cells cell density remained low after 2 
days of cultures (1.74 ± 0.26) and showed significant increase only after 4 and 6 days  
(6.52 ± 1.70 and 13.30 ± 2.20 fold-increase respectively). Whereas pericyte 
monocultures also showed an increase cell density over time, the cellular proliferation 
rate appeared much modest than RBE4 cells, reaching a maximal value of only 4.50 ± 
0.51 after 6 days. Astrocyte monocultures remarkably differed from the two other 
monocultures by a constant cell density over time, showing an average value of 1.36 
± 0.54 after 4 days. These results suggests that formation of a 3-dimensional network 
does not necessarily requires an increase in cell population over time but also suggests 
that the collagen extracellular matrix may acts differently on the proliferation of each 
cell type. Thus it is important to consider such parameter for the establishment of co-
cultures that respect cell ratios obtained in vivo.  
 Quantification of RBE4-associated vasculogenesis and angiogenesis  
Characterization of RBE4-associated cellular features constitutes an important step 
for the standardization of our model. Therefore we quantified the different features 
that chronologically appeared in our model and monitored changes over time. 
We firstly quantified cysts number per droplet over time (Fig.2b) to observe a 
possible correlation between increased cell density and cysts number. Notably cyst 
numbers remained stable over time, with a minimal value at day 1 (137.2 ± 33.01 
cysts/droplet) and a maximal value at day 2 (166.7 ± 34.90), suggesting that increase 
in cell density unlikely correlates with cysts number over time. Moreover, we 
quantified intercystal connections formed over time in RBE4 monocultures and 
normalized against cysts number (Fig.2c). Despites intercystal connections number 
was low even after 2 days of cultures (0.08 ± 0.01 intercystal connection/cyst), their 
number rapidly increased reaching a maximal value of 0.59 ± 0.11 after 6 days. 
Furthermore, such increase in intercystal connections was accompanied by an 
increase in intercystal connections length (Fig.2d). We observed that the median 
length significantly increased from 70.79µm at day 2 to 83.25µm at day 4 and finally 
reached a maximal value of 146.6µm at day 6. In parallel, increased length correlated 
with increased diameter (Fig.2e) as we observed an increase from 9.91µm at day 2 to 
21.47 µm at day 6. These results suggests that intercystal connections formation 
constitute a dynamic process over time but also demonstrate that these formed 
intercystal connections undergo a certain maturation process since we observed a 
continuous increase in both length and diameter. 
 
Tube-like structures formation translates an angiogenic activity 
In order to quantify tube-like structures from intercystal connections, we performed a 
series of immunocytochemistry in 6-days old cultures; obtained values were directly 
compared to intercystal connections (Fig.2f-h). Notably we observed 4-times more 
tubes than intercystal connections in our experimental setup (Fig.2f), showing values 
of 1.93 ± 0.02 versus 0.59 ± 0.11 features/cyst respectively. Despites median length 
(Fig.2g) appeared similar between intercystal connections and tube-like structures 
(146.6 and 154.3µm respectively), the heterogeneity observed in the tube-like 
structure group resulted in significant difference in population distribution between 
the two groups. Minimal values obtained for intercystal connections and tube-like 
structures were 86.8 and 68.6µm respectively, maximal values were 202.5 and 
290.4µm. At the opposite, diameter comparison (Fig.2h) outlined that tube-like 
structure diameter was significantly smaller than intercystal connections, showing 
median values of 16.44 and 21.47µm respectively. In conclusion, tube-like structures 
appeared as a dynamic process involving de novo formation but also a morphological 
evolution of pre-existing intercystal connections and thus reflect the presence of an 
angiogenic activity over the intercystal connection mediated-vasculogenesis. 
 
Astrocyte and pericyte co-cultures do not impair RBE4 vasculogenesis, but 
down-regulate RBE4 cell proliferation. 
As addition of astrocytes and pericytes cannot be performed after tube like structure 
onset, we simultaneously co-cultivated RBE4 cells with astrocytes and/or pericytes 
and monitored possible impairment in RBE4 vasculogenesis/angiogenesis 
(Supplemental Fig.2a). Decrease in initial RBE4 cell density from 500.000 cells/mL 
to 250.000 cells/mL as well as presence of astrocytes and/or pericytes did not 
interfere with RBE4 morphogenesis as we observed cysts, intercystal connections and 
ultimately tube-like structures formation in the different co-cultures. Furthermore, we 
quantified cell density in our different culturing conditions (Fig.3a). Decrease in 
initial RBE4 cell density did not affected cell density increase over time as observed 
in our previous culturing condition (Fig.2a), reaching a maximal value of 6.78 ± 2.18 
fold-increase after 6 days of culture. Interestingly, presence of astrocytes at a ratio of 
5:1 (astrocytes/RBE4) resulted in absence of significant increase over time, showing a 
maximal value of 1.14 ± 0.15 at 6 days. Similar observation were performed in RBE4 
cells co-cultured at a ratio of 1:1 displaying a value of 1.17 ± 0.46 fold-increase after 
6 days of culture. Presence of both astrocytes and pericytes resulted in a value of 1.52 
± 0.85 in 6 days-old co-cultures. These results suggests that astrocytes and pericytes 
may down-regulate RBE4 cells proliferation, thus may result in angiogenesis 
modulation. 
 
Astrocytes and pericytes down-regulate both RBE4 cysts and intercystal 
connections number 
We further investigate whether cell density maintenance over time was associated 
with a decrease in cysts and intercystal connections number. We firstly investigated 
the possible cysts number modulation by astrocytes and pericytes (Fig.3b). Astrocyte  
co-cultures  showed significant decrease after 6 days compared to RBE4 
monocultures (79.19 ± 26.89 cysts/droplet). Outstandingly, pericyte co-cultures 
outlined other cultures by showing significant lower values than RBE4 monocultures 
already after 2 days of cultures, reaching the lowest value of all groups after 6 days 
(31.42 ± 6.85 respectively). However, it is important to denote that presence of both 
astrocytes and pericytes resulted to similar effect than astrocyte co-cultures (79.00 ± 
22.49 cysts/droplet at 6 days). These results suggest that the blunted cell density 
increase observed in our co-cultures correlates with decrease cysts formation, but also 
highlighted that pericytes may have a distinct effect compared to astrocytes on RBE4 
morphogenesis.  
Thus, we further investigated intercystal connections formation in our co-cultures 
(Fig.3c). As expected, intercystal connections number significantly increased from 2 
days (0.087 ± 0.010) to 6 days (0.59 ± 0.11) in RBE4 cells monocultures. Astrocyte 
co-cultures attenuated such increase reaching a value of 0.031±0.008 after 6 days 
whereas pericyte co-cultures showed a value of 0.157±0.161 intercystal 
connections/cyst. Presence of both astrocytes and pericytes resulted in an intermediate 
value of 0.096 ± 0.064. These results suggest to us that astrocytes and pericytes down-
regulate formation of intercystal connections ad thus may modulate RBE4-mediated 
vasculogenesis. However, neither astrocytes nor pericytes significantly induced 
changes in intercystal connections length or diameter (Supplemental Fig.2b & 2c) and 
therefore may suggest that the impact of astrocytes and pericytes on vasculogenesis 
may be limited to certain aspects. 
 
Astrocytes and pericytes oppositely regulates RBE4 angiogenesis 
As our previous results suggested a limited contribution to RBE4 vasculogenesis, we 
investigated whether astrocytes and pericytes were able to modulate tube-like 
structures and subsequently to play a role in angiogenesis. We firstly counted the 
number of tube-like structures present in our different cultures and normalized it to 
the number of cysts (Fig.3d). Interestingly, astrocyte co-cultures did not display 
significant differences compared to RBE4 monocultures (1.80 ± 0.15 and 1.92 ± 0.02 
tubes/cyst) whereas pericyte co-cultures outperformed all other groups by showing a 
value of 13.55 ± 1.05 tubes/cyst demonstrating the important pro-angiogenic effects 
carried on by pericytes. Surprisingly, presence of both astrocytes and pericytes 
abolished the pro-angiogenic effect carried on by pericytes as we measured an 
average value of 0.97 ± 0.43 tubes/cyst. Again, such results comfort our hypothesis 
that astrocytes and pericytes may have differential effects on RBE4 morphogenesis as 
observed in Fig.3b. Despite astrocyte co-culture had limited effect on the number of 
tube-like structure formed, it significantly increased tube length (Fig.3e) compared to 
RBE4 monocultures (median values of 208.7µm and 154.3µm respectively). Presence 
of pericytes did not significantly induced longer tubes, with a median value of 
173.3µm. Surprisingly, presence of both astrocytes and pericytes resulted to the 
longest tubes, showing a median value of 227.0 µm.  
Notably, the increased tube length observed in astrocyte co-cultures was accompanied 
by an increased tube diameter (Fig.3f) compared to RBE4 monocultures (20.53µm 
versus 16.55µm respectively), whereas pericyte co-cultures presented tubes with the 
smallest diameter of all groups (11.88µm). Surprisingly, presence of both astrocytes 
and pericytes resulted not only in slightly smaller tube diameter than RBE4 
monocultures (15.40µm), but also to a diameter significantly different than the other 
co-culture groups.  
In conclusion, our results clearly show that pericytes have differential effects. In our 
model, pericytes played an important pro-angiogenic role whereas astrocytes rather 
played a role in tube maturation. However, we observed that presence of both 
astrocytes and pericytes did not only blunted the pericyte pro-angiogenic effect, but 
potentiated the astrocytic effect, suggesting a synergistic function between these two 
cell types in favor to astrocytes. 
 
The 3-dimensional BBB model reproduces astrocyte-endothelial and pericyte-
endothelial in vivo interactions. 
In this experiment, we assessed that our model allows suitable cellular interactions 
between RBE4 cells, astrocytes and pericytes. Thus, we analyzed cellular interactions 
by immunocytochemistry using cell specific markers (Fig.4a-d). Endothelial-
astrocytes interactions (Fig.4a) were marked by presence of GFAP-positive astrocyte 
end-feet processes investing Tie-2 positive RBE4 tube-like structures, reproducing 
nicely the interactions classically described in the literature. In the other hand, 
endothelial-pericyte interactions (Fig.4b) differed by the absence of branching 
processes, replaced by the recruitment and tube-like structure overlap by pericytes 
cellular bodies. Remarkably, presence of the three cells (Fig. 4c & 4d) maintained 
distinct cellular interactions between astrocytes and RBE4 on one hand, pericytes and 
RBE4 on the other hand. These results show that in our model, both astrocytes and 
pericytes interact with RBE4 cells through processes that naturally occur in vivo.   
 
Co-culture with astrocytes or pericytes is necessary to induce BBB phenotype. 
Maturation of newly formed blood vessels is characterized by formation of cell-cell 
junctions. In order to appreciate the maturity levels of RBE4 tube-like structures we 
examined adherens junction (AJ) and tight junction (TJ) complexes protein 
localization in our different cultures (Fig.4e-4t). Interestingly, tube-like structures 
formed in RBE4 monocultures showed adequate β-catenin (Fig.4e) localization 
suggesting AJ complexes formation. However PECAM-1 staining (Fig.4i) as well as 
claudin-5 (Fig.4m) and ZO-1 (Fig.4q) appeared diffused inside the whole structure, 
suggesting that despites RBE4 cell tube-like structures were able to form cohesive 
cell-cell contacts by AJ, absence of TJ complexes highlight an absence of BBB 
phenotype in these tubes. Presence of astrocytes in the co-cultures resulted in an 
important segregation of all these four cell junction proteins studied (Fig.4e; Fig.4j; 
Fig.4n & Fig.4r) at the cell borders forming appropriate AJ and TJ complexes. 
Interestingly, pericyte co-cultures appeared to have an immunolocalization profile 
between RBE4 monocultures and astrocyte co-cultures. Whereas β-catenin (Fig.4g) 
and PECAM-1 (Fig.4k) appeared more diffuse than astrocyte co-cultures, presence of 
TJ complexes was much visible, both for claudin-5 (Fig.4o) and ZO-1 (Fig.4s) 
suggesting the presence of a barrier phenotype. Presence of both astrocytes and 
pericytes resulted in similar results that observed with pericyte co-cultures, as 
observed with β-catenin (Fig.4h), PECAM-1 (Fig.4l), claudin-5 (Fig.4p) and ZO-1 
(Fig.4t). Our results thus suggest that RBE4 cells by their own cannot induces TJ 
complexes formation and requires the presence of either astrocytes or pericytes. In 
addition, our data suggest that the differences observed between astrocytes and 
pericytes may reflect the importance of the cellular contacts in cell junctions 
formation and localization.  
 
RBE4 lumen polarization requires presence of astrocytes or pericytes 
As our previous experiment suggested the importance of astrocytes and pericytes in 
induction of TJ complexes, we therefore investigated their possible involvement in 
induction of tube polarity by z-stack image reconstruction obtained from 
immunostained tube-like structures (Fig.5).  
We firstly investigated abluminal side polarization using utrophin, a cytoskeleton 
protein localized at the abluminal face in endothelial cells (Fig.5a). RBE4 
monocultures tube section showed a heterogeneous utrophin localization. 
Interestingly, tube sections obtained from astrocyte co-cultures (Fig.5b) displayed a 
more restricted utrophin staining suggesting certain localization. However, pericytes 
co-cultures tube sections (Fig.5c) clearly showed an utrophin positive staining on the 
tube periphery suggesting an appropriate utrophin staining localization compared to 
the lumen. Such localization also appeared in three-cell co-cultures (Fig.5d), overlaid 
by the PECAM-1 staining. These results may suggests that pericytes and in lesser 
extent astrocytes may play crucial roles in the polarization of the abluminal face. 
We further investigated lumen side polarization by investigating P-gp (Fig.5e-h) and 
MRP2 (Fig.5i-l), two important ABC proteins localized in the luminal face. As 
observed with utrophin, RBE4 cells monocultures tubes were not able to localize 
either P-gp (Fig.5e) or MRP2 (Fig.5i) inside the lumen as the staining appears on the 
outer side of the tubes. Interestingly, astrocyte co-cultures showed localization of both 
proteins  (Fig.5f-5j) at the luminal face as suggested the staining facing the lumen. 
Similar observations were visible for pericyte co-cultures (Fig.5g-5k) and three-cell 
co-cultures (Fig.5h-5l). In conclusion, our data suggests that as observed with TJ 
complexes, tube polarization requires the presence of astrocytes or pericytes and thus 
confirm their importance for proper tube maturation. 
 
Validation of the 3-dimensional model: the O2 deprivation insult test 
In order to validate our 3-dimensional in vitro model, we challenged our co-cultures 
to prolonged O2 deprivation insult (Fig.6) and compared the ability of astrocytes and 
pericytes to maintain TJ complexes according to our previous study performed on an 
established 2-dimensional in vitro data 8. We firstly investigated changes in claudin-5 
localization (Fig.6a-l). RBE4 cells monocultures were not able to induce TJ 
complexes under normal conditions, as seen for both claudin-5 (Fig.6a) and ZO-1 
(Fig.6m), whereas presence of astrocytes (Fig.6b; Fig.6n), pericytes (Fig.6c; Fig.6o) 
or both cells (Fig.6d; Fig.6p) resulted in localization of both claudin-5 and ZO-1 at 
the cell borders. Exposure to 48h at 1% O2 induced a certain claudin-5 distribution in 
the middle of the tube (Fig.6e) but also showed presence of gaps inside (white 
arrows), whereas more severe O2 deprivation stress (Fig.6i) resulted in tube 
dislocation. Notably, similar observation were obtained for ZO-1 either at 1% O2 
(Fig.6q) or 0.1% O2 (Fig.6u) suggesting that O2 deprivation stress did not induce 
discrepancy in TJ protein localization and subsequently loss of barrier phenotype. 
Interestingly, astrocyte co-cultures exposed to 1% O2 concentration induced a certain 
loss in claudin-5 (Fig.6f) and ZO-1 (Fig.6r) delocalization from the cell borders to the 
cytoplasm but still partially displayed presence of TJ complexes. However, exposure 
to more severe O2 deprivation stress resulted in complete loss of claudin-5 (Fig.6j) 
and ZO-1 (Fig.6v) localization at the cell borders and therefore let us suggests 
complete abrogation of the barrier phenotype observed under normal conditions 
(Fig.6b & 6n). Pericyte co-cultures presented the most interesting results from all 
groups. Whereas prolonged exposure to 1% O2 resulted in loss of claudin-5 
expression (Fig.6g), more severe conditions (0.1% O2) allowed indeed reinforcement 
of existing TJ complexes as observed with both claudin-5 (Fig.6k) and ZO-1 (Fig.6w) 
and clearly outperformed astrocyte co-cultures and thus agrees with our results found 
in our previous study. Presence of both astrocytes and pericytes resulted in more 
contrasted results. We observed that both cell types were necessary to obtain a 
complete maintenance of TJ complexes during prolonged exposure at 1% O2 as 
observed with claudin-5 staining (Fig.6h) whereas exposure at 0.1% O2 (Fig.6l) 
showed a diffuse claudin-5 staining along the tubes. ZO-1 staining appeared diffuse 
during prolonged exposure at 1% O2 (Fig.6t) whereas it clearly appeared decreased in 
0.1% O2 (Fig.6x). 
In conclusion, our model response to O2 deprivation stress nicely fitted with our study 
performed on an established 2-dimensional in vitro model and thus constitutes an 
argument in favor of its validation and its suitability as a model. 
 
DISCUSSION 
The BBB (a neurovascular unit formed by endothelial cells, astrocytes and pericytes) 
plays a crucial role in the brain homeostasis. Despites BBB breakdown was 
classically associated with cerebral hypoxia/ischemia 8,21,22, recent studies 
demonstrates indeed that loss f barrier function occurs in many neurological diseases 
that including Alzheimer’s disease 13,23,24, multiple sclerosis 14,25,26, 
neuroinflammation 16,27, neuroAIDS 15 or Parkinson’s disease 13,28. It appears 
therefore crucial that maintenance of the barrier function constitute an important 
therapeutical target to fight such diseases. Although our knowledge on the cellular 
and molecular mechanisms underlying BBB physiology and pathophysiology is 
constantly increasing, the capacity to translate our in vitro findings to in vivo situation 
remains sub-optimal.  
A major drawback encountered with current in vitro models concerns the absence of 
appropriate cellular interactions as observed in vivo. In this study, we designed a 
novel in vitro BBB model based on a 3-dimensional matrix containing three important 
cell types of the BBB: endothelial cells, astrocytes and pericytes. Our extracellular 
matrix is based on collagen I, a scaffold protein widely used in 3-dimensional in vitro 
models of vasculogenesis and angiogenesis 18,29-34. In our model, RBE4 cells 
presented many multicellular structures such as cysts, intercystal connections and 
tube-like structures that were comparable to those observed during vascular 
development in vertebrates such as blood islands, primary vascular plexus and 
angiogenic blood vessels 35,36. Although our study do not constitute the first that 
demonstrate the ability of cerebral endothelial cells to form a 3-dimensional vascular 
network in vitro 29,32, we are the first group to provide to provide a quantitative 
approach to such phenomenon, but also to pinpoint the roles played by astrocytes and 
pericytes during cerebral angiogenesis in vitro. Our study showed that presence of 
astrocyte in the co-cultures moderately on vasculogenesis, showing a down-regulation 
of intercystal connections formed compared to RBE4 monocultures and rather played 
important roles on angiogenesis by increasing average tube length and diameter. 
However, pericytes showed the most interesting results. Presence of pericytes 
significantly decreased cysts and intercystal connections on one hand and showed the 
highest tube-like structure numbers on the other hand. These results demonstrate that 
pericytes act definitively as a crucial pro-angiogenic factor towards RBE4 cells and 
agrees with previous studies highlighting the pro-angiogenic effects of pericytes 37,38. 
However we demonstrated that presence of astrocytes and pericytes resulted in 
abolishment of the pro-angiogenic stimulus induced by pericytes. The nature of such 
inhibition is not known yet and we do not yet if such inhibiting mechanisms act on 
pericytes or rather involve a competition between astrocytes and pericytes signaling. 
Pericytes appear to be the first cell type to interact with cerebral microvessels during 
early stages of embryogenesis 11,12, whereas astrocyte-endothelial interactions are 
initiated only in late developmental stages, when maturation of the BBB occurs 39-41. 
We can therefore speculate that pericytes might promote angiogenesis during early 
development to provide the developing central nervous system with optimal O2 and 
nutrient supply. Once neurogenesis start to decline and intitate neuronal 
differentiation, differentiated astrocytes may therefore inhibit the pro-angiogenic 
effect of pericytes and act synergistically to induce BBB maturation. Our group has 
recently demonstrated that astrocytes and pericytes were able to synergistically act on 
endothelial barrier function during physiological and during O2 deprivation stress 
8, 
demonstrating the presence of a cellular cross-talk between these two cell types. We 
can therefore imagine that similar cross-talk might occur in our model, however the 
nature of such signaling remains unclear and requires further investigations. 
It is interesting to note the ability of RBE4 cells to induce the formation of a complete 
vascular network from only single cells, suggesting an important disruption inside the 
endothelial cell phenotype that might result in endothelial de-differentiation and 
subsequently loss of barrier function. Our model showed an absence of TJ strands as 
observed by absence of proper claudin-5 and ZO-1 localization in newly formed tube-
like structures. Our study therefore agrees with other observation denoting that barrier 
function loss in prolonged primary cell cultures 42,43 and support therefore that the 
maintenance of the barrier function in cultured brain endothelial cells requires the 
presence of other components of the neurovascular unit. Our study shows that either 
presence of astrocytes or pericytes is required to induce adequate both TJ complexes 
formation and endothelial cell tube polarization. Such observation demonstrates the 
active functions played by astrocytes and pericytes to RBE4 tube-like structures 
maturation and subsequently establishment of a barrier phenotype and thus agree with  
two-dimensional in vitro models 8,9.  Despites the establishment of a validation 
procedure for our model is limited by its innovative approach, the ability of our co-
cultures to modulate TJ complexes localization under O2 deprivation stress reflect the 
ability of astrocytes and pericytes to modulate barrier function in 2-dimensional in 
vitro models 8 under similar stress conditions. Subsequently, we can consider the 
ability of our model to reproduce similar behavior than established in vitro models as 
an argument to favor its validation as a research tool. Although our model supersedes 
existing in vitro models by many features, it constitutes an excellent complementary 
model rather than a replacement of those well-established models.  
Our model highlighted the important functions played by astrocytes and pericytes 
during the BBB maturation processes and clearly raise questions about the cellular 
and molecular mechanisms underlying such phenomenon. The nature by which 
astrocytes and pericytes induce the barrier function remains unclear, however it has 
been that different factors such as angiopoietin-1 44, basic fibroblast growth factor 45, 
transforming growth factor-β 46,47 and vascular endothelial growth factor 48,49 
constitute some of the important factors secreted by both cells. However, secreted 
factors may represent only a partial mechanism by astrocytes and pericytes exert 
induction of BBB phenotype. Presence of both secreted basement membrane matrices 
and direct cellular contacts may also provide an important contribution in barrier 
induction 50,51.  We are convinced that our model opens therefore the crucial keys to 
attempt the answers of such questions. 
In conclusion, our model demonstrated the ability to develop an innovative in vitro 
BBB model outlining existing models by its integrative approach. We hope that the 
usage of such model will contribute to foster a better understanding of the BBB 
during physiological and pathological states.  
 
MATERIAL AND METHODS 
Cell culture 
Rat brain endothelial cell line (RBE4, 52) from passages 45 to 55 were used for 
experiments and cultured on gelatin-coated dishes (Corning Inc, Corning, NY). RBE4 
cells were maintained in MEM-α/Ham’s Nutrient F-10 Mix (1:1) (GIBCO, 
Invitrogen, Basel, Switzerland) supplemented with 10% fetal bovine serum, 
100µg/mL penicillin, 100U/mL streptomycin and 1 ng/mL basic fibroblast growth 
factor (Roche Diagnostics, Rotkreuz, Switzerland). Primary rat astrocytes were 
isolated from neonatal pups as described previously 29. Astrocytes were cultured on 
gelatin-coated dishes and maintained with DMEM supplemented with 10% FBS and 
50mg/mL gentamycin sulfate. Primary rat brain pericytes were obtained from adult 
rat brains and isolated following the protocol established by Dore-Duffy 53. Isolated 
pericytes were cultured in DMEM supplemented with 20% FBS, 50 mg/mL 
gentamycin sulfate and 2,5mg/mL amphotericin B. After the first passage, pericytes 
were cultivated in DMEM supplemented with 10% FBS and 50mg/mL gentamycin 
sulfate. Pericytes purity was assessed by α-smooth muscle actin (α-SMA) and glial 
fibrillary acidic protein (GFAP). Pericytes cultures showed over 95% of α-SMA 
positive cells whereas GFAP-positive cells were less than 1%. 
 
Collagen matrix  
Rat tail collagen was extracted following a method established by Bell and colleagues 
54. Briefly, rat-tail tendrils were sectioned, minced and solubilized overnight at 4°C in 
15mmol/L acetic acid solution (Sigma-Aldrich, Buchs, Switzerland). Collagen 
solution was purified by ultracentrifugation during 1h, 20.000g at 4°C (RC 5C Plus, 
Sorvall Products, Newton, CT). Supernatant was lyophilized using a vacuum 
desiccator (RC 10.10, Jouan, France) and stored at -20°C upon usage. Collagen I 
solution was prepared at a concentration of 2.5mg/mL (dry weight) dissolved in 
15mmol/L acetic acid solution and stored at 4°C upon usage. 
 
Cell density determination 
Cells grown on Petri dishes were routinely dissociated using 0.25% Trypsin/EDTA 
solution (GIBCO). Collagen matrix was dissociated in collagen digestion buffer 
(1mg/mL collagenase, 0.1mmol/L CaCl2, 1mmol/L MgCl2) incubated for 20 minutes 
at 37°C. Cells were centrifuged for 5 minutes at 1000rpm and resuspended in 100 µL 
of medium. An aliquot of cell suspension was mixed with equal volume of 0.4% 
Trypan Blue (Sigma-Aldrich) prepared in PBS. Cell density was determined using a 
glass hematocytometer (Neubauer, Brand, Wertheim, Germany).  
 
Three-dimensional cell culture 
The detailled technical procedure concerning the establishment of 3-dimensional cell 
culture is schematized in Fig.1a. In brief, collagen solution was mixed with 1/10th 
volume of 10X Earle’s Buffered Saline Solution (Sigma-Aldrich) containing phenol 
red. Acidity was neutralized by addition of 1N NaOH solution (Sigma-Aldrich). Cell 
suspension was added at a density of 5 x 105 cells/mL in monoculture experiments. In 
co-culture experiments, RBE4 cells and pericytes were added at a density of 2.5 x 105 
cells/mL each. Astrocytes and pericytes were added at a density of 1.25 x 106 and 2.5 
x 105 cells/mL respectively, in accordance with the literature 55 56. Cell suspension 
was disposed as droplets onto 60mm Petri dishes (Nunc, Roskilde, Denmark), 
incubated 10 minutes at 37°C to allow gel formation. Collagen droplets were overlaid 
with 5mL of RBE4 medium and incubated at 37°C with 5% CO2. Medium was 
replaced after 3 days of culture. 
 
Morphological analysis 
Droplets were observed using inverted fluorescence microscope (Axiovert 200M, 
Carl Zeiss, Feldbach, Switzerland) set in brightfield mode. Micrographs pictures were 
acquired in 10X magnification field using an 8-bit CCD camera (Axiocam HRm, Carl 
Zeiss) and processed using Axiovision 4.6 software (Carl Zeiss). Features observed 
were determined in four droplets per experiment. Length and diameter features were 
determined using the measure tool included in Axiovision software package. 
 
Immunocytochemistry    
After 5 days of culture, droplets were washed with cold PBS and fixed with 4% 
paraformaldehyde solution. Cells were permeabilized with 0.1% Triton X-100 
solution and blocked with 10% normal goat serum during 4h at room temperature. 
Droplets were incubated overnight at 4°C with primary antibodies raised against 
platelet-endothelial cell adhesion molecule-1 (PECAM-1, mouse, 1:100, Chemicon, 
Millipore, Zug, Switzerland); glial fibrillary acidic protein (GFAP, mouse, 1:100, 
Sigma-Aldrich), α-smooth muscle actin isoform (α-SMA, mouse, 1:100, Sigma-
Aldrich), ZO-1 (rabbit, 1:100. Invitrogen), claudin-5 (rabbit, 1:100, Invitrogen), β-
catenin (mouse, 1:100, Chemicon), Tie2 (rabbit, 1:100, Santa Cruz Biotechnology, 
Heidelberg, Germany), and P-glycoprotein (C219 clone, mouse, 1:100, Calbiochem, 
VWR, Dietikon, Switzerland). Utrophin and MRP2 rabbit polyclonal antibodies were 
a gift from J.M. Frtischy 7. Nuclei counterstaining was obtained by incubation with 
propidium iodide (PI, Calbiochem).Detection was performed using either Alexa-488 
or Alexa-546 conjugated antibodies (Invitrogen). Samples were observed using a 
Leica SP2 confocal microscope (Leica Microsystems, Heerbrugg, Switzerland) and 
acquired with Leica Confocal Software. Obtained micrographs pictures and 
subsequent 3-dimensional and z-stack image reconstructions were performed by 
Imaris 6.0 software (Bitplane, Zurich, Switzerland). In the observation of the three 
cell types, pericytes were labeled with DiD lipophilic dye (Invitrogen) diluted at 
1:200, following the manufacturer instructions for the dye incorporation. Pericytes 
were stained before incorporation inside the collagen matrix.     
 
Transmitted electron microscopy 
5 days old droplets were fixated with 3% glutaraldehyde buffer and postfixed with 2% 
OsO4 buffer and dehydrated with 70-100% ethanol-containing solutions. Dehydrated 
samples were embedded into Epon 813 resin (Epon, Hexion, Rotterdam, The 
Netherlands). Slices were cut at a thickness of 70nm using a diamond knife 
ultramicrotome. Samples were observed using a transmission electron microscope 
(CM-100, Philips Research, Eindhoven, The Netherlands), micrograph pictures were 
obtained using a 12-megapixel digital camera (Gatan GmbH, München, Germany) 
and acquired by Digital Micrograph software (Gatan GmbH). Images were processed 
using ImageJ 1.41 (ImageJ, NIH, Bethesda, MD).      
 O2 deprivation stress experiments 
Experiments were performed in a purpose-built hypoxic glove-box chamber (InVivO2 
400, Ruskinn Technologies, Pencoed, UK) maintained at 37°C with 5% CO2. Cells 
were exposed to either 1% (hypoxia) or 0.1% (near-anoxia) O2 for 48h. Using this 
instrument O2 concentration is constantly monitored internally by an O2 sensor and 
automatically adjusted.  
 
Statistical analysis 
Data are expressed as mean ± SD of minimum three experiments. n-way ANOVA 
were used for comparison inside and between groups, t-tests in the comparison 
between intercystal connections and tube-like structures. 
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FIGURE LEGENDS 
Figure 1: Collagen matrix induces 3-dimensional cell morphogenesis. 
(a) Schematic representation of the 3-dimensional cell culture model. The micrograph 
picture shows the single cell suspension within the matrix (b) RBE4 cells form cysts, 
intercystal connections and tube-like structures. Upper panels: Brightfield micrograph 
pictures. Lower panels: Immunocytochemistry performed against ZO-1. Nuclei 
counterstained with PI. Scale bar = 50µm.  (c-f) 3-dimensional image reconstruction 
obtained from RBE4, astrocytes and pericytes monocultures stained against PECAM-
1, GFAP and α-SMA respectively. Scale bar = 100µm. (f) Tube-like structure sagittal 
electron micrograph picture. ecm = extracellular matrix, endo = endothelial cell. (g) 
Medial electron micrograph picture. ecm = extracellular matrix, endo = endothelial 
cell, lum = lumen, nuc = nucleus.  
 
Figure 2: Quantification of RBE4 cell mediated-vasculogenesis and angiogenesis. 
(a) Cell density increased in RBE4 and pericytes monocultures only. ** denotes P < 
0.01 compared to 0 day timepoint, ## P <0.01 versus RBE4 cells group. (b) Cysts 
number per droplet remained constant in RBE4 cells monocultures. n=5 experiments. 
(c) Number of intercystal connections increased over time. Intercystal connections 
were normalized to cysts number at the defined timepoint. ** = P <0.01, n=5 
experiments. (d-e) Intercystal connection length and diameter box-plots. Note the 
widened distribution for both length and diameter in 6 days-old droplets.  *  P<0.05, 
** P <0.01 versus day 2 timepoint, n=40-60 intercystal connections counted in 5 
experiments. (f) Tube-like structures (TLS) outnumber intercystal connections (ICC). 
TLS were normalized against cysts number counted in 6 days-old droplets and 
compared to ICC counted for the same timepoint. ** P <0.01, n=5 experiments. (g-h)  
TLS and ICC length and diameter comparative box-plots. Data were collected from 6 
days-old cultures. * P <0.05, n=40-60 collected from 5 experiments. 
 
Figure 3: Astrocytes and pericytes modulate RBE4 morphogenesis.  
(a) Astrocyte (AC) and pericyte (PC) co-cultures resulted in cell density maintenance 
over time. Cell ratios were 5:1, 1:1 and 5:1:1 for astrocyte, pericyte and three cells co-
cultures respectively. ** P<0.01 versus day 0 timepoint, ## P<0.01 between mono- 
and co-cultures, n=5/group. (b) PC and long-term AC co-cultures down-regulate cyst 
numbers. ** P<0.01 versus day 0 timepoint, ## P<0.01 between mono- and co-
cultures, n=5 experiments/group. (c) Co-cultures reduced formation of intercystal 
connections. Intercystal connections were normalized against cyst numbers. ** 
P<0.01 versus day 0 timepoint. ## = P<0.01 between mono- and co-cultures, n=5 
experiments/groups. (d) PC strongly up-regulated tube-like structures number 
compared to RBE4 monocultures and astrocyte co-cultures. Values were obtained 
from 6 days-old cultures and normalized against cyst numbers. ** P<0.01 versus 
RBE4 monocultures, n=5 experiments/group. (e) Tube-like structure length box-plot 
** P<0.01 versus RBE4 monocultures, n=25-70. (f) Tube-like structure diamater box-
plot ** P<0.01 versus RBE4 monocultures, ## = P<0.01 between co-cultures. n=25-
70.  
 
Figure 4: Astrocyte and pericytes interactions correlate with barrier maturation 
phenotype. (a) Astrocyte co-cultures show tube investiture by astrocytes end-feet 
processes. Astrocytes stained with GFAP (green), RBE4 tubes stained with Tie2 
(red). (b) Pericytes overlap tube-like structures. Pericytes are stained with DiD (blue), 
RBE4 cells with Tie2 (red). (c-d) Representative three-cells confocal micrograph 
pictures. Astrocytes are stained with GFAP (green), pericytes with DiD (blue) and 
RBE4 tubes with Tie2 (red). (e-h) β-catenin staining micrograph pictures. AC denotes 
astrocytes, PC denotes pericytes. Scale bar = 50µm. (i-l) PECAM-1 staining 
micrograph pictures. Note the clear discrepancy between RBE4 monocultures and 
astrocytes co-cultures. Claudin-5 (m-p) and ZO-1 (q-t) staining micrograph pictures 
demonstrates the inability of RBE4 monocultures to obtain adequate TJ complexes.  
 
Figure 5: Astrocytes and pericytes are necessary to induce tube polarity. z-stack 
image reconstruction obtained from a z-step of 500nm. RBE4 cell monocultures are 
unable to locate utrophin (a) on the abluminal side as well as to locate P-gp and 
MRP2 in luminal side (e & I respectively). Despite astrocytes did not show adequate 
utrophin localization (b), it clearly localize P-gp (f) and MRP2 (j) in the luminal side. 
Presence of pericytes was necessary to induce utrophin localization at the abluminal 
side (c). Pericyte co-cultures also induced proper P-gp (g) and MRP2 (k) localization 
at the luminal side. Presence of both astrocytes and pericytes allowed optimal 
utrophin (d), P-gp (h) and MRP2 (l) localization. Scale bar = 10 µm. 
Figure 6: Co-cultures partially maintain TJ complexes during O2 deprivation insult. 
Claudin-5 staining was performed on cultures exposed 48h at 21% (a-d), 1% (e-h) or 
0.1% (i-l) O2 concentrations. ZO-1 staining was performed on cultures exposed 48h at 
21% (m-p), 1% (q-t) or 0.1% (u-x) O2 concentrations. AC denotes astrocytes, PC 
denotes pericytes. Scale bar = 50µm. 
 
Supplemental figure 1: Astrocytes and pericytes do not reproduce RBE4 
morphogenesis. Representative brightfield micrograph pictures. Scale bar = 100µm. 
 
Supplemental figure 2: Astrocytes & pericytes do not alter RBE4 morphogenesis. 
(a) Representative brightfield micrograph pictures. AC denotes astrocytes, PC denotes 
pericytes. Scale bar = 100µm. (b-c) intercystal connections length & diameter box-
plots obtained from co-cultures. * P<0.05; **<0.01 versus day 2. n=20-60 from 5 
experiments   
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Abstract 1: 
Al Ahmad A, Gassmann M, Ogunshola OO.  
Maintaining blood-brain barrier integrity: pericytes perform better than astrocytes 
during prolonged oxygen deprivation. FENS Abstracts (2008) 4; A051.01. 
 
The blood-brain barrier (BBB), consisting of specialized endothelial cells surrounded 
by astrocytes and pericytes, plays a crucial role in maintaining cerebral homeostasis. 
Many neurological diseases are associated with BBB breakdown and hypoxia 
constitutes one of the critical factors that onsets its disruption. We investigated the 
effect of astrocytes and/or pericytes on endothelial cell permeability and survival 
during different degrees of O2 deprivation. Prolonged exposure to 1% O2 was 
necessary to induce barrier breakdown and exposure to 0.1% O2 dramatically 
accelerated disruption. Of note, reoxygenation allowed cells exposed to 1% O2 to 
reestablish barrier function whereas 0.1% O2 deprivation resulted in significant cell 
death mediated at least in part via caspase 3 activation. Under normoxic conditions, 
co-culture with astrocytes and pericytes substantially induced barrier function. 
Interestingly, although O2 deprivation caused barrier breakdown in all situations, we 
observed differential hypoxic responses with astrocytes and pericytes. At 1% O2 
astrocytes partially maintained tight junctions whereas pericytes accelerated 
disruption of the barrier in the short term, having positive effects only after prolonged 
exposure. Unexpectedly, at 0.1% O2 pericytes displayed a marked protective effect 
whereas astrocytes did not perform as well. Both astrocytes and pericytes appear to 
protect against monolayer disruption at least in part by preventing activation of 
caspase-3. Our data suggests that pericytes, but not astrocytes, play a significant role 
in maintaining barrier function during severe and prolonged oxygen deprivation. 
 
 
 
 
Abstract 2: 
Al Ahmad A, Gassmann M, Ogunshola OO.  
Designing an accurate three-dimensional blood-brain barrier model - fact or fiction? 
FASEB J. 2007 21:749.1 
 
The blood-brain barrier (BBB) is an anatomical barrier formed by specialized brain 
endothelial cells surrounded by astrocytes and pericytes - cells described to induce 
this BBB phenotype in endothelial cells. Specific cellular interactions are crucial for a 
proper BBB induction and their disruption during cerebral vascular diseases leads to 
barrier disruption. Most BBB in vitro models developed so far are limited by the 2-
dimensional nature of the model, use of only 2 of the three cell types that form the 
barrier as well as the absence of normal cellular interactions. In this study, we have 
developed a novel in vitro three-dimensional BBB model. Brain endothelial cells form 
tube-like structures in three-dimensional matrices and astrocytes co-cultured with the 
endothelial cells interact through astrocytic end-feet contact as described in vivo. 
Recently we completed the model with pericytes. This model system will provide 
information on specific cellular interactions and signals that promote induction of 
BBB formation during development and can be readily subjected to different insults 
to understand BBB disruption. 
 
Supported by 3R Research Foundation Switzerland, Project number 93/04 to O.O. 
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